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Parkinson’s disease (PD) is a debilitating neurodegenerative disorder causing many 
physical limitations. Rhythmic auditory stimulation (RAS) influences motor complications not 
alleviated by medicine and has been used to modify straight line walking in this population. 
However, motor complications are exacerbated during more complex movements including 
those involving direction changes. Thus immediate RAS effects on direction switch duration 
(DSD) and other kinematic measures during a multi-directional step task were investigated in PD 
patients. Long term RAS application was also explored by evaluating functional gait and balance 
and kinematic step measures before and after 6 weeks of multi-directional stepping either with 
(Cue, C group) or without (No cue, NC group) RAS use. Evaluations were also administered 1, 4 
and 8 weeks after training termination. Kinematic measures were collected during stepping 
without, then with RAS for the C group and without RAS for the NC group. Step testing/training 
was performed at slow, normal and fast speeds in forward, back and side directions.  
Participants with PD switched step direction during the stepping task faster with RAS use 
before training. Like straight line walking RAS application influenced the more complex task of 
direction switching and counteracted the well-known bradykinesia in PD.  
  After training both groups improved their functional gait and balance measures and 
maintained balance improvements for at least 8 weeks. Only the C group retained gait 
improvements for at least 8 weeks after training termination. Adding RAS resulted in functional 
benefits not observed in training without it. 
Kinematic measures compared before and after step training clarified the underlying 
contributors to functional performances. Both groups reduced the variability of DSD. The C 
group participants maintained this alteration longer. DSD reduction also occurred after training 
x 
 
and was retained for at least 8 weeks for this group. These outcomes further support the 
advantages of adding RAS to training regiments for those with PD. 
The current results indicate that RAS effects are not limited to simple activities like 
straight line walking. Moreover, RAS can be used for improving and maintaining improvements 
longer in activities involving various forms of transition which present most difficulties for those 
with PD.
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CHAPTER 1: INTRODUCTION 
Parkinson’s disease (PD) is a neurodegenerative disorder first introduced by James 
Parkinson in Essay on the Shaking Palsy in 1817 as ―Paralysis agitans‖ [1]. PD is the most 
common neurodegenerative disease after Alzheimer’s disease with an annual incidence of 13.4 
in 10,000 Americans [2]. The main problem in PD is the dopaminergic deficiency of the basal 
ganglia (BG) [3]. Under normal conditions dopamine release allows the basal ganglia to serve as 
an internal trigger, enabling movements to occur in a sequential manner. Disruption of dopamine 
due to PD disrupts the normal functioning of the basal ganglia, thus voluntary movements. 
Consequently, motor deficits remain a primary complaint of patients from this population.  
Despite the arduous efforts of scientists that have increased our knowledge of the disease, 
there is neither a cure for PD nor a definitive treatment for its symptoms. Current rehabilitation 
techniques provide a means for reducing some of the motor complications associated with PD [4] 
that are not relieved with medication or surgical interventions. Use of external stimuli to help 
trigger movement has received special attention, as PD patients show the ability to improve some 
of their symptoms under externally triggered conditions that do not occur with other treatments 
(i.e. movement variability and efficiency).  
External Stimulation 
―Kinesia paradoxical‖ refers to the ability of PD patients to produce normal movements 
under certain conditions. The use of external stimulation is one condition that can enable patients 
to perform a motor task more like their healthy peers. Such ability has been associated with 
gaining direct access to other areas of the motor cortex through bypassing the basal ganglia-
supplementary motor area (BG-SMA) pathway under external stimulation [4-7]. This was 
observed directly in a study on regional cerebral flow measures, where authors reported less 
activity in SMA and putamen cortical areas in PD patients during an internally driven task but 
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similar activity of the cortical areas of PD patients to that of controls during an externally 
(auditory) driven task [7]. 
Visual stimuli [8-10], cutaneous triggers such as vibration [11] and electrical stimulation 
[12] and auditory stimulation [13, 14] are types of external stimulation used successfully in 
assisting PD patients alter movement. Although auditory and visual cues are the most common 
modalities used as external stimuli for treatment of PD symptoms, there is evidence that 
rhythmic auditory stimulation (RAS) may have benefits over visual cues. The termination of 
activation of the auditory specific brain areas upon removal of RAS is unlike the continuous 
activity of visual specific brain areas after removal of visual stimulation. This phenomenon is 
interpreted as direct transfer of auditory information to a stable motor output [15] and/or 
inadequacy of the CNS to direct generation of a motor response in response to visual stimuli 
[16]. Encoding temporal characteristics of rhythmic visual stimulation to the auditory cortex 
accounts for the prolonged brain activity of the visual modality [17]. Increase in excitability of 
spinal motor neurons via the reticulo-spinal pathway in response to an unexpected noise [18] and 
facilitation of the H-reflex in response to a low threshold single auditory sound [19] are evidence 
for sub-cortical processing of auditory stimuli [20, 21] and add to the potential benefits of its use. 
Superiority of RAS to visual stimulation is evident with better performance of normal 
participants in synchronizing and syncopating a movement to the former modality when 
compared to the latter. Because syncopation is considered more complex due to additional 
cognitive demands this finding suggests that RAS is easier to follow regardless of the task 
complexity [15]. Individuals have a higher tendency to match the pattern of their finger tapping 
to auditory distracters during a visual synchronization task when compared to the opposite 
condition [22]. In presence of both RAS and visual stimuli the temporal pattern of the inter 
response interval (IRI) of finger tapping [23] and the benefits of improving gait velocity and 
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stride length [24] are similar to that of auditory alone. Moreover, reaction time is longest for 
vision, followed by that of touch, then by audition [25], allowing for faster initiation of motor 
responses to auditory cues than the other senses.  
The advantages of auditory stimulation use for motor responses are numerous. Auditory 
stimulation offers superior temporal organization of movement and perception, and thus appears 
to be the most appropriate external stimulation modality for motor control. Moreover, RAS 
seems to activate neural areas that remain functional in PD patients, thus may offer benefits in 
rehab for this population that are not offered through other methods. 
Methodological Considerations for Intervention 
The current literature involving use of different therapeutic techniques incorporate 
several characteristics of a good intervention in a guideline suggested for use with PD patients 
after a comprehensive Physical Therapy (PT) literature review. This guideline suggests avoiding 
simultaneous tasks especially at initial stages of therapy for PD patients and advises breaking a 
sequential task into its components at initial stages of the disease for PD patients [4]. This  
guideline results in training regimes that follow several motor learning strategies designed to 
promote better learning and retention of certain skills, including the practice of single simple 
tasks prior to increasing task difficulty. The following text reveals additional factors that should 
be considered when designing training regiments for those with PD. 
Measures of Evaluation 
Tests of balance and mobility and kinematic/kinetic measures of movement performance 
offer insight to movement dysfunction in different populations, including PD. In general PD 
patients who experience falls perform poorly on the functional reach test [26, 27], as well as 
various balance and gait measures such as tandem gait, tandem stance and turning around, the 
dynamic gait index (DGI) and the Tinetti gait and balance tests [28]. PD patients with higher 
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rates of falls also show a significant amount of increase in the number of steps when required to 
turn [29] and during the Timed-Up-and-Go (TUG) test [27]. Functional outcomes are important 
for evaluation of the effectiveness of a program because they offer insight to the potential for 
individual success in more ―natural‖ settings and have been linked fall risk. In contrast 
kinematic/kinetic measures offer insight to specific functional performances that can help 
explain functional outcomes. Slower movement velocity common in PD patients [8], which does 
not allow for quick recovery could be from decreases in movement distance, movement 
frequency or both. Kinematic analyses of performances help determine the movement 
characteristics and the potential causal factors of functional deficits and training results. Testing 
of functional outcomes without movement kinematics/kinetics or vice versa may limit the 
generalization of the findings, hence by testing different measures one can offer greater insight 
needed to better understand the nature of functional performances, including practice outcomes. 
Duration of Practice and Retention  
Duration of training or practice of a skill can often influence performance outcomes. 
Most auditory cued training studies for PD involve single session practices [13, 14, 30, 31]. The 
number of studies identifying long term outcomes for this population after intervention with only 
RAS use is limited. Many of the collected measures were recorded immediately after practice 
termination [32-34].Studies including a retention analysis are few and reveal conflicting results 
from methodological differences [35, 36]. Hence, it is very difficult to determine and/or predict 
the benefits of auditory stimulation as a rehabilitation regimen. Improvements using RAS 
occurring in a short practice period are impressive, however there is still need to determine the 




Direction of Movement 
Direction of movement can influence task difficulty thus movement performance and 
enhancement with practice. The cause of falls can be specific in PD patients and appears linked 
to more complex tasks such as changes in movement direction. Unlike healthy older adults, PD 
patients experience indoor falls more than outdoor falls [28]. PD patients report problems (i.e. 
freezing, akinesia) while changing directions and crossing over obstacles [37-39]. Freezing due 
to a direction change is not a major concern for most older adults without neurological disease. 
The literature on RAS use with PD patients primarily focuses on forward movements such as 
that used for walking forward in a straight line path (straight line walking). Although these 
studies offer good insight to gait function, they exclude movements made in different directions 
used commonly for daily movement such as stepping backwards or to the side after hand 
washing. Studies for improving more complex movements in PD patients are still needed. 
Speed 
Changing performance speed often affects performance outcomes. Daily activities are not 
always performed at the same speeds. Rushing to answer a ringing phone may be performed 
faster than a movement to go check the mail. PD patients perform movements slower than their 
aged matched controls [40] and have difficulty controlling relatively fast and slow movements 
[41]. Incorporating different speeds in training protocol allows the PD patients opportunity to 
prepare for different tasks, while changing the level of movement difficulty.  
Multimodal Training  
Several recent studies have used auditory cues within their therapeutic design for PD 
patients after completion of 3-8 weeks of training. Some report long term retention in functional 
improvements after training with external cues compared to those PD participants using the same 
techniques with no external cues [36, 42]. These studies incorporate various training strategies. 
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For example, in one study auditory cues of a metronome were combined with other forms of 
external stimuli (visual/tactile) [36]. In another study a combination of mobility and stretch 
exercises were utilized with various visual cues and ―sounds‖ [42]. Thus while these studies 
offer some insight regarding the existence of continuation effects after long term practice with 
external stimulation they make it difficult to determine which strategy/strategies led to the 
successful outcomes.  
Additional Considerations 
Motor learning strategies used by scientists are proven effective for normal healthy 
people and PD patients alike. Adjusting the amount of feedback [43, 44] and the order of practice 
(blocked/random) [45] can affect and enhance motor learning results in those with PD. These 
strategies appear to vary according to the task studied, resulting in ambiguities for choosing the 
correct technique. Thus while more research is required, it is important to carefully design the 
training protocol and utilize the most appropriate learning techniques. 
In summary the outcomes of several studies showed that including external stimuli in 
rehabilitation are effective in improving various aspects of movement in PD patients. Although 
studies involving training with RAS showed improved movement, the effectiveness of RAS 
when used as the only external cue for long term intervention and after practice termination are 
rare in this population. It appears that the need for an intervention involving training PD patients 
with RAS is necessary to understand its effects on motor symptoms and functional performance 
in this population. To enhance the chances for success, the training should be for a relatively 
long time period (4-6 weeks), should gradually increase task difficulty, use different movement 
speeds and utilize movements involving different directions and/or obstacle avoidance. 
Successful results in this type of study would offer behavioral evidence that support previous 
 7 
work for use of altered neural pathways underlying movements with RAS. A more detailed 
literature review is included in Appendix A. 
Dissertation Outline 
Chapter 1 provided the background information to motivate the experiments to follow. 
Background information regarding PD and related motor complications offered insight to the 
population studied. Review of the existing literature allowed us to justify the use of RAS and to 
identify techniques useful for helping those with PD to improve their existing motor 
complications. This was especially important for activities that increase risks of falls such as 
those that involve more complex movements such as direction changes. We chose to determine 
whether modifications observed for straight line walking in those with PD with the use of RAS 
would occur for tasks involving the more difficult task of direction transitions during 
performance of a multi-directional step task, while simultaneously improving functional abilities 
linked to fall risk. As a result Chapter 2 was designed to explore the immediate effects of RAS 
on the multi-directional step task by having individuals with PD perform the task without and 
with RAS. The primary goal was to determine the immediate effects of RAS on duration of step 
direction switching abilities or direction switching duration (DSD). Several other kinematic 
measures were collected and calculated for additional insight to short term effects of RAS on 
stepping performance. The results allowed us to determine the immediate effects of RAS on 
multi-directional stepping and to pose assumptions regarding the potential long term application 
of multi-directional step training with the use RAS.  
A training program can be considered effective if participants can generalize what they 
learn to similar activities in different contexts of everyday life. Individuals with PD are no 
exception and should be able to benefit from a training program beyond the borders of a 
laboratory or clinic. In Chapter 3 results of the effects of 6 weeks of multi-directional step 
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training with and without the use of RAS on functional gait and balance activities were 
determined. We explored the effects of training on various functional activities immediately after 
and up to 8 weeks after training termination. These results provided us with key information 
regarding the abilities of those with PD to generalize and maintain step training effects on gait 
and balance measures depending on whether they practiced stepping with or without RAS.  
In Chapter 4 we compared the kinematic results from performance of the multi-
directional step task with and without RAS use before and after training to better understand the 
training alterations to functional performances identified in chapter 3. The primary goal was to 
determine whether DSD and other kinematics, calculated during performance of the multi-
directional step task without RAS use, were influenced by training with and without the use of 
RAS differently. The results of this chapter allowed us to better understand the underlying 
factors of the observed functional improvements and to pose speculations regarding the involved 
central mechanisms.  
Figure 1.1 provides an outline of how chapters 2, 3 and 4 were developed as 
subcomponents of one large study. All participants completed functional tests of gait and balance 
which were always collected without RAS. Step training and testing differed slightly for the two 
defined groups so that those who trained with RAS (Cue, C group) were tested without and with 
cues in the No RAS and RAS conditions, respectively, while those who trained without RAS (No 
Cue, NC group) were only tested in the No RAS condition. In chapter 2 analyses concentrated on 
pre-test measures and immediate effects of RAS use. In chapter 3 analyses from training effects 
on functional measures were presented. Analyses from training effects on kinematic measure 
were offered in chapter 4 to give insight to functional alterations. 
The outcomes of chapters 2, 3 and 4, add to previous literature and provide insight 
regarding the effects of RAS on activities that have not been explored previously. Chapter 5 
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brings this manuscript to a close by reviewing the key findings, discussing how certain key 
findings of each chapter relate, indicating limitations of the current work and offering future 













Figure 1.1 The general outline of the overall dissertation study. The outline indicates screening, 
testing and training visits and associated training and testing for each group. Results were 
separated and presented in three chapters (2, 3 and 4) as shown. 
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CHAPTER 2: DURATION TO SWITCH STEP DIRECTION DURING A MULTI-
DIRECTIONAL STEP TASK IN PARKINSON’S PATIENTS IMPROVES WITH 
RHYTHMIC AUDITORY STIMULATION 
Introduction 
Parkinson’s disease (PD) is a progressive neurodegenerative disorder associated with 
many motor complications. Although deficits in performing voluntary movements are evident 
in individuals with PD, research suggests that the ability to generate normal movement is not 
lost [1]. The main problem in this population involves the inability of the basal ganglia (BG) to 
―switch‖ an existing motor pattern with a more suitable response according to the environment 
or task demands [2, 3]. The ―switching‖ problem is evident during unilateral [4] or bilateral [5] 
multi-limb movements, dual task performance [6, 7], multi-task performance [8] and when 
required to change movement direction [9, 10].  
 Bradykinesia accompanies the difficulties in changing movement direction in PD. 
Individuals with PD experience longer transition in muscle activation during a rise-to-toe task  
when gastrocnemius activity replaces that of the tibialis anterior [11]. They also experience a 
longer gap when switching from hip flexion to hip extension during forward and back direction 
stepping [9] and the sit-to-stand task [10]. Delays in switching movement direction accounts for 
overall slowness [10] and the augmentation of temporal (longer step durations) and spatial 
(smaller step lengths) step deficits in turning compared to straight line walking [12].  
In PD the deficient BG are incapable of triggering inhibition and releasing relevant 
motor responses [13, 14]. Replacement of this failing internal trigger is suggested in order to 
counteract the associated movement deficiencies [15]. Candidates for trigger replacement 
include visual [16, 17], auditory [16, 18] and tactile [19, 20] external cues. More extensive 
application of rhythmic auditory stimulation (RAS) compared to other external cues for 
sequential movements likely occurs because of robust connections between temporal aspects of 
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RAS and movement generation [21, 22]. Moreover, RAS can result in temporal gait alterations 
for people with PD that do not occur with visual [23] or tactile [24] stimuli.    
 Gait difficulties are one of the most noticeable motor deficits in individuals with PD [25], 
involving spatial [26, 27] and temporal [28-30] aspects of movement. Interestingly, different 
frequencies of RAS can influence temporal and spatial measures of walking. Observed changes 
in velocity [18, 22, 31-33], step amplitude [22], step duration variability [22], step length [22, 
23, 31-33] and cadence  [18, 31, 33] contribute to our understanding of RAS applications for 
straight line walking. However turning difficulties commonly contribute to gait complications 
in this population [34], causing higher incidence of falls [35-37] and regular freezing episodes 
[38, 39]. Research on the effects of RAS use involving direction transitions are still needed. 
Beneficial effects of RAS use for gait turns performed by individuals with PD exist [38, 40]. In 
the present work we continue the study of RAS application for its immediate use in step 
direction transitions performed by those with PD as a precursor to training applications.  
 The primary goal of the current study was to investigate the effects of RAS on step 
kinematics obtained when PD patients performed a multi-directional step task. The time 
required to switch step direction (direction switch duration, DSD) served as the primary 
measure, due to slowing difficulties in shifting direction in this population. We hypothesized 
that DSD would decrease with application of RAS compared to without it. As an added value 
we explored the relationships between DSD, disease severity and functional performance 
measures in this population. Because of the progressive nature of the disease [41] and 
associated worsening of motor symptoms [42], we expected longer and/or more variability in 




 Twenty-seven people with idiopathic PD volunteered for the study. Six people were 
excluded, thus 21 individuals served as participates in the experiment. 
 Participants consented to partake in the study approved by the university’s Internal 
Review Board. The Hoehn and Yahr (H&Y) scale [43] and Unified Parkinson’s Disease Rating 
Scale (UPDRS) [44] were used for determining severity of the disease and PD motor symptoms, 
respectively. The participating volunteers were diagnosed with idiopathic PD with disease 
severity of 2 to 4 according to H&Y. Inclusion criteria were also contingent on stable drug use, 
the ability to stand and walk with or without an assistive device, the ability to hear and 
differentiate auditory tones (described below) and a Mini Mental State Examination (MMSE) 
score > 24 [45]. Participants were also excluded if they had other disorders that could affect their 
performance, if they experienced unexpected off periods (the time when medication effects wear 
off and many off medication symptoms return) indicated by items 37 and 39 of UPDRS (scores 
= 1 and > 2, respectively), and if they reported a change in medication.  
Study Design 
 During an initial screening visit PD participants were evaluated and informed about the 
study. Preliminary data from 5 volunteers provided insight to the effectiveness of the initial 
experimental design, thus were placed in a pilot group (group P). Design changes led to limited 
data from this group (see characteristic list from all participants in Table 2.1). These 
characteristics and various step kinematics during performance of the multi-directional step task 
were collected on the remaining 16 volunteers. Eight of these participants performed stepping 
with no external cues (No cue group or NC), while the remaining 8 performed the task with and 
without external cues (Cue group or C). The grouping for NC and C participants resulted from 
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commitments to a step training program with and without RAS use. Overall, we analyzed initial 
functional measures from 21/21 qualified participants, kinematic measures for stepping with No 
RAS from 16/21 participants and kinematic measures with and without use of RAS from 8/21 
participants.  
Comfortable/normal walking and/or stepping cadences were determined for each 
participant on the screening visit. Participants were asked to walk approximately 6 m at a 
comfortable walking speed 5 times. Cadence for 4 m was averaged over the 5 trials and used to 
determine each participant’s normal walking cadence. Calculating cadence for the shorter 
distance allowed avoidance of large changes expected at the beginning and end of the walkway. 
Because participants in group P reported difficulties in using the walking cadence as their step 
cadence, C and NC participants were asked to perform forward stepping (see below) for 10 s 5 
times to determine an average comfortable stepping cadence. This cadence was used for RAS 
frequency determination for individuals in group C. Average step cadence for this group is 
presented in Table 2.2. 
Multi-directional Step Task 
 Sixteen participants performed the stepping task approximately 1 hour after medication 
intake. Participants from group C performed the task with and without RAS, while group NC 
only performed the latter, which is described next.   
During the No RAS condition, participants started with legs in anatomical position at a 
self-selected distance apart. Instructions and/or a demonstration of the stepping protocol 
preceded testing and were repeated after every break. Participants were instructed to step away 
and back in three directions (forward—F, side—S and back—B) at a predetermined speed: 
―normal‖ or ―relatively faster‖ or ―relatively slower‖ than normal. Stepping started after the 
verbal trigger of ―Ready? Start.‖ Stepping in one direction was performed for approximately   
 17 
Table 2.1 Characteristics and test measures from 21 participants  
 
Subject details Mean ± 1 SEM 
Age (years)  72.0 ± 1.26 
Gender F = 8; M = 13 
Height (cm) 170.1 ± 2.4 
Weight (kg) 76.9 ± 3.8 
Disease duration (years) 8.9 ± 1.8 
Modified H&Y = number of  
participants for each stage 
2 = 3 
2.5 = 13 
3 = 3 
4 = 2 
Normal walking cadence (steps/min) 110.8 ± 4.1 
MMSE 28.1 ± 0.4 
DGI 16.3 ± 0.6 
UPDRS-Motor 27.6 ± 2.3 
UPDRS-ADL 14.3 ± 0.9 
UPDRS-Composite 7.6 ± 0.7 
Tinetti-total 17.5 ± 1.1 
Tinetti-gait 7.0 ± 0.5 
Tinetti-blance 10.6 ± 0.7 
TUG (s)                                                                                14.7 ± 1.3 
FOGQ 11.4 ± 1.4 
 
Mean ± 1 standard error of the mean for various characteristics and functional measures of the 21 
participants. H&Y—Hoehn and Yahr scale; F—female; M—male; Mini Mental State Examination—
MMSE; Dynamic Gait Index—DGI; Unified Parkinson’s Disease Rating Scale—UPDRS; 




Table 2.2 Characteristics and test measures from C group participants 
 
Subject details Mean ± 1 SEM 
Age (years)  73.3 ± 2.22 
Gender F= 3, M = 5 
Height (cm) 168.8 ± 3.3 
Weight (kg) 79.5 ± 0.18 
Disease duration (years) 8.9 ± 1.8 
Modified H &Y = number of  
participants for each stage 
2 = 1 
2.5 = 5 
3 = 1 
4 = 1 
Normal walking cadence (steps/min) 110.5 ± 4.8 
Normal stepping cadence (steps/min) 56.8 ± 6.0 
MMSE 28.3 ± 0.50 
DGI 16.3 ± 1.0 
UPDRS-Motor 27.1 ± 3.6 
UPDRS-ADL 13.9 ± 1.31 
Composite-Score 8.1 ± 1.0 
Tinetti-Total 17.0 ± 1.8 
Tinetti-gait 6.4 ± 0.7 
Tinetti-balance 10.6 ± 1.2 
TUG (s)                                                                              15.0  ± 2.0 
FOGQ 12.5 ± 1.9 
 
Mean ± 1 standard error of the mean for various characteristics and functional measures of the 
Cue group participants (N=8). Normal walking cadence represents the average step frequency of 
a 4 meter walk. Normal stepping cadence was calculated from 10 seconds of the forward step 
task. H&Y—Hoehn and Yahr scale; F—female; M—male; Mini Mental State Examination—
MMSE; Dynamic Gait Index—DGI; Unified Parkinson’s Disease Rating Scale—UPDRS; 
Activities of Daily Living—ADL; Timed-Up-and-Go—TUG; Freezing of Gait Questionnaire—
FOGQ.   
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11.25 s before switching to the next direction, resulting in the total trial duration of 33.75 s to 
complete steps in each direction. Note the relatively short time period (~ 30 s) to avoid fatigue 
[46]. For each step participants were told that the foot should be lifted completely from the 
ground then come to complete contact with the underlying surface. Instructions to keep speed 
constant within each trial and within a speed range were also given. In order to avoid mental 
overload that could occur with step counting participants were given a ―Last step‖ cue 
approximately 1 second prior to a direction switch and a ―stop‖ cue at the end of the trial.  
 Participants in the group C were also asked to perform the multi-directional step task with 
RAS. Auditory tones, one for each direction, were presented at three stepping speeds: normal 
step cadence and 10% faster and slower than normal step cadence, +/-10%, respectively. 
Participants were instructed to step in time with the auditory cues. A verbal preparatory 
command of ―Ready? Here it comes.‖ was provided prior to the first cue used to signal stepping 
onset. A tone change signaled a direction change after the 11.25 s and 22.5 s of the preceding 
directions and participants stopped when the beats stopped.  
 Three different auditory cues: cluck, ding and soft cork, were recorded at a 22.5 kHz. The 
cluck, ding and soft cork sounds had frequencies of 1003.3 Hz, 784.93 Hz and 529.38 Hz, 
durations of 88 ms, 915 ms and 127 ms and corresponded to the forward, side and back step 
directions, respectively. Cue presentations for RAS were generated by a specially designed 
LabView program and presented through two speakers at approximately 75 dB, well above the 
average hearing loss range (25-40 dB) suggested for older population [47]. Prior to testing P and 
C participants were presented with cues in a random order and were able to raise their hands and 
describe them when heard.  
 Several factors were taken into consideration to design the trials for the multi-directional 
stepping. The original goal was to test participants on their abilities to switch directions to and 
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from all possible directions and speeds. Six direction combinations (FSB, FBS, 
BSF, BFS, SFB and SB) at each speed were performed with and without 
RAS to total 36 trials during pilot tests. Despite taking sufficient breaks P group participants 
were exhausted after functional evaluations and equipment prep time. To offset fatigue effects 
during a single session we limited direction combinations to FSB, SFB, and BSF 
to yield 18 trials (9 with RAS, 9 without RAS) for the C group and 9 trials for the NC group (No 
RAS only). These direction combinations allowed participants to initiate stepping to each of the 
three directions and included step changes to each direction. Trials were randomized and 
repeated if participants did not adhere to primary instructions. Two participants from group C 
and one participant from group NC repeated 1 to 3 trials for not adhering to instructions in the 
No RAS condition. Two participants repeated 3 and 4 trials for not adhering to instructions in the 
RAS condition.  
Evaluation  
Participants were evaluated for experimental inclusion and functional measures on 
screening and test visits. Comfortable walking/step cadence determined on the screening visit 
was used for the stepping task performed on the test day. Visits were at the same time of the day 
and in the same location. Medication intake was confirmed prior to each session. Collecting 
functional measures during both visits allowed us to determine the stability of these 
measurements in participants. RAS frequencies used for step cueing on the test day were 
determined from comfortable/normal walking cadence (P group) or step cadence (C group) 
determined at the screening visit. Functional tests were conducted before performance of the 
multi-directional step task. Order of functional measurements was randomized. The multi-
directional stepping with RAS always followed the No RAS condition (for P and C groups) to 
avoid carry over effects from the auditory stimulation (e.g. [48, 49]). As mentioned previously, 
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speed and direction combinations were randomized within each condition. Reducing direction 
combinations along with scheduled and optional breaks for C and NC participants allowed these 
participants to complete setup and testing within 1.5 hours and without the fatigue concerns 
observed in the P group. 
PD symptom severity scores and tests of physical and mental function were evaluated in 
all participants. The H&Y and MMSE scores, described previously, offered insight to disease 
severity and mental function, respectively. The Dynamic Gait Index (DGI) determined the 
likelihood of falling in older adults by testing eight facets of simple and complex gait. The 
Timed-Up-and-Go (TUG) offered another measure of fall risk [50]. The Motor and Activities of 
Daily Living (ADL) sections of the UPDRS determined the level of overall motor and ADL 
functional disability in participants. Similar to previous work [51], the UPDRS-composite score 
involving UPDRS gait and balance items (13-15, and 29-30), was also included. The Tinetti gait 
and balance test was also used as a measure of fall risk. Lastly, the Freezing of Gait 
Questionnaire (FOGQ) determined perceived gait in daily living skills and the quality and 
frequency of freezing of gait [52]. See Appendix B for the functional tests’ instructions and score 
sheets. 
 Step kinematics were also determined. Three-dimensional motions of passive reflective 
markers placed on the lateral malleoli of the ankles were monitored during the multi-directional 
step task using a four camera digital video system (Qualisys Mediacla AB). The first auditory 
cue in a trial triggered signal capture at 60 Hz. For the No RAS condition this program was 
muted during collection. The visual display corresponded to temporal occurrences in a trial and 
allowed the examiner to signal the participant for step initiation, direction switching and 
termination in the No RAS condition.  
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Position data of ankle markers were filtered using a zero-phase lag 10 point averaging 
process. Tangential velocity profiles were calculated using five-point differentiation of the 
filtered position data. Position and velocity profiles were plotted across time, visually inspected 
and marked to determine kinematic measures. Movement end (END) corresponded to the frame 
just after the movement ended and was determined as the last discernable change in the given 
movement direction from position profiles. Onset of movement (ON) was determined as the 
frame prior to the first discernable movement determined in a given direction.  
Several movement kinematics were determined to offer insight to the temporal and 
spatial characteristics of stepping in those with PD. We used the average duration to switch step 
direction, direction switch duration (DSD), as the primary measure because it offered insight into 
temporal transitions in movement direction which are disrupted in PD [9, 10]. DSD was defined 
as the interval in seconds between the time one foot returned to the platform and stopped moving 
in one direction and the time the opposite foot moved to leave the platform in another direction. 
For example, the absolute difference between the frame for END of right ankle back and the 
frame for ON of left ankle side was divided by the 60 Hz sampling frequency. Illustration of 
vertical bars used to identify frames for END DSD and ON DSD of one trial for one participant 
are shown in Fig. 2.1A. Average DSD values were calculated for each direction to which the 
switch was made within a given speed for each participant. Peak tangential velocity, known to 
decrease in individuals with PD when performing voluntary movements [53], offered insight to 
the spatiotemporal kinematics of stepping. This was determined by identifying the maximal step 
velocity (VEL) between ON and END of each step from the tangential velocity profiles of the 
ankle markers (see ON MOV and END MOV, Fig 2.1B). Step length (SL), step height (SH) and 
step number (SN) were also calculated due to reductions in step length [32], increased shuffling 
[54] and changes in cadence [55] commonly observed in this population. SL was calculated as 
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the displacement of the ankle marker in the lateral (y-) direction for side steps or 
anterior/posterior (x-) direction for forward or back steps (see SL, Fig. 2.1B). In a back step for 
example, SL was the difference between the x-values at ON and END of a given step. SH was 
determined as the z-value difference between the step END and the initial trial z-value during 
stance and prior to step initiation (see SH, Fig. 2.1B). Velocity profiles were also used to 
determine SN in whole or half steps for each direction of a trial during the 11.25 s. A half trial 
was counted if more than half, but less than the whole velocity profile was included in the time 
frame. Peak of the velocity profile was used as the half way mark. One can count 7.5 steps in the 
back direction using velocity profiles in Fig. 2.1B (the interval between frame 0 and the line 
marking 11.25 identify the duration s for this direction). For each participant average SL, VEL, 
SH and SN values were determined for each direction within a given speed for each leg (R, L). 
Standard deviations were used for variability of these measures, excluding SN, and are presented 
with a ―var‖ subscript in the text.  
Statistical Analyses  
Pair wise t tests were used to determine whether values of patient characteristics and 
functional measures did not differ for screening and test visits. In order to evaluate participants’ 
abilities to follow the presented RAS beats t tests were performed to determine if the number of 
steps taken within each speed and direction were similar to the number of RAS beats presented. 
A randomized blocked on subject design with a 2 x 3 x 3 treatment analysis and Kenward Rogers 
adjusted degrees of freedom was used to determine if differences in each kinematic measure 
existed for group C when performing with and without RAS. Within subject factors included: 
Condition (RAS, No RAS), Speed (fast, normal, slow) and Direction (forward, side, back). 
Subject was the only random factor. Tukey’s post-hoc tests were used when significant main 
effects or interactions were identified. A Pearson Correlation Matrix was performed to assess the 
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 Figure 2.1 Example of position and velocity marking. Examples of position (A and B) and 
velocity (B) profiles used for identifying different kinematic variables are presented. Data are 
from two different trials for plots in A and B. Example markings used for direction switch 
duration (DSD) are plotted in A and those for peak step velocity (VEL), step length (SL), step 
height (SH), step number (SN) and reaction time (RT) are plotted in B. Position and velocity 
profiles are separated in B for better clarity. Plots in A show the end of the movement of the right 
ankle marker in the back direction (x) is indicated by the END DSD solid line and the onset of 
the movement of the left ankle marker in the side direction (y) is indicated by the ON DSD solid 
line. Plots in B show corresponding lines determined for a single step and indicate ON MOV and 
END MOV of the first back step (x) of the right ankle marker. The vertical dashed line 
represents 11.25 s associated with the timing for a direction change.  
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relationship between kinematic measures (N = 16; C and NC), functional measures (N = 21) and 
disease severity (N = 21). Data were analyzed using SAS (V.9.1) with significance level set at  
= 0.05.  
Results 
Several measurements from the 21 participants and 8 participants in group C are included 
in Tables 2.1 and 2.2, respectively, to offer insights to the populations used. The majority of 
participants were males and at a moderate stage of the disease (H&Y = 2.5) with 3 participants at 
stages 2 and 3, and 2 participants at stage 4 (Table 2.1). Fall risk of participants was high as 
indicated by scores on the DGI (≤ 22 [56]), TUG (> 8.50 s [50]) and Tinetti gait and balance test 
(total < 19 [57]). Average normal step cadence for the 16 participants used in kinematic analyses 
(56.9 ± 4.8 steps/min) was much lower than that for normal walking cadence for all participants 
listed in Table 2.1. Step cadence included each foot placement during the forward step task (i.e. 
stepping forward and back) with alternating legs, thus required opposing direction adjustments 
that account for the slower cadence. According to the t tests walking cadence was similar (p > 
0.05) across the 3 groups (C = 110.5 ± 4.8 steps/min NC = 111.3 ± 5.3 steps/min P =110.6 ± 2.4 
steps/min) and step cadence was similar for groups C (56.8 ± 6.0 steps/min) and NC (57.0 ± 7.1 
steps/min). 
Correlations 
Significant correlations among disease severity, functional measures and certain 
kinematic measures during multi-directional stepping with No RAS were identified. Correlations 
between H&Y scores and functional measures from all participants are presented in Table 2.3 
and show several significant associations. Higher H&Y scores significantly correlated with lower 
DGI and Tinetti scores and higher TUG scores indicating greater fall risk for those with greater 
disease severity. Higher H&Y scores also correlated with higher UPDRS-Motor, UPDRS-ADL, 
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and UPDRS-Composite scores indicating greater functional motor impairment with greater 
disease severity. Moreover, higher scores on the FOGQ correlated with higher H&Y scores 
indicating greater perceived gait deficits with greater disease severity. A significant positive 
correlation between DSD and H&Y scores was also determined (Table 2.4) so that higher DSD 
values were associated with greater disease severity. Thus, it was not surprising to find 
significant correlations of functional measures with DSD in the same direction as those with 
disease severity (compare signs in Table 2.5 for DSD and Table 2.3 for H&Y), regardless of the 
lower number of participants used for kinematic comparisons (N = 16 compared to N = 21). 
Moreover, significant correlations of DSDvar with the UPDRS-Motor and FOGQ suggested that 
the more variable the DSD, the greater overall motor impairment and the greater perceived gait 
dysfunction, respectively. Slowness during step direction switching, and possibly greater 
variability in these durations, are associated with greater actual or perceived functional 
impairments in those with PD.  
RAS vs No RAS 
 Kinematic measures were determined with and without RAS for the 8 participants in the 
C group. Analyses demonstrated no significant difference between the numbers of steps taken 
with RAS for each speed (S = 6.0 ± 1.1 steps, N = 9.5 ± 1.1 steps, F = 12.3 ± 1.1 steps) and the 
number of RAS beats for compatible speeds (S= 8.6 beats, N= 10.6 beats, F= 12.6 beats). See 
Appendix C for average number of steps and RAS beats for each subject. These results provide 
evidence that participants were able to step to the different auditory cue frequencies. Similar to 
previous work [20], we identified no significant differences between the right and the left sides 
for all collected kinematics using pair wise t test comparisons. Therefore data from the two sides 
were combined and associated analyses performed. Results presented next are from the 
combined data. 
 27 















H&Y -0.63 0.79 -0.73 -0.58 0.72 0.65 0.54 0.65 
 
The r-values from the Pearson correlation between disease severity (Hoehn and Yahr scale— 
H&Y) and functional measures of the 21 participants. Bold numbers represents significant r-
values. Dynamic Gait Index—DGI; Timed-Up-and-Go—TUG; Unified Parkinson’s Disease 
Rating Scale—UPDRS; Activities of Daily Living = ADL; Freezing of Gait Questionnaire—
FOGQ. 
 
Table 2.4 Correlation analysis of disease severity and kinematic measures 
 
 DSD DSDvar VEL VELvar SL SLvar SH SHvar SN 
H&Y 0.60 0.00 -0.22 0.02 0.06 0.02 -0.35 0.39 -0.28 
 
The r-values from the Pearson correlation between disease severity (Hoehn and Yahr scale, 
H&Y) and various kinematic measures obtained from the 16 participants from C and No cue NC 
groups performing the multi-directional step task in the No RAS condition. Bold numbers 
represent significant r-values. Direction switch duration—DSD; velocity—VEL; step length—
SL; step height—SH; step number—SN. Variability of presented measures is shown with a ―var‖ 
subscript. 
 
Significant main effects of Direction and Speed were identified for various kinematic 
variables, however a Condition x Speed interaction was also revealed. Results of the Condition x 
Speed interactions for DSD (F2, 26 = 6.10, p = 0.01), VEL (F2,25.8 = 9.59, p = 0.04) and SN (F2,20.9 
= 23.66, p < 0.01) are shown in Fig. 2.2A, B and C, respectively. Plots reveal the main effects of 
speed (square brackets with asterisks) with or without RAS for DSD (F2,23.91 = 5.81, p = 0.045), 
VEL (F2,26.21 = 8.32, p = 0.04) and SN (F2,24 = 3.62, p = 0.04), showing that for the faster cadence 
VEL (0.51 ± 0.03 m/s) and SN (11.3 ± 0.8 steps) increased and DSD (1.04 ± 0.14 s) decreased 
compared to the normal cadence (VEL = 0.44 ± 0.03 m/s, SN = 8.8 ± 0.8 steps, DSD = 1.23 
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Table 2.5 Correlation analysis of kinematic and functional measures 
 












DSD -0.89 0.93 -0.64 -0.67 0.72 0.52 0.70 0.76 
DSDvar -0.22 -0.40 -0.38 -0.41 0.39 0.56 0.40 0.58 
VEL 0.08 0.25 0.01 -0.28 -0.11 0.28 0.19 0.30 
VELvar -0.12 0.23 0.05 -0.09 0.12 0.08 0.11 0.07 
SL 0.20 0.31 -0.05 -0.21 0.14 0.18 0.09 0.17 
SLvar -0.23 0.35 -0.05 -0.19 0.19 0.19 0.21 0.20 
SH 0.44 -0.46 -0.33 0.34 0.49 0.33 0.37 0.59 
SHvar -0.42 0.32 -0.31 -0.46 0.49 0.30 0.26 0.38 
SN 0.32 0.24 -0.29 -0.38 0.29 0.37 0.41 0.28 
 
The r-values from the Pearson correlation analysis of kinematic and functional measures of the 
16 participants from the C and NC groups. Bold numbers represent significant r-values. Dynamic 
Gait Index—DGI; Timed-Up-and-Go—TUG; Unified Parkinson’s Disease Rating Scale—
UPDRS; Activities of Daily Living—ADL; Freezing of Gait Questionnaire—FOGQ; Direction 
switch duration—DSD; velocity—VEL; step length—SL; step height—SH; step number—SN. 
Variability of presented measures is shown with a ―var‖ subscript. 
 
±0.13 s). In addition VEL (0.31 ± 0.02 m/s) and SN (5.8 ± 0.8 steps) decreased while DSD (1.47 
± 0.14 s) increased at slower cadences compared to normal cadence values. Voluntary speed 
changes and those induced by RAS had a similar relative influence on VEL, SN and DSD. Plots 
also reveal shorter DSD (Fig. 2.2A) and faster VEL (Fig. 2.2B) values for the RAS condition 
compared to the No RAS condition (see asterisks for curly bracket comparisons). SN also 
increased for some subjects with the use of RAS, however the larger mean SN values with RAS 
use (Fig. 2.2C) did not achieve significance for slow (p = 0.07), normal (p = 0.07) and fast (p = 
0.06) speeds. Overall, stepping with RAS resulted in shorter durations in switching step direction 
and increased peak step velocity.  
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 Analyses also revealed a significant main effect of Direction for SLvar  (F2,29.6 = 3.89 , p = 
0.03) and SHvar (F2,25.4 = 9.56 , p < 0.001) and showed that variability of step length and height 
were greater during back steps (SLvar = 0.17 ± 0.02 m, SHvar = 0.035 ± 0.003 m) compared to 
forward (SLvar = 0.15 ± 0.02 m, SHvar = 0.028 ± 0.002 m) and side (SLvar = 0.16 ± 0.02 m, SHvar = 
0.026 ± 0.003 m) stepping directions. These results demonstrate that the back stepping direction 
involved the highest variability of these spatial measures compared to the other directions. In 
summary individuals with PD were able to modify their stepping movements under various 
speed requests with or without the use of RAS. 
RAS use influenced the movement regardless of the movement direction and speed, but 
did not affect spatial aspects of the movement, unlike that of movement direction effects on SL 
and SH variability. Moreover, DSD was significantly correlated with disease severity, both of 
which were significantly correlated with functional measures. Implications of these results are 
discussed in the following section.  
Discussion 
Everyday activities require constant changes in movement patterns that present problems for 
those with PD. We expanded on the limited findings for RAS effects and its use in direction 
switching in this population for which we also describe associations among disease severity, 
functional performance and kinematic measures. Those with less severe PD had shorter durations 
for switching step direction during multi-directional stepping with No RAS and greater 
functional abilities than those in later stages of the disease. Participants with disease stages 2-4, 
were able to move faster during stepping and when switching directions, and some participants 
did this with a greater number of steps with the use of RAS during task performance. These 
findings add to the evidence on effects of RAS that offset certain deficits in movement 
kinematics resulting from the disease. 
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Figure 2.2 Kinematic measures across different speeds with and without RAS. Kinematic 
measures of (A) direction switch duration (DSD), (B) peak step velocity (VEL) and (C) step 
number (SN) for slow (triangles), normal (squares) and fast (circles) speeds are shown. Filled 
shapes represent the No RAS condition while the empty shapes represent the RAS condition. 
Note, curly brackets are for RAS and No RAS condition comparisons within a given speed, 
while square brackets are for slow and fast comparisons relative to the normal speed. The 
























































Disease severity was associated with several functional measures. Functional scales such 
as the DGI [56], TUG [50] and Tinetti [57] are successful tools for identifying PD fallers. 
Frequencies of falls from self-reports also have a robust linear relationship with disease severity 
[58, 59]. Together these results explain the significant correlations of DGI, TUG and Tinetti with 
disease severity as identified on the H&Y scale. Results from significant associations between 
FOGQ and disease severity here and elsewhere [39] indicated that perceptions of gait 
deficiencies also increase with severity of the disease in PD. The significant correlations between 
UPDRS scores and disease severity were expected, as the H&Y scale was used to determine the 
convergent validity of UPDRS scores [60], which are known to worsen (increase) with advanced 
stages of the disease [52].  
Only one kinematic measure determined during multi-directional stepping with No RAS 
(i.e. DSD) was significantly correlated with disease severity (Table 2.4) and functional measures 
(Table 2.5). In addition greater variability in DSD (DSDvar) showed a significant correlation with 
UPDRS-Motor and FOGQ, thus overall motor and perceived gait dysfunction. In other studies 
step duration variability of PD patients was significantly correlated to disease severity [26], 
incidence of falls, UPDRS-Motor and UPDRS-ADL [61] during straight line walking, while 
mean step duration was not [61]. With evidence that transitions during movement is abnormally 
slow in PD [10], we suggest that transition durations and variability of step durations or step 
transition durations can be valuable measures that offer insight to motor complications in PD.  
Non-significant results of the present work also support previous findings from gait 
studies in this population. For instance, although the time from toe off to heel contact when 
walking differs from the time to switch step direction as defined in this study, step length during 
walking was not significantly associated with disease severity [26]. Moreover, peak step velocity 
 32 
during walking was not significantly associated with incident of falls, UPDRS-Motor or 
UPDRS-ADL [61]. Clearly, temporal kinematics differ from spatial and spatiotemporal 
kinematics by definition. Their relative change may also differ for certain behaviors and 
populations, suggesting different mechanistic control [26].  
Direction Effects 
For people with PD backward directional effects for variability of step length and height 
for multi-directional stepping match those for postural instabilities in the backward direction 
[62]. Authors identified that smaller stability margins in the backward direction after 
perturbation in this direction exist in PD patients. Abnormal muscular function [63] as indicated 
by higher muscular noise and higher variability of generated forces [64] explain the greater 
instabilities. Such muscular abnormalities could also explain the greater variability in step length 
and height in the back stepping direction in the present study and the shorter backward walking 
step lengths elsewhere [65]. One may blame less activity after disease diagnosis for the abnormal 
muscular behavior, however with no significant correlations between SLvar and SHvar and disease 
severity, it appears that  neural connections associated with temporal movement control are 
responsible. The disruption of BG-SMA connections in PD, which disrupt the temporal 
organization of movement [66], support this view. Further testing is required to verify this 
hypothesis.  
Speed Effects 
Speed effects in peak step velocity and duration of step direction switching were 
observed when stepping with and without the use of RAS. Participants in the current study 
adjusted DSD, VEL and SN from their comfortable self-selected stepping cadence, regardless of 
RAS use. Previous research also reports adaptation abilities for voluntary speed change in 
activities like a self-selected [67] or cued [68] sit-to-stand task. Furthermore, individuals with PD 
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can modify cadence, average gait velocity and step duration at different self-generated walking 
speeds [55]. Cadence, average velocity and step duration during walking can also be modified at 
lower [22, 31] and higher [18, 22, 31] RAS frequencies. Despite their ability to modify 
movement with speed, individuals with PD have a lower peak velocity, a lower amplitude of 
muscular activity [53] and an abnormal motor firing pattern during speed changes [69] compared 
to healthy age-matched controls. Thus although participants modified the movement speed 
relative to their comfortable stepping, it is probable that the underlying muscular pattern was not 
comparable to that of healthy adults performing the same task.  
 Spatial measures in the current manuscript including step length and step height were not 
influenced by speed. This is in line with previous work which reports no changes in step length 
[55] and step height [70] at different non-cued gait speeds and for step length with RAS set to 
7.5% and 15% higher than the comfortable waking speed [18]. Low muscle activation at 
different speeds of gait apparently does not allow those with PD to alter step amplitude changes 
while walking [55]. 
PD patients maintain the ability to increase or decrease their stepping cadence for 
relatively small changes in RAS frequencies (e.g. ±10% [31] and ±15% [18]). This is not true for 
frequencies of ±20%, for which those with PD are unable to modify cadence and average gait 
velocity [22, 31]. In addition both PD and age-matched healthy individuals show irregularities in 
stride length regulations at these frequencies [18, 22]. Thus, it seems that larger speed alterations 
lead to spatial gait irregularities for healthy and individuals with PD, alike. Whether PD 
individuals can become accustomed to more extreme cadence alterations with training is yet to 
be determined.  
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RAS and No RAS Comparisons 
Despite an overall ability to modify stepping speed regardless of RAS use, additional 
differences were observed when use of RAS was compared to the No RAS condition within each 
speed (i.e. fast, normal and slow). Higher peak step velocities were observed with RAS 
frequencies compared to the compatible No RAS conditions. Higher values of average gait 
velocity were also reported during gait with a 10% faster RAS frequency compared to a self-
generated maximum gait speed for individuals with PD, on and off medication [32]. Another 
investigation revealed increased average gait velocity with use of a comfortable RAS frequency 
compared to a self-selected, comfortable walking cadence in PD [22]. Interestingly, a higher 
average velocity of gait was observed for PD patients walking with a 10% lower RAS frequency 
in comparison to their comfortable self-generated gait speeds [22]. Clearly use of RAS can and 
does increase movement velocity. Two possibilities can be used to explain the greater movement 
velocity with RAS use. It may be that the underlying central mechanism for movement control 
differs in the presence of RAS [22] and/or that certain central neurons entrain to temporal RAS 
features [71]. Regardless of the underlying explanation for RAS control, its use in PD patients 
also results in significant reduction in DSD during the multi-directional step task, a decrease in 
step duration variability and the overall duration during gait with a turn [38, 40]. Therefore, RAS 
use is not limited to increases in movement velocity for straight line walking, as it can modify 
temporally related variables during various tasks, including those that require direction change.  
 We expected changes in step number with the use of RAS to accompany the decreases in 
DSD and increases in peak step velocity in this same condition. One can reason that if time 
between each step decreases and the movement speed during the step increases with no increase 
in step length, that step number should also increase. It is possible that the duration between each 
step in the same direction increased or stayed the same instead of a reduction similar to that for 
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DSD. It is also possible that the average step velocity increased or remained constant while the 
peak step velocity increased. However, it seems more likely that step number changes with RAS 
were not deemed significant because the magnitude of the counts (in half steps) was not sensitive 
enough to detect such a change given the relatively large variability among subjects. This is 
highly possible, especially when one considers the relatively small p-values reported for SN at 
each speed (p < 0.10).  
Conclusion 
The current findings indicate that the effects of RAS on lower limb movements are not 
limited to temporal features of straight line walking. RAS can also influence temporal features of 
the multi-directional step task where participants must constantly change directions to oppose the 
movement (out and back) and intermittently change their radial direction of movement. These 
abilities are not limited to one stepping speed or direction. Moreover, the short term alterations 
mirror those of other studies, while offering a task that requires little space and a setup which 
makes it easy to monitor using a gait belt for safety. Use of the multi-directional step task with 
RAS for a potential training regime in the PD population is currently underway. 
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CHAPTER3: PARKINSON’S PATIENTS TRANSFER MULTI-DIRECTIONAL STEP 
TRAINING EFFECTS TO FUNCTIONAL MEASURES OF GAIT AND BALANCE 
 
Introduction 
Neurodegeneration of the basal ganglia (BG) results in Parkinson’s disease (PD) which is 
a common disorder disrupting gait and balance. These difficulties are not well treated by 
medication [1] or surgery [2] and can lead to falls [3]. Individuals with PD have a 9 times greater 
risk than age-matched controls of experiencing falls [4]. Therefore, complications of gait and 
balance affect patients’ perceptions of their quality of life [5] and are considered key factors of 
PD disability [5]. 
When people with PD encounter multiple movement options or require movement 
changes, the BG do not function properly to release appropriate motor responses, while 
inhibiting others [6]. These individuals experience problems, especially when adaptations to the 
environment become necessary (i.e. changing directions, clearing obstacles, etc) [7]. They 
experience falls while turning [4 ], and freeze during gait initiation [8], turning [9] and dual 
tasking [8]. This explains why difficulty in movement transition is a fundamental motor 
performance issue for PD [10]. Difficulties in timely inhibition and release of movement further 
explain poor functional performance on the Dynamic Gait Index (DGI), Tinetti gait and balance 
test [4] and Timed-Up-and-Go (TUG) test [11], tasks which involve several movement 
transitions.  
Medication and surgery limitations on functional performance, and the debilitating 
consequences of falls on physical and emotional welfare of individuals with PD, highlight the 
importance of supplementing standard medical treatments with effective rehabilitation. Although 
successful conjunctive rehabilitation for PD patients exists [12], use of inconsistent strategies 
and inadequate support for many applied methods do not offer clinicians the most effective 
training approach for use with this population. One tactic that appears effective for enhancing 
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motor aspects in PD is the use of external cues. It is assumed that those with PD maintain the 
ability to generate correct movements [6] and that proper movement can be released by replacing 
the lost internal trigger with an external cue [13]. Research provides support for its use with PD 
[14]. 
External cues vary by sensory modality, however auditory cueing appears the most 
effective in terms of its translation to motor output. Temporal components of auditory cues can 
directly transfer into accurate and stable motor output, dismissing the need for continuous 
activation of modality-specific brain areas after stimulation removal [15]. Auditory stimulation 
can increase excitability of spinal motor neurons using the reticulospinal pathway [16] and 
facilitate the H-reflex, thus enhance motor activation [17] without involving the damaged BG. 
This becomes significant as limitations in temporal movement organization via connections 
between the BG and Supplementary Motor Area lead to inadequate movement execution in 
Parkinson’s patients [18].  
Rhythmic auditory cues directly alter gait kinematics of individuals with PD [19-21]. 
Single session application of rhythmic auditory stimulation (RAS) leads to increased gait 
velocity [20], step length [20] and cadence [22] and decreased double support time [22]. Practice 
with auditory stimulation can also alter movement. Practice with RAS results in reduced 
variability of leg muscle activity patterns [23], increased gait velocity [21], stride length [21] and 
cadence [24], however RAS shows no change in the number of freezing episodes [19]. 
Research on the ability of individuals with PD to retain practice effects [25] or transfer 
training effects to non-cued functional performance [21, 25] using RAS are limited. RAS effects 
for straight, single direction walking are promising, and may or may not transfer to more 
complex environments like those in the home, where PD gait complications occur most often due 
to the need for constant adjustments [4]. Use of auditory, visual and sensory external stimuli with 
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multi-directional gait practice as its primary intervention has produced immediate functional 
benefits in PD patients [25]. However further research is needed to clarify training effects with 
RAS alone on skills for which people with Parkinson’s have difficulties performing (i.e. 
changing direction). 
The goal of this study was to test the hypothesis that a RAS based intervention would 
improve the abilities of PD patients to transfer multi-directional step training effects to gait as 
measured by the DGI and to retain the functional improvements that occur. Specifically, we 
wanted to determine: if training with and without RAS for 6 weeks would improve functional 
gait of people with PD (immediate training effects); if any improvements beyond pre-training 
values would be maintained for 1, 4 and/or 8 weeks after practice terminated (retention effects); 
and if differences in functional gait immediately after training and during retention tests existed 
between the groups trained with and without RAS. We hypothesized that 6 weeks of multi-
directional stepping would significantly improve gait function for individuals with PD and that 
improvements in gait function would still be observed after eight weeks of no practice for those 
who trained with RAS. 
Methods 
Participants 
 Twenty-seven individuals with PD were screened to take part in this study. Six patients 
did not meet all the inclusion and exclusion criteria and 5 participants were used for pilot tests. 
As such, 16 volunteers participated in this study. Participants signed informed consent approved 
by the university’s Internal Review Board. Inclusion criteria was as follows: diagnosed with 
idiopathic PD; identified as Hoehn and Yahr (H&Y) stage 2 to 4; maintained stable drug use; 
could stand independently and walk with or without an assistive device; and be able to hear and 
differentiate auditory cues (described below). Disease severity from the modified H&Y scale 
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[26] was administered alongside the Unified Parkinson’s Disease Rating Scale (UPDRS) [27] for 
categorizing PD motor symptoms. Participants were excluded if they presented with: cognitive 
deficits (Mini Mental State Examination Score (MMSE) < 24); history of disorders other than 
PD that could potentially influence balance and walking abilities and interfere with successful 
completion of the program; long lasting unexpected off periods indicated by items 37 (score = 1) 
and 39 (score > 2) of UPDRS or medication change.  
Study Design 
 PD participants were given study details, consented to participate and were evaluated for 
participation during a screening visit. Qualified participants were pseudo-randomly assigned to 
one of two training groups: a group that received auditory cues during training (Cue, C) or one 
that did not (No cue, NC). Once disease stage was determined, the individual was randomly 
assigned to a group. The next participant with the same disease stage was assigned to the 
opposite group to maintain the same distribution of disease severity between groups. Pilot data 
from 5 people with PD indicated that 6 individuals per group were needed to achieve 80% power 
on our primary measure, the DGI. Participant and group information are included in Table 3.1.  
Comfortable/normal stepping cadence was also determined during the screening visit. Forward 
stepping cadence of 5 trials each lasting 10 seconds was averaged to establish this cadence and 
RAS frequencies.  
Multi-directional Step Training  
 Participants trained 3 times per week (45-60 minutes) for 6 weeks. Pre-tests on the 
screening visit and day 1 of training (PRE), a post-test on the last day of training (POST), and 
retention tests, 1 week (RTW1), 4 weeks (RTW4) and 8 weeks (RTW8) after training  
terminated, were conducted in the same location. Collections during the screening and PRE visits 
allowed us to determine the initial stability of measurements in participants. Participants were   
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Table 3.1 Characteristics and pre-test measures from the C and NC groups 
 
Items C group NC group p value 
Age (years) 73.3 ± 2.2 70.5 ± 2.2 0.59 
Gender F=3, M=5 F=2, M=6  
Height (cm) 168.8 ± 3.3 171.8 ± 4.3 0.52 
Weight (kg) 79.5 ± 0.2 78.4 ± 0.2 0.80 
Disease duration (years) 8.9 ± 1.8 7.5 ± 1.2 0.28 
Modified H&Y = number of  






MMSE 28.3 ± 0.5 27.8 ± 0.8 0.23 
DGI 16.3 ±  1.0 15.4 ± 0.8 0.46 
UPDRS-Motor 27.1 ± 3.6 27.0 ± 3.4 0.98 
UPDRS-ADL 13.9 ± 1.3 14.9 ± 1.2 0.61 
UPDRS-Composite 8.1 ± 1.0 8.1 ± 0.8 0.71 
Tinetti-total 17.0 ± 1.8 16.6 ± 1.5 0.67 
Tinetti-gait 6.4 ± 0.7 6.5 ± 0.8 0.91 
Tinetti-balance 10.6 ± 1.2 10.1 ± 0.8 0.71 
TUG (s)                                                                                15.0 ± 2.0 15.4 ± 2.2 0.93 
FOGQ 12.5 ± 1.9 12.8 ± 2.1 0.67 
 
Mean ± 1 standard error for various characteristics and functional measures of the C (cue) and NC (no 
cue) groups recorded on the first day of practice are provided. The p-value results of t tests used to 
compare groups on these measures are listed. F—female; M—male; Hoehn and Yahr— H&Y; Mini 
Mental State Examination—MMSE; Dynamic Gait Index —DGI; Unified Parkinson’s Disease 
Rating Scale —UPDRS; Activities of Daily Living—ADL; Timed-Up-and-Go—TUG; Freezing 
of Gait Questionnaire—FOGQ. 
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encouraged to continue with normal daily activities from screening to RTW8 periods, but 
received no step training after POST.  
 A physical therapist, certified in UPDRS collection, evaluated and trained all participants. 
Each participant attended training and testing sessions 1 hour after medication intake at the same 
time of day. Medication intake was confirmed before each session. Sessions were postponed and 
repeated on the earliest available date within the same week 1 time each for 3 participants due to 
off periods or improper medication intake.  
 When training with RAS, participants started with feet in anatomical position at a self-
selected distance apart. They stepped away and back in time with each beat of RAS presented at 
one of 3 speeds: normal/comfortable cadence—N and 10% faster (fast) and slower (slow) than 
normal cadence. Each tone represented one step direction (forward—F, side—S, back—B). Trial 
step time was 33.75 s close to 30 seconds to avoid fatigue in this population [28]. Participants 
were instructed to step in time with the beat and that the foot should completely leave the 
surface, then completely contact the floor with each step. Speed remained constant within trials. 
Demonstrations and/or instructions were repeated every session before practice/testing, after 
breaks and when requested. Due to challenges in alternating limbs [29] and changing directions 
[30] for this population, training increased in complexity based on the following schedule: 
Week 1: each direction separately, legs separately (e.g. right leg, forward steps (and back) for 
33.75 s);  
Week 2: each direction separately, legs alternated; 
Week 3: two directions per trial, legs separately (e.g. left leg, backward steps for 11.25 s, 
then sideward steps for 22.5 s);  
Week 4: two directions, legs alternated; 
 47 
Week 5: three directions per trial, legs separately (e.g. left leg, sideward steps for 11.25 s, 
then forward steps for 11.25 s, then backward steps for 11.25 s; and 
Week 6: three directions, legs alternated. 
 Thirty-six trials were performed in each training session. During week 1, participants 
performed each speed/direction combination twice (3 speeds x 3 directions x 2 legs x 2 times). 
During week 3, 6 direction combinations (BF, BS, FS, FB, SF and SB) were 
performed (3 speeds x 6 direction combinations x 2 legs). During week 5, 6 different direction 
combinations (FSB, FBS, BSF, BFS, SFB and SBF) were 
performed (3 speeds x 6 direction combinations x 2 legs). During even numbered weeks 
alternating feet replaced performing each side independently. Combinations were randomized 
within each training day and for each leg separately on odd weeks. One to five trials were 
repeated for 4 participants for not adhering to instructions. 
 Auditory cues used for the RAS training included cluck, ding and soft cork sounds  
recorded at a 22.5 kHz with durations of 88 ms, 915 ms and 127 ms, respectively. Sound 
volumes were approximately 75 dB, well above average hearing loss range (25-40 dB) reported 
for older adults [31]. Participants acknowledged cues upon presentation and could describe each. 
 Step training setup and scheduling for the No RAS condition were the same as that for 
the RAS condition with the following exceptions. Participants were to keep speed constant 
within a speed category and to perform the task for each direction at ―comfortable‖, ―relatively 
faster‖ or ―relatively slower‖ pace than normal. Participants were given a ―last step‖ verbal cue 
approximately 1 second before a direction switch and a ―stop‖ cue to end the trial to maintain the 
desired protocol and lessen the potential cognitive load. Three participants repeated 3-5 trials for 
not adhering to instructions.  
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Evaluation 
 Several functional measures were performed to offer a comprehensive determination of 
gait and postural difficulties associated with PD [32] and to gain insight to improvements 
participants experienced after training. The DGI, a fall risk indicator that challenges participants 
to perform simple to difficult gait patterns, was selected as the primary measure of functional 
gait. Secondary measures included the UPDRS-Motor and UPDRS-ADL sections to evaluate 
overall motor symptoms of PD and activities of daily living (ADL), respectively. Similar to 
previous work [25], the UPDRS-Composite score, involving UPDRS gait and balance items (13-
15, and 29-30), was also included. The TUG test evaluated fall risk as the time to stand from a 
chair, walk 3 meters, turn, walk back and sit down. Evaluations of the Tinetti (gait, balance and 
total) identified impaired gait and balance and assessed fall risk [33]. The Freezing of Gait 
Questionnaire (FOGQ) assessed perceived changes in gait and the quality and frequency of 
freezing of gait [34]. Measurement order was randomized within evaluation sessions. 
Statistical Analyses  
Pair-wise t tests were performed on functional measurements collected during screening 
and PRE visits to determine short term stability of these measures within our participants. Pair-
wise t tests were also used to compare MMSE scores, disease duration, age, height, weight and 
PRE functional measures of groups prior to training to determine group similarities. Repeated 
measures ANOVAs with a random factor for subject, a between subject factor of Group (C, NC) 
and repeated measures of Test-day (PRE, POST, RTW1, RTW4 and RTW8) were used to 
compared measurement differences between groups and among test days. A Kenward Rogers 
adjusted degrees of freedom was used because of the relatively small sample size and some 
missing test values (Fig. 3.1). Tukey’s post-hoc tests were used when appropriate to answer the 
experimental questions via PRE/POST comparisons and PRE/retention comparison for each  
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Figure 3.1 A schematic of the number of participants (N) at various stages of the study. Pre-test 
(PRE), post-test (POST) and retention tests 1 week (RTW1), 4 weeks (RTW4) and 8 weeks 
(RTW8) after training were performed. C—Cue group; NC—No cue group. Reasons for reduced 
numbers are provided: Med change—change in medication and conflict—scheduling conflict 
that was not made up. 
group and C and NC comparisons for each POST and retention test. Significance level was 
preset at p < 0.05 for all analyses (SAS V.9.1).  
Results 
Similarities in functional measures identified between screening and PRE visits suggest 
that participants were functionally stable before training. Values of various group characteristics 
and PRE measurements are presented in Table 3.1 and reveal relatively poor scores associated 
with increased fall risk (DGI ≤ 22 [32]; TUG > 8.5 s [35] and Tinetti-total < 19 [33]) in 
participants before training. Groups did not differ in age, height, weight, disease duration or 
PD participants assessed for eligibility (N=27)
Enrollment (N=16: 11 did not meet inclusion/exclusion criteria; 0 refused to participate)





RTW4 (N=6: 1 med change; 1 conflict) (N=7: 1 med change)
RTW8 (N=7: 1 med change) (N=6: 2 med changes)
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mental status and had similar functional scores at baseline. A moderate disease stage (2.5 H&Y) 
was most common. Seven freezers (4 C and 3 NC) were identified as those who experienced 
freezing at least once per week [25]. Figure 3.1 depicts the number of participants at each stage 
of the study and shows that all participants completed training, yet not all completed follow-up 
evaluations due to scheduling conflicts or a medication change. 
Figures 3.2 and 3.3 depict the primary training results of the study. It is important to note 
that the analyses and plots account for the missing participants for RTW4 and RTW8. The 
number of participants were C = 6 and NC = 7 on RTW4 and C = 7 and NC = 6 on RTW8. A 
main effect of Test-day (F4,35.2 = 55.62, p < 0.0001) and a Group x Test-day interaction (F4,35.2 = 
16.30, p < 0.0001) were observed for the DGI. Figure 3.2 shows that although higher DGI scores 
for both groups were identified immediately (POST) and 1 week (RTW1) after training 
compared to pre-training (PRE), scores for the C group were greater than those for the NC group 
for 1 week and 4 week follow-up evaluations. Only people in the C group retained higher scores 
relative to PRE values for 8 weeks. Moreover, 4 participants in the C group recorded scores 
greater than 22 at POST, thus were identified as non-fallers [32] immediately after training. A 
main effect of Test-day for Tinetti-balance scores (F4,37.9 = 11.67, p < 0.0001) revealed that 
scores higher than PRE values for combined groups were achieved immediately after training 
and maintained for 8 weeks (Fig. 3.3). These findings indicated that multi-directional step 
training results in functional gait and balance improvements in PD patients and that use of RAS 
can enhance the retention effects on gait function.  
Outcomes from secondary measures show several similar results to those reported for the 
DGI. Significant effects of Test-day were identified for all measurements, UPDRS-ADL (F4,32.1 = 




Figure 3.2 Mean scores of the Dynamic Gait Index (DGI) for the C and NC groups. C and NC 
groups are presented in blue and red colors respectively. The DGI scores are shown for the pre-
test (PRE), post-test (POST) and retention tests 1 week (RTW1), 4 weeks (RTW4) and 8 weeks 
(RTW8) after training. Colored asterisks represent a significant difference from the PRE values 
for the corresponding group. Curly brackets with black asterisks indicate significant differences 
between C and NC groups. 
 
=26.84, p < 0.0001), Tinetti-total (F4,36.2 = 30.19, p < 0.0001), Tinetti-balance (F4,37.9 = 11.67, p < 
0.0001), Tinetti-gait (F4,40.4 = 22.17, p < 0.0001), TUG (F4,18.18 = 23.30, p < 0.0001) and 
FOGQ(F4,37.6 = 32.76, p < 0.0001), indicating improvements over PRE values. UPDRS-Motor 
measurements were back to baseline values within 1 week (Table 3.2). Group x Test-day 
interactions identified for the UPDRS-ADL (F4,32.1 = 2.8, p = 0.0425), UPDRS-Composite (F4,33.5 
= 3.33, p = 0.024), Tinetti-total (F4,36.2 = 3.63, p = 0.014), Tinetti-gait (F4,40.4 = 3.91, p = 0.009), 
TUG (F4,18.18 = 8.16, p = 0.0005) and FOGQ (F4,25.8 = 5.34, p = 0.0029) are also shown in 





















Figure 3.3 Mean Tinetti-balance scores for the two groups combined. These values are shown 
for the pre-test (PRE), post-test (POST) and retention tests 1 week (RTW1), 4 weeks (RTW4) 
and 8 weeks (RTW8) after training. Asterisks represent a significant difference from PRE values. 
Error bars represent 1 standard error.   
 
total, Tinetti-gait, TUG and FOGQ scores relative to PRE values for 8 weeks. UPDRS-ADL 
improvements were also maintained up to 4 weeks for this group. The NC group only maintained 
improvements over PRE values in the UPDRS-Composite, Tinetti-total and Tinetti-gait for 1 
week and in the UPDRS-ADL and the TUG on the post-test. Clearly, use of RAS resulted in 
retention of better functional scores over training without it. Furthermore, self-identified freezers 
in the C group received FOGQ scores of 16-22 before training and 10-14 after training, whereas 
scores for freezers in the NC group only dropped from 15-20 before training to 13-19 after 
training. FOGQ scores for the NC group did not change significantly, suggesting this group did 
not perceive meaningful changes in gait with training like group C. Overall, 6 weeks of multi-
directional step training enhanced participant function. Results also revealed important benefits 






















 Table 3.2 Secondary functional measures of C and NC groups for each test day  
 
Test Group PRE POST RTW1 RTW4 RTW8 
UPDRS 
ADL 
C 13.9 ± 1.3 11.0 ± 0.8 11.6 ± 1.0 10.8 ± 0.7 12.7 ± 1.3 
NC 14.9 ± 1.2 13.5 ± 1.1 14.0 ± 1.1 14.9 ± 1.3 13.2 ± 1.3 
       
UPDRS C 27.1 ± 2.7 25.1 ± 3.3 25.6 ± 3.5 22.8 ± 2.3 26.3 ± 3.8 







8.1 ±1.0  
 
6.3 ± 0.9 
 
6.8 ± 1.0 
 
6.3 ± 1.1 
 
8.3 ± 1.2 







17.0 ± 1.8 
 
22.9 ± 1.3 
 
22.8 ± 1.4 
 
23.7 ± 1.1 
 
24.0 ± 1.2 







6.4 ± 0.7 
 
9.9 ± 0.6 
 
9.8 ± 0.6 
 
10.3 ± 0.4 
 
9.4 ± 0.7 






15.0  ± 2.0 
 
9.4 ± 1.1 
 
9.9 ± 1.1 
 
9.1 ± 0.8 
 
11.1 ± 1.3 






12.5 ± 1.9 
 
7.5 ± 1.3 
 
8.3 ± 1.2 
 
9.7 ± 1.6 
 
11.4 ± 1.8 
NC 12.8 ± 2.1 11.9 ± 1.9 12.3 ± 2.0 11.6 ± 2.0 10.3 ± 2.2 
 
Mean ± 1 standard error of several secondary functional measures are provided for the C (cue) 
and NC (no cue) groups on each test day. Values are for the pre-test (PRE), post-test (POST) and 
retention tests, 1 week (RTW1), 4 weeks (RTW4) and 8 weeks (RTW8) after training. Bold 
values represent a significant difference from the PRE values. Unified Parkinson’s Disease 
Rating Scale—UPDRS; Activities of Daily Living—ADL; Timed-Up-and-Go—TUG; Freezing 
of Gait Questionnaire—FOGQ. 
 
Discussion 
 Eighteen sessions of multi-directional step training improved the DGI scores and other 
functional measures for individuals with PD and thereby demonstrate that practicing step training 
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transfers to a variety of functional gait and balance tasks. Although RAS use did not always 
provide immediate post-training improvements over step training with No RAS, it was superior 
to help participants extend the maintained improvements in gait function for 8 weeks after 
training ended. These findings support other studies that show positive outcomes of PD training 
programs, and highlight the importance of supplementing regular treatments with rehabilitation 
for this population. 
 The present results support evidence that motor learning abilities are preserved in people 
with PD [36]. Participants generalized multi-directional step training effects to the different 
contexts of gait and balance, two well-known deficiencies in this population [37]. The abilities of 
the participants to improve functional gait measures after step training, that unlike others [25, 38, 
39] did not involve walking, indicate that the training context for PD patients may be generalized 
to different tasks. PD patients’ abilities to generalize 8 weeks of pedaling practice to manual 
dexterity skills [40] support this view. However PD patients were also unable to reach the 
desired arm movement speed in a blocked or random practice paradigm after training in the 
opposite paradigm for 2 days [41]. This inability to transfer training outcomes to a different 
context may be due to short term practice or practice using the upper limb in this population, 
however further tests are needed to test these possibilities. 
Balance in Parkinson’s patients improved with multi-directional step training. Inability of 
individuals with PD, to properly respond to external (i.e. platform movement [42]), and internal 
(i.e voluntary movements such as rising-to-toes [43]) demands account for balance difficulties in 
these individuals. Some researchers blame immobility for these problems [44], explaining why 
balance improvements occur after 10 weeks of tai chi [45] and 8 weeks of gait training [39] and 
are maintained after 10 weeks of balance and strength training exercises [46]. Increased activity 
partially explains the improved balance observed in the present study as 9/16 participants 
 55 
reported no commitments to regular physical activity before training. We reasoned that switching 
between different movement components and standing between trials during training also helped 
participants improve Tinetti-balance items for standing balance and turning.  
 Different abilities of groups to maintain improvements after training adds to the limited 
research on effects of external cues on retention abilities in PD patients [21, 25, 38]. Longer 
training duration [47], providing augmented [48] and positive feedback [49], higher intensity of 
practice [40] and modifying levels of contextual interference [50] can result in longer retention. 
Adherence to one or more of these strategies resulted in longer retention of accurate/better 
performance of sequential whole body positioning and shirt buttoning [47], balancing (Jessop et 
al., 2006; Jobges et al., 2004) and grasping [40] in this population. Longer retention abilities for 
the C group compared to the NC group indicates that use of RAS is effective for acquiring longer 
retention of certain motor skills. These results comply with reported retention of UPDRS-ADL 
scores 6 weeks after 6 weeks of physical therapy with auditory cues compared to those without 
them [38]. With reduced improvements in TUG and UPDRS-Composite scores 6 weeks after a 
3-week cued gait training protocol [25], it is clear that training duration and external cues can 
influence retention abilities, thus should be considered when enhancing retention in PD patients 
is desired. 
Using RAS during multi-directional step training may alter fall risk in people with PD. 
The greater improvement in POST scores on the DGI for the C group and individual differences 
exemplify such benefits. Remember that 4 participants in the C group scored greater than 22 on 
the DGI, while all NC participants scored less than 22 immediately after training. Thus, half the 
C participants at low disease stage (H&Y ≤ 2.5) changed from faller to non-faller status (i.e. DGI 
> 22 [32]) after training. Although possible, the idea that longer training with RAS may result in 
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better scores for those at higher disease stages requires verification. Regardless, the use of RAS 
clearly enhanced performance to a more meaningful extent from a fall risk perspective.  
C group participants also identified perceptible differences in their gait and/or number of 
freezing episodes. Self-identified freezers in the C group dropped 5-8 points in their FOGQ after 
training, revealing an obvious dichotomy and significant change for PRE/POST score 
comparisons (Table 3.3). The 1-2 point FOGQ score drop for freezers in the NC group did not 
produce significant changes in this measure. With freezing episodes associated with temporal 
gait deficits [51] and rhythmic auditory cues targeting temporal aspects of the movement [52], 
we associate C group FOGQ improvements with temporal improvements in movement. The 
current freezing results also follow those where PD patients revealed less freezing after 3 weeks 
of cued gait training [25]. Since freezing episodes remained unchanged after 1 week of home cue 
training [19], the observed freezing improvements were attributed to longer cue training 
duration, further emphasizing the necessity of relatively long training periods for individuals 
with PD. 
 Group similarities in UPDRS-Motor scores were identified so that improvements 
observed immediately after training were not maintained on follow-up evaluations. This seems to 
contradict the effectiveness of long term rehabilitation protocols in improving UPDRS-Motor 
scores, thus overall motor deficits in Parkinson’s patients [40, 53, 54]. Note this measure was 
unsuccessful in presenting an accurate portrayal of mobility in this population based on its low 
correlation with functional measures (TUG, Berg Balance scores and Functional Reach tests 
[55]), while gait and posture items of the UPDRS showed high correlations with functional 
measures of the Tinetti [33]. These associations explain the different outcomes for UPDRS-
Composite and UPDRS-Motor scores observed in this study. Further investigations are required 
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to determine the sensitivity of the UPDRS-Motor in detecting more specific motor changes in PD 
patients.  
 Current results are indicative of central changes as research indicates that practicing 
sequential movements with [56] or without RAS [57, 58]  results in changes in activity of 
various brain areas. Activation of additional cortical and sub-cortical regions despite continuous 
activity of the deficient BG in those with PD allows these individuals to achieve motor 
improvements after practice without RAS [57, 58]. RAS use also enhances motor performance 
by recruiting similar brain regions [56]. However, unlike self-generated movements, activity of 
the BG is not required because the movement is externally paced [59]. This pattern of activity is 
sustained after withdrawal of auditory tones [56]. Apparently, individuals with PD can benefit 
from practice alone however application of RAS holds additional benefits. Although not tested 
directly, the current results add to the evidence that rhythmic auditory cues facilitate a 
compensatory pathway in people with PD that offers at least a temporary substitute for the 
defective internal clock, the BG. How long such improvements are maintained in people with PD 
is likely linked to disease severity, but requires further testing for verification.  
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CHAPTER 4: PEOPLE WITH PARKINSON’S DISEASE CHANGE STEPPING 
DIRECTION FASTER AFTER MULTI-DIRECTIONAL STEP TRAINING WITH 
RHYTHMIC AUDITORY STIMULATION 
 
Introduction 
Movement difficulties [1], including those with walking [2], are prominent in 
individuals with Parkinson’s disease (PD). Walking deficits also contribute greatly to the 
perception of quality of life and disability for these individuals [3]. Their gait manifests 
decreased stride length and gait speed [4, 5], hypokinesia, increased cadence [6], freezing of 
gait and stride-to-stride variability [7]. Longer step duration and reduced step length observed 
in people with PD during straight line walking [8] worsen during a turn [9]. Some of these gait 
abnormalities are observed in other populations and do not limit daily function. For example, 
decreases in stride length and gait speed commonly exist in normal older persons [10], but do 
not limit these people’s abilities to grocery shop or perform other daily tasks. However other 
difficulties such as those associated with turning can play a significant role in loss of stability 
and balance [11]. Additional complications such as freezing of gait are also experienced during 
turning [12] and further contribute to increased fall risk in this population [13].  
In PD central problems with the basal ganglia (BG) inadequately inhibit and release 
movement responses to the task demands [14, 15], thus are most observable during tasks 
involving transitions. The transition problem is evident in several activities. For example, 
difficulties are experienced during unilateral [16] or bilateral [17] multi-limb movements, dual 
task performance [18, 19], multi-task performance [20], when performing a sit-to-stand task 
[21] and when required to change movement directions during gait [22]. Orderly inhibition and 
excitation of associated muscles are necessary for transitions in each of these tasks.  
Scientists suggest that training with rhythmic auditory stimulation (RAS) is an effective 
method for improving gait and balance in PD [23, 24]. It is thought that RAS serves as an 
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external trigger to replace the deficient internal trigger, the BG [25]. Training of this type 
involves the use of repetitive auditory cueing to which individuals attempt to synchronize a 
sequential and repetitive task. Finger tapping [10, 26], repetitive reaching [27] and stepping 
[28-31] to a rhythmic input are common tasks for investigation, although stepping is more 
common when gait is of interest. Music and metronomes offer different sources of rhythmic 
input [32]. Use of a metronome seems to offer advantages over music [33]. Other forms of 
external modalities such as visual [34] and tactile [35, 36] cues are also used for those with PD. 
However the inherent temporal connections between RAS and movement generation appear to 
surpass the effects of the other modalities [37, 38].  
Immediate effects of RAS on gait have been investigated to a great extent and reveal 
changes according to that of RAS frequency. For example, frequencies of RAS higher than the 
normal/comfortable walking cadence result in increased velocity [30, 37, 39, 40, 41, 57], step 
amplitude [37], step length [28 , 42] and cadence [30, 39, 41]. Frequencies of RAS lower than 
normal cadence usually cause the opposite response. Use of RAS commonly decreases step 
duration variability [37], regardless of frequency, as long as the frequency is not too extreme 
relative to the comfortable cadence (e.g. [43]). Few immediate RAS effects for turning exist for 
those with PD. These studies reveal turning alterations in response to RAS similar to those of 
walking [44, 45].These findings provide useful information for applications of RAS but do not 
offer insights regarding the potential long term use of RAS.  
Unlike the short term investigations, effects of RAS on movement after its long term use 
are rare for PD. Those that do exist have offered several insights to RAS use for straight line 
walking. These studies report changes in the pattern of leg muscle activation [46, 47], velocity 
[47, 29], stride length [47] and cadence [29] more similar to those of healthy age-matched 
controls after weeks of RAS gait training. Some retention abilities after weeks of training with 
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RAS use also exist. Improved activities of daily living were maintained 6 weeks after 6 weeks 
of physical therapy with auditory cues imbedded in the training [49]. In contrast gait, balance 
and physical function measures were not maintained 6 weeks after a 3 week cued gait training 
protocol [50]. Further investigations are warranted to uncover whether the retention effects of 
using RAS are limited to the duration of training and to establish RAS effects on more difficult 
movement patterns.  
The primary goal of the current study was to explore the abilities of individuals with PD 
to alter their stepping performance with no cues after 6 weeks of multi-directional step training 
with RAS. Since switching from one task to another is a major function of the BG and this 
ability is impaired in PD, the duration of switching step direction (direction switch duration, 
DSD) served as the primary kinematic measure of step performance. The ability of PD patients 
to retain changes over baseline values for a relatively long period of time was also investigated. 
We hypothesized that DSD during step performance without RAS would decrease after training 
with RAS and that changes would remain at least for several weeks after training. Other 
kinematic measures were determined to offer comparisons between the present step task and the 
more commonly used task of walking. Step performance with RAS before and after training 
offered additional insight to training effects on the trained task (task specificity).  
Methods 
Participants 
Twenty-seven individuals diagnosed with PD volunteered to participate in the study. Of 
the 21 who qualified for participation 5 were used for pilot tests (group P), leaving 16 to 
participate using the final protocol. All participants provided consent approved by the 
university’s Internal Review Board. Disease severity was identified according to the Hoehn and 
Yahr (H&Y) scale [51] and the intensity of the motor symptoms was determined according to 
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Unified Parkinson’s Disease Rating Scale (UPDRS) [52]. Qualified participants: 1) were 
diagnosed with idiopathic PD; 2) presented with disease severity stages 2 to 4 (H&Y); 3) had 
stable drug usage; 4) were capable of standing and walking independently with or without an 
assistive device; 5) were able to identify auditory cues and 6) had no signs of cognitive deficits 
as determined by the Mini Mental State Examination Score (MMSE > 24, [53]). Participants 
were also disqualified if they reported a history of other disorders or acute injuries that could 
influence their ability to complete the program. Unstable drug use was determined according to 
individual reports of medication change and according to items 37 (score = 1) and 39 (score > 2) 
of the UPDRS. 
Study Design 
 Participants visited the training site during a screening visit where they became familiar 
with the study design, were evaluated for qualification and agreed to participate. Once qualified, 
participants were assigned to a Cue (C) or a No cue (NC) training group in a pseudo-random 
fashion. This design allowed homogeneity across groups by randomly assigning the first 
qualified volunteer to one group and allocating the next participant with the same disease level to 
the opposite group, yielding 8 participants per group. Those in the C group participated in a 
multi-directional step training protocol with and without RAS while those in the NC group 
performed the step training with No RAS only. In addition to several individual characteristics 
an average forward stepping cadence from five 10 second trials was calculated to obtain a 
comfortable/normal step cadence (Table 4.1). Screening, training and evaluations were 
conducted in the same location by a physical therapist, certified in UPDRS collection. 
Multi-directional Step Training  
 Step training took place 3 times per week for 6 weeks in sessions approximately 1 hour in 
length. Participants took medication about 1 hour prior to each session, which was confirmed 
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upon arrival. Three participants had to postpone 1 session each for not adhering to their 
medication schedule.  
 During RAS step training participants received instructions and demonstrations for the 
corresponding step training task at the beginning of each session, after given breaks and upon 
request. Participants started with their feet in anatomical position at a self-selected distance apart. 
They were asked to step away and back in time with the RAS beats and told that the foot should 
completely leave the ground and foot sole completely contact the floor with each step. Trial 
duration was kept relatively short (33.75 s) in order to avoid fatigue [54]. This duration resulted 
from the specially designed software. The training schedule followed previous suggestions for 
PD training regiments, which suggest breaking down complex movements at initial training 
sessions [23]. Accordingly, the following weekly schedule was implemented:  
Week 1: each direction separately, legs separately (e.g. right leg, forward steps (and 
back) for 33.75 s);  
Week 2: each direction separately, legs alternated; 
Week 3: two directions per trial, legs separately (e.g. left leg, back steps for 11.25 s, then 
side steps for 22.5 s);  
Week 4: two directions, legs alternated; 
Week 5: three directions per trial, legs separately (e.g. left leg, side steps for 11.25 s, then 
forward steps for 11.25 s, then back steps for 11.25 s; and 
Week 6: three directions, legs alternated. 
 Thirty-six trials were performed in each training session. During week 1 participants 
performed each speed/direction combination twice (3 speeds x 3 directions x 2 legs x 2 times). 
Participants performed 6 direction combinations (BF, BS, FS, FB, SF and SB) for 
week 3 (3 speeds x 6 direction combinations x 2 legs). They performed 6 different direction 
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combinations (FSB, FBS, BSF, BFS, SFB and SBF) for week 5 (3 
speeds x 6 direction combinations x 2 legs). During even numbered weeks the number of trials 
was equal to that of the two legs combined of the odd weeks, as alternating feet replaced 
performing each side independently. Combinations were randomized within each training day 
and for each leg separately on odd weeks. One to five trials were repeated for 4 participants for 
not adhering to instructions. 
 Three different auditory cues, cluck, ding and soft cork, were recorded at a 22.5 kHz. The 
cluck, ding and soft cork sounds had frequencies of 1003.3 Hz, 784.93 Hz and 529.38 Hz and 
durations of 88 ms, 915 ms and 127 ms, respectively. Cue presentation for RAS was generated 
by a specially designed LabView program and presented through two speakers at approximately 
75 dB, well above the average hearing loss range (25-40 dB) for older adults [55]. Prior to 
testing participants in P and C groups were presented with cues in a random order and were 
asked and able to raise their hands and describe them when heard. 
  RAS was absent during the No RAS condition, thus individuals were instructed to step at 
a ―comfortable‖ cadence or ―relatively faster‖ or ―relatively slower‖ than their normal step 
cadence. In order to avoid mental fatigue and allow accurate performance within a specified 
direction, participants were given a ―last step‖ verbal cue approximately 1 second before a 
direction switch. Initiation of trials was prompted by ―Ready?‖, pause, ―Start‖ command and a 
―Stop‖ command was used for trial termination. Other details of the training protocol were 
similar to the RAS condition. Three to 5 trials were repeated for 3 participants for not adhering to 
instructions.  
Evaluation 
 Testing sessions involved the multi-directional step task performed on week 6 to gain 
insight to kinematic alterations that were expected with training. Three direction combinations, 
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FSB, SFB, and BSF, were performed at the 3 speeds to yield 9 trials without RAS 
for the NC group and 18 trials (9 RAS and 9 No RAS) for group C. These direction 
combinations allowed participants to initiate stepping in each of the three directions and to 
change step direction to and from each direction. The reduction from the 6 possible combinations 
to 3 resulted from fatigue effects noted with group P. Since group C was tested with and without 
RAS, the No RAS condition was always tested first. This allowed comparison of the No RAS 
condition after similar warm up to the NC group and eliminated immediate short term effects of 
RAS. The order of direction combinations was randomized within each condition on each test 
day. 
 Stepping performance of participants was recorded on the first day of training for a pre-
test (PRE), on the last day of training for a post-test (POST), and for retention tests, 1 week 
(RTW1), 4 weeks (RTW4) and 8 weeks (RTW8) after training. Three-dimensional motion of 
reflective markers placed on the lateral malleoli of the two ankles, were recorded with a four 
camera digital video system (Qualisys Mediacla AB). The first auditory cue of RAS triggered 
initiation of the camera capture and simultaneous 60 Hz data collection of markers. The RAS 
cues in a direction change occurred after the 11.25 s and 22.5 s according to the given cadence 
for a given speed. For the No RAS conditions this program was silenced and the visual display of 
the programs allowed the examiner to signal the participant for movement initiation, direction 
switching and termination as described previously. Participants did not receive step training 
between POST and RTW8 and were asked to continue with normal activities during the 
program.  
 Data from the ankle markers were analyzed through customized Matlab and LabView 
programs. Position data were filtered through a zero phase lag 10 point averaging design. 
Tangential velocity profiles were calculated by five-point differentiation of the filtered position 
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data. Position and tangential velocity profiles were plotted across time, visually scanned and 
marked to help determine kinematic measures. Figures 4.1A and 4.1B) show plots from these 
profiles and example markings used for calculating kinematic measures described below. 
Movement onset (ON) and end (END) corresponded to the frame prior to the first discernable 
movement in the given direction and the frame after the last discernable change in the given 
movement direction, respectively, from position profiles.  
Several spatial and temporal kinematic measures affected by PD were calculated to offer 
insight regarding movement changes before and after training. Selected measures were based on 
reductions in gait velocity [56] and step length [57] in addition to shuffling of the feet during 
gait[6] and changes in cadence [58] for those with PD. Direction switch duration (DSD) was 
selected as the primary measure because temporal movement transition is a well-known 
disruption in PD [21, 22]. DSD was defined as the duration between the time the foot returning 
to the platform stopped moving in one direction and the time when the opposite foot moved to 
leave the platform to the next direction according to ankle markers. For example, the frame for 
ON of the left ankle side was subtracted from the frame for END of the right foot back divided 
by the 60 Hz sampling frequency (see ON-DSD and END-DSD, Fig. 4.1A). Peak tangential step 
velocity (VEL) was identified as the maximal step velocity between ON and END of each step 
from the tangential velocity profile of the ankle marker of interest (see ON-MOV and END-
MOV, Fig. 4.1B). Kinematic variables of step length (SL), step height (SH) and step number 
(SN) were also calculated. SL was calculated as the displacement of the ankle marker in the 
lateral (y-) direction for side steps or anterior/posterior (x-) direction for forward or back steps. 
In a back step, for example, SL was the difference between the x-values at END and ON of a 
given step (see END-MOV and ON-MOV, Fig. 4.1B). SH was determined as the maximal z-
value during this same time minus the average of the first five z-value frames during stance at 
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Figure 4.1 Example of position and velocity marking. Examples of position (A and B) and 
velocity (B) profiles used for identifying different kinematic variables are indicated. Data are 
from two different trials for plots in A and B. Example markings used for direction switch 
duration (DSD) are plotted in A and those for peak step velocity (VEL), step length (SL), step 
height (SH), step number (SN) and reaction time (RT) are plotted in B. Position and velocity 
profiles are separated in B for better clarity. Plots in A show the end of the movement of the right 
ankle marker in the back direction (x) is indicated by the END DSD solid line and the onset of 
the movement of the left ankle marker in the side direction (y) is indicated by the ON DSD solid 
line. Plots in B show corresponding lines determined for a single step and indicate ON MOV and 
END MOV of the first back step (x) of the right ankle marker. The vertical dashed line 
represents 11.25 s associated with the timing for a direction change.  
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the beginning of a trial. SN in whole or half steps for each direction of a trial during the 11.25 s 
was also determined. A half trial was counted if the peak of the profile was included in the time 
frame while the END was not (7.5 steps were identified for Fig. 4.1B). For SL, VEL, SH and SN 
average values for each participant were determined for each direction within a given speed. For 
DSD trials were separated based on the direction to which switching occurred. For example, a 
BSF trial included switching to S and to F directions, thus DSD was determined for these 
directions, before average values were calculated for each direction within a given speed for each 
participant. Standard deviations were used to determine variability of these measures (see ―var‖ 
subscripts), except for step number. Including initial reaction time (RT) in the RAS condition for 
the C group allowed us to determine effects of RAS use on RT, if any. RTs to the first cue of 
each trial were calculated. These measures were determined as the time interval between the first 
cue and the ON frame of the ankle marker of interest (see RT between frame 0 and ON-MOV, 
Fig. 4.1B). Final RT values were averaged for each direction, speed and participant. 
Statistical Analyses  
Pair-wise t tests were performed to compare group characteristics obtained before training (see 
characteristics under subject details, Table 4.1). Repeated measures ANOVAs with a random 
factor for subject,, between subject factor of Group (C, NC), within subject factors of Direction 
(F, S, B) and Speed (F, N, S) and repeated measures on Test-day (PRE, POST, RTW1, RTW4, 
and RTW8) were used to compared differences between groups and among test days for the No 
RAS condition while accounting for direction and speed effects. A similar design with a within 
subject factor of Direction and Speed and repeated measures on Test-day was used to compared 
the RAS condition across test days. A Kenward Rogers adjusted degrees of freedom was used 
because of the relatively small sample size and missing participants on certain test days. Tukey’s 
post-hoc tests were used when appropriate to compare selected measures across test days. 
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Table 4.1 Characteristics and pre-test measures from C and NC groups. 
Subject details C group NC group p-value 
Age (years)  73.3 ± 2.2 70.5 ± 2.2 0.59 
Gender F= 3, M = 5 F = 2, M = 6  
Height (cm) 168.8 ± 3.3 171.8 ± 4.3 0.52 
Weight (kg) 79.5 ± 0.18 78.4 ± 0.2 0.80 
Disease duration (years) 8.9 ± 1.8 7.5 ± 1.2 0.28 
Modified H&Y = number of 
participants for each stage 
2 = 1 
2.5 = 5 
3 = 1 
4 = 1 
2 = 1 
2.5 = 5 
3 = 1 
4 = 1 
 
Normal step cadence (steps/min) 56.8 ± 6.0 57.0 ± 7.1 0.63 
DSD (s) 1.34 ± 0.19 1.36 ± 0.25 0.59 
DSDvar (s) 
 
0.41 ±  0.08 
 
 
0.45 ± 0 .09 
 
0.41 
VEL (m/s) 0.37 ± 0.04 0.31 ± 0.05 0.56 
VELvar (m/s) 0.47 ± 0.08 0.33 ± 0.08 0.53 
SN (steps/11.25 s) 8.0 ± 0.9 8.3 ± 0.8 0.27 
SL (m) 0.28  ± 0.02 0.26 ± 0.02 0.40 
SLvar (m) 
 
0.15 ± 0.02 
 
 




0.06 ± 0.04 
 
0.06 ± 0.03 
 
0.23 
SHvar (m) 0.027  ± 0.032 0.024 ± 0.037 0.18 
 
Mean ± 1 standard error for subject characteristics and kinematic measures of the C (cue) and NC (no 
cue) groups recorded on the first day of practice are provided. The p-value results of t tests used to 
compare groups on these measures are listed. F—female; M—male; H&Y—Hoehn and Yahr score; 
DSD—direction switch duration; VEL—peak step velocity; SN—step number; SL—step length and 
SH—step height. The ―var‖ subscript stands for variability of associated measures. 
Significance level was preset at p < 0.05 for all analyses (SAS V.9.1). 
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Results 
Sixteen participants completed 6 weeks of training and PRE, POST and RTW1 tests. Three 
participants were unable to complete RTW4 and RTW8 tests either because of medication 
change or a scheduling conflict. Two participants from the C group and 1 participant from the 
NC group missed testing on RTW4, while 1 participant from the C group and 2 participants from 
the NC group missed testing on RTW8. Analyses and plots in Figs. 4.2 and 4.3 and Table 4.2 
account for the change in participant numbers during tests conducted 4 and 8 weeks after training 
ended. 
Subject characteristics and pre-training kinematic measures for stepping with No RAS 
are presented in Table 4.1 to offer insight to the C and NC participants. These data verify the 
disease matching between groups and show that most participants were at the moderate stage of 
the disease (H&Y = 2.5). Results from t tests show that age, weight, height, disease duration, 
MMSE scores, normal stepping cadence and kinematic measures did not differ between groups.  
Training Effects for the No RAS Condition 
Certain step kinematics were influenced by training type, but only when accounting for 
Test-day. Significant Group x Test-day interactions existed for DSD (F4,99.2 = 7.74, p < 0.0001), 
DSDvar (F4,66.1 = 7.03, p < 0.0001), SN (F4,58.9 = 21.03, p < 0.0001) and VEL (F4,65.9 = 10.03, p < 
0.0001) and reveal the major results of this study. For the C group DSD values decreased (Fig. 
4.2A), while those of VEL (Fig. 4.2B) and SN (Fig. 4.2C) increased after training and alterations 
compared to pre-training values were maintained for at least 8 weeks (see blue asterisks, Fig. 
4.2). DSD, VEL and SN were significantly different for the C group compared to the NC group 
on POST, RTW1 and RTW4 (see black asterisks on brackets in corresponding plots identifying 
group differences). DSDvar also remained lower than PRE values up to RTW4 for both groups 
and was maintained up to RTW8 for the C group (Table 4.2). Differences between groups were 
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Figure 4.2 Mean kinematic values during the No RAS condition for C and NC groups. Values of 
(A) direction switch duration (DSD), (B) peak step velocity (VEL) and (C) step number (SN) for 
C (blue diamonds) and NC (red squares) groups are shown for pre-test (PRE), post-test (POST) 
and retention tests 1 week (RTW1), 4 weeks (RTW4) and 8 weeks (RTW8) after training for the 
No RAS condition. Blue asterisks represent a significant difference from the PRE values for the 
C group. Curly brackets with black asterisks represent a significant difference between groups on 














































Table 4.2 Mean direction switch duration variability for test day 
Group PRE POST RTW1 RTW4 RTW8 
C 0.413 (8)  0.247 (8)  0.259 (8) 0.189 (6) 0.231 (7) 
NC 0.449 (8) 0.264 (8) 0.244 (8) 0.324 (7) 0.331 (6) 
Mean variability of direction switch duration (DSDvar) during the No RAS condition of the C 
(cue) and NC (no cue) groups for each test day are shown for the pre-test (PRE), post-test 
(POST) and follow-up retention tests 1 week (RTW1), 4 weeks (RTW4) and 8 weeks (RTW8) 
after training. The values in parenthesis represent the number of participants for that test day. 
Bold values represent significant differences from the PRE values. Asterisks on curly brackets 
represent a significant difference between groups for the given day.  
 
Figure 4.3 Mean variability values during the RAS condition. Variability measures of (A) 
direction switch duration (DSDvar), (B) peak step velocity (VELvar), (C) step length (SLvar) and 
(D) step height (SHvar) for the C (cue) group are shown for the pre-test (PRE), post-test (POST) 
and retention tests 1 week (RTW1), 4 weeks (RTW4) and 8 weeks (RTW8) after training. 
Asterisks indicate significant differences from the PRE test. Error bars represent 1 standard error. 
 
identified for RTW4 and RTW8 (see asterisks on brackets, Table 4.2), showing that training with 




































































without it. Overall these findings indicate that certain step kinematics changed more or lasted 
longer for those training with RAS compared to those without it for the No RAS condition. 
Training Effects for the RAS Condition 
Training effects on kinematic variables during step performance with RAS for group C 
showed that variability of the different kinematics during multi-directional stepping was  
influenced by training with RAS use. A significant effect of Test-day existed for DSDvar (F4,117 = 
3.00, p = 0.0214), VELvar (F4,91.9 = 3.40, p = 0.0122), SLvar (F4,74.1 = 6.54, p = 0.0001) and SHvar 
(F4,70.5 = 6.56,  p = 0.0002). Plots in Figs 4.3A-D, show that these values decreased after training 
termination, and remained below PRE values on all retention tests. Other spatial and temporal 
measures, including RT, did not change significantly after training. Thus 6 weeks of multi-
directional step training with RAS decreased the variability of spatial and temporal measures 
during task performance that were maintained at least 8 weeks after training termination.  
Speed and Direction Effects 
A main effect of Speed was identified for different kinematic variables obtained during 
step task regardless of RAS condition. Main effects of Speed were determined for DSD (No 
RAS: F2,222 = 18.73, p = 0.002; RAS: F2,115 = 7.35, p = 0.001), VEL (No RAS: F2,110 = 10.51, p  = 
0.006; RAS: F2,117 = 13.42, p < 0.0001) and SN (No RAS: F2,78.2  = 14.19,  p = < 0.0001; RAS: 
F2,115 = 9.13, p = 0.002). Figure 4.4 shows that VEL (A) and SN (B) increased for the fast speed 
and decreased for the slow speed relative to the normal stepping speed for No RAS (left panels) 
and RAS (right panels) conditions. Participants also decreased DSD for the fast speed and 
increased it for the slow speed in comparison to the normal stepping speed (Fig 4.4C). These 
results suggest that participants were able to adjust peak step velocity, duration of step direction 
switching and number of steps to either follow task instructions related to speed change in the No 
RAS condition or follow auditory cues in the RAS condition. Direction effects were also 
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Figure 4.4 Mean kinematic values across speeds without and with RAS. Mean values of the (A) 
peak step velocity (VEL), (B) step number (SN) and (C) direction switch duration (DSD) are 
shown for slow, normal and fast speeds for the No RAS (black plots, left panel) and RAS (blue 
plots, right panel) conditions. N = 16 (C and NC participants) for the No RAS plots and N = 8 (C 
participants) for the RAS plots. Asterisks between slow and normal and normal and fast speeds 
indicate a significant difference between the corresponding values. Error bars represent ±1 
standard error. Note, some bars are too small to see in plots. 
 
identified for most kinematic variables during the step task whether RAS was used or not. 
Significant main effects of Direction were determined for SL (No RAS: F2,88.2 = 13.69, p < 
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17.02, p < 0.0001), SH (No RAS: F2,229 =17.21, p < 0 .0001; RAS: F2,116 = 5.03,  p < 0.0001), 
SHvar (No RAS: F2,141 = 21.82, p < 0.0001; RAS: F2,116 = 3.84, p = 0.001), VEL (No RAS: F2,118 = 
24.31, p < 0.0001; RAS: F2,118 = 18.01, p < 0.0001) and VELvar(No RAS: F2, 171  = 3.48, p = 0.03; 
RAS: F2,115 = 268.65, p < 0.0001). Figure 4.5 shows that SL(A), SH (B) and VEL (C) were always 
smallest for the back stepping direction for the No RAS (left panels) and RAS (right panels) conditions. 
In contrast the variability of these measures were largest for back steps (No RAS: SLvar = 0.17 ± 0.09 m, 
SH var = 0.028 ± 0.002 m, VELvar = 0.44 ± 0.05 m/s; RAS: SLvar = 0.15 ± 0.09 m, SH var = 0.027 ± 0.002 m, 
VELvar = 0.41 ± 0.02 m/s) and significantly different from forward (No RAS: SLvar = 0.13 ± 0.09 m, SH var 
= 0.025  ± 0.009 m, VELvar = 0.40 ± 0.05 m/s; RAS: SLvar = 0.12 ± 0.09 m, SH var = 0.020 ± 0.002 m,  
VELvar = 0.29 ± 0.03 m/s) and side (No RAS: SLvar = 0.13 ± 0.94 m, SH var = 0.023  ± 0.002 m, VELvar = 
0.39 ± 0.05 m/s; RAS: SLvar = 0.12 ± 0.89 m, SHvar = 0.021 ± 0.002 m, VELvar = 0.31 ± 0.02 m/s) step 
directions. Step length, step height and peak step velocity clearly differed for back steps compared to the 
forward and side steps in this task. Overall, 6 weeks of multi-directional step training with and without 
RAS resulted in alterations that were maintained at least 4 weeks after training termination. These 
alterations are discussed further in the following section.  
Discussion 
 This study was conducted in order to add to the limited research on long term training 
effects of RAS use on transitional movements for those with PD. The multi-directional step 
protocol was designed to focus on step direction changes in a supervised environment. Such 
changes in movement are known to cause difficulties for people with PD [22]. C group 
participants decreased their absolute duration of step direction switching, increased their peak  
step velocity and the number of steps in a given time period and maintained these improvements 
 above baseline values at least 8 weeks after practice terminated. Step practice resulted in 
decreased variability of the duration of step direction switching during the No RAS task 
regardless of RAS use in training. Participants who trained with RAS were able to maintain these  
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 Figure 4.5 Mean kinematic values across directions without and with RAS. Mean values of the 
(A) step length (SL), (B) step height (SH) and (C) peak step velocity (VEL) are shown for 
forward, side and back directions for the No RAS (black plots, left panel) and RAS (blue plots, 
right panel) conditions. N = 16 (C and NC participants) for the No RAS plots and N = 8 (C 
participants) for the RAS plots. Horizontal bars indicate significant differences at the bars’ ends. 
Error bars represent ±1 standard error. Note, most bars are too small to see in plots. 
 
improvements longer. Supplementing multi-directional step training with RAS offered several 
kinematic alterations when performing the step task without RAS use that were not observed in 
those training without it. These alterations appear beneficial as the changes that occurred mimic 







































The severe slowness during transitions observed previously for PD patients [22, 69] led 
to expected slowing of step direction switch durations in this population prior to training. The 
present study did not, nor was it designed to observe this slowing prior to training. Rather, it 
revealed a significant reduction in DSD accompanied by increase in peak step velocity and step 
number for the No RAS condition after training for the C group participants. No such changes 
were detected for those in the NC group. These findings follow those of straight line walking 
where reduced durations of Vastus Lateralis activity accompanied increased step cadence and 
average gait velocity only for PD participants who received 3 weeks of gait training with RAS 
[47]. Minimal, non-significant changes were detected for individuals with PD receiving the same 
type and amount of training with no external cues [47]. Together these studies provide evidence 
that RAS training results in movement modifications when performing tasks involving 
directional adjustments without cues that do not occur without use of RAS in training. Moreover, 
results from the current study showed that PD patients were able to retain such improvements in 
the stepping task for at least 8 weeks.  
Unlike the aforesaid measures DSDvar obtained during stepping in the No RAS condition 
decreased similarly for both groups immediately after training termination and was maintained 
for at least 1 week. Higher temporal variability without cues reported for finger tapping [59], 
repetitive wrist flexion [60] and stepping [4] in this population is observed, thus it is not 
surprising that temporal variability can decrease with certain applications. Remember that verbal 
commands were given at the end of each direction time period for participants during the No 
RAS condition. Results from the No RAS condition mimic those for reduced variability of 
movement duration after presentation of a single auditory tone provided shortly before initiation 
of a multi-segmented reaching task compared to reaching without a tone [61]. It is possible that 
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the attention control offered by a verbal start cue [21] for the direction change in the No RAS 
condition for both groups was adequate to result in the immediate decrease in DSDvar. However, 
this does not explain why participants in the C group were able to maintain these improvements 
longer. Alterations in neural pathways may help explain the greater retention capabilities 
observed for this group as reductions in step to step variability during non-cued walking after 
RAS gait training are directly linked to changes in central pathways according to Positron 
Emission Topography (PET) records [62]. These activated pathways were similar to those 
reported during RAS paced finger tapping and different from those of internally generated finger 
tapping [63]. Further studies are warranted to verify such direct effects of RAS on attention and 
neural pathway alterations in this population. 
Retention abilities in No RAS conditions were not exclusive to DSDvar as changes in 
DSD, VEL and SN, were also maintained 8 weeks after training termination for the C group 
participants. Using RAS during training appears to help people with PD maintain alterations in 
step kinematics for a period of time longer than the training period, exceeding that of equal 
retention reported previously; 6-week retention of UPDRS-ADL scores were observed after 6 
weeks of physical therapy with auditory cues compared to that with no cues [49]. The present 
results suggest that longer retention of these scores would be observed if tested, however 
maintaining movement alterations for a period of time twice as long as the training period seems 
unlikely for walking or stepping, as loss of improvements in average gait velocity and stride 
length were observed when walking without RAS, 6 weeks after a 3-week RAS gait training 
protocol [50]. Future studies could determine whether longer training regimes such as 6 weeks 
can produce longer relative training retention over shorter training regimes such as 3 weeks. 
Regardless of such findings, it seems clear that supplementing training with RAS results in 
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certain kinematic changes that carry over to the No RAS condition and can be maintained over a 
relatively long period of time. 
Training effects with RAS use on spatial kinematic measures during the No RAS 
condition are not as consistent as the kinematic measures just discussed. No changes in spatial 
values of SL, SH and their associated variability measures were detected for the No RAS 
condition of the multi-directional step task. Increase in step length with and after application of 
RAS was reported in some cases of straight line walking (e.g. [41]), however not in others [30, 
40]. It is thought that RAS use may not influence muscular amplitude to an extent to cause 
absolute step length changes [40], as its primary influence is on temporal aspects of movement 
[30, 40]. Thus although effects of RAS on spatial measures do exist, these different outcomes 
may result from indirect rather than direct links to RAS use. Direct effects of RAS use on spatial 
variability help explain the different study findings in absolute length changes and offer further 
insight on this issue. 
Kinematic outcomes from multi-directional step training with RAS for the C group often 
differed from those in the No RAS condition. Kinematic alterations after training were limited to 
the variability measures for RAS condition. These variability reductions remained at least 8 
weeks post training. Thus, although temporal variability reductions were detected for both RAS 
and No RAS conditions for DSDvar, changes in spatial variability were limited to the RAS 
condition. Different neural mechanisms suggested for temporal and spatial variability measures 
are blamed for this disparity. While temporal variability appears under the control of central time 
keepers, possibly located in BG and cerebellum [62], spatial variability has been linked to the 
noisy muscle output [64]. Specifically, the abnormal activity of sub-cortical structures such as 
the reticular formation is linked to the abnormal muscle activity in PD [65]. Thus, it is possible 
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that changes in spatial variability represent the influence of RAS on the proposed reticulo-spinal 
pathway [66, 67] because it does not carry over to the No RAS condition.  
Results on reaction time (RT) support previous findings for people with PD. Step RT to 
initial cues did not change for C participants after training. Previous work indicated no changes 
in simple and choice RT after hundreds of practice trials for a discrete reaching task for those 
with PD [68]. It appears that, whether using the upper or lower limbs or simple or choice RT, 
training does not affect RT in certain subgroups of this population. These findings are not 
verified for PD patients with more or less disease severities or severe freezers with the disease. 
Several alterations in kinematics determined during performance of the multi-directional 
step task after practice with RAS use were observed. On the other hand only one measure, the 
variability of step direction switch duration, changed after training without RAS use. Training 
with RAS resulted in significant reductions in spatial and temporal variability measures. In this 
case the temporal variability of step measures reduced in the No RAS condition after training, no 
such alterations occurred for spatial variability measures. Thus, not all RAS training effects 
transferred to the No RAS condition.  
Speed and Direction Effects  
Certain kinematic alterations were identified during multi-directional step performances 
in RAS and No RAS conditions. Most effects of speed and direction on these variables occurred 
regardless of training.  
Individuals with PD are capable of adjusting muscular force internally [69] and to 
external demands [21]} when movement speed requires adjustments. However, the peak 
movement velocity and muscle amplitude remain abnormally low [69] due to deficient muscle 
activation [70]. Thus, individuals with PD can also modify cadence, average step velocity and 
step duration for different non-cued [58] and cued [39] walking speeds even though the overall 
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speed remains slower than healthy controls [39, 58]. In the current study participants showed 
similar capabilities by adjusting DSD, VEL and SN to slow and fast stepping speeds regardless 
of the RAS condition. They also showed no alterations in step length like other PD individuals 
walking at different speeds [58] or with different RAS frequencies [30]. Therefore, PD 
participants in the current study were able to adjust certain step kinematics to alter their speed for 
the selected stepping task even with expected low muscle activation levels and overall slowness.  
It is important to note that although individuals with PD can modulate movement speed, 
adding RAS can enforce further alterations for a given speed. For example, gait velocity 
increased with use of a comfortable RAS frequency compared to a self-selected walking speed in 
PD [37]. Higher values of velocity detected during gait with +10% RAS compared to a self-
generated maximum gait for individuals with PD, on and off medication also exist [57]. 
Furthermore previous findings indicated higher VEL and lower DSD values for all RAS speeds 
compared to their corresponding No RAS stepping speed prior to training (see chapter 2). 
According to these findings it is evident that speed regulation occurs regardless of RAS, but 
adding this modality may lead to faster movements in response to a given speed (e.g. peak step 
velocity for the normal speed with RAS was higher than peak velocity for the normal speed 
without RAS, Chapter 2). Moreover, the speed adaptations occurred, regardless of the movement 
direction and despite higher instabilities reported for the back direction [71].  
Moving in the back direction clearly differs from side and forward movements for those 
with PD. In the current study stepping back resulted in lower VEL and higher VEL variability. 
These findings agree with a previous report which indicated that back direction stepping is 
significantly slower than forward stepping for those with PD [72]. However no known reports on 
greater peak step velocity variability for this direction and population exist until now. The lower 
SL, SH and associated variability measures for back stepping in the present work is likely 
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indicative of greater imbalance in this direction. This is because higher stride length variability 
[73], reduced step height [74] and stride length [72] are associated with gait initiation 
instabilities.  
 Conclusion 
Results from the current study indicate that movement kinematics for multi-directional 
stepping are modified after RAS training. This was indicated by a faster step direction transition 
(DSD), greater step frequency and velocity and lower variability for DSD. These changes were 
maintained at least 8 weeks after training terminated and indicate the effectiveness of this 
modality for modifying activities that require direction transition, a difficult movement for those 
with PD. 
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CHAPTER 5: GENERAL DISCUSSION 
Key Results 
 The debilitating effects of PD on motor performances have led to many investigations for 
alleviating motor symptoms for this population. Medical and surgical treatments relieve several 
motor symptoms but some complications such as temporal movement parameters are resistant to 
these treatments. Rehabilitation methods such as RAS application hold many benefits as 
noninvasive strategies for improving motor performance for repetitive movements such as 
straight line walking in those with PD. In this document studies on the effects of RAS use during 
performance of the multi-directional step task extend the knowledge of RAS use to a more 
complex activity which presents difficulties for those with PD.  
 In chapter 2 we explored the effects of RAS on multi-directional stepping kinematics in 
PD participants where they performed the stepping task with and without RAS. Results showed 
that direction switch duration (DSD) of stepping, peak step velocity (VEL) and step number 
(SN) differed across speeds for performances with and without the use of RAS. An increase in 
VEL and decrease in DSD was observed for participants stepping with the use of RAS. Various 
functional gait and balance measures were also collected to evaluate associations of kinematic 
and functional measures with one another and disease severity. Results showed that DSD was the 
only kinematic measure with significant links to disease severity and various functional measures 
of gait and balance including the primary measure of interest, the dynamic gait index (DGI). 
These results offered short term effects of RAS use on the multi-directional step task.  
Investigation of the long term effects of RAS use with multi-directional step training 
were explored in chapters 3 and 4. Step training and RAS influence on functional gait and 
balance measures were presented in chapter 3. The multi-directional step task was performed by 
two groups of PD patients, those who received RAS/auditory cues (Cue, C) and those who did 
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not (No cue, NC). Both groups underwent 3 days/week of multi-directional step training for 6 
weeks with increasing difficulty each week. Performance of PD participants during non-cued 
gait and balance functional testing was investigated before training, immediately after training 
and up to 8 weeks after training termination. Immediately after practice both C and NC groups 
showed improvements in the primary gait measure of interest (DGI), as well as other gait 
measures. Although both groups were able to maintain balance improvements for at least 8 
weeks, only the participants from the C group maintained gait improvements during this time. 
Chapter 4 was used to explore the underlying cause of such functional improvements. 
Kinematics obtained from C and NC groups during performance of the multi-directional step 
task without RAS use was studied along with functional tests before training, immediately after 
training and up to 8 weeks post training. The variability of DSD (DSDvar) during step 
performance without RAS use reduced immediately after practice and remained lower than pre-
test measures at least 4 weeks post training for both groups. The C group maintained this change 
for at least 8 weeks. Participants in this group were also able to decrease DSD and increase VEL 
and SN after training and maintain these changes relative to pre-test measures on all retention 
tests. After training the C group was also able to reduce the variability of SL, SH, VEL and DSD, 
retaining these changes on all post training visits in the RAS condition. 
 The following sections will focus on discussion of the relationship among the major 
results from chapters 2-4. Limitations of the current work and suggestions for future research 
directions complete this chapter. 
Discussion of the Key Results 
Linking Immediate and Long Term RAS Effects 
 Several investigators have evaluated the use of RAS on gait related activities for various 
populations to offer insight to either its short term (immediate) or long term (training) effects. 
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The following section will focus on RAS effects for such immediate and training comparisons 
for the PD population.  
Studies to examine RAS effects after its short term [1-7]  and long term [8-11] use exist. 
While in the short term studies investigators evaluate activities with and without RAS, those for 
the long term investigations emphasize assessment of non-cued performances only. This latter 
assessment offers excellent insight into generalization of activities to a more common, non-cued 
environment but does not clarify the specific cue influence on movement after practicing with 
RAS. The current design allowed us to compare some short term and long term training effects 
with use of RAS on multi-directional step performance with and without cueing.   
 Figure 5.1 shows the major outcomes for the RAS/No RAS comparisons of different 
kinematic measures for the C group. Immediate RAS effects were identified for DSD and VEL 
during the pre-test (Fig. 2.2A, B) and did not change significantly with training (chapter 4). The 
values for each of these variables after training for post and retention tests were very similar to 
pre-test values and similar to values for the No RAS condition (see Fig. 5.1A, B). The non-
significant trend identified for immediate RAS effects for SN (Fig. 2.2) also did not change 
significantly with training (chapter 4), however post-test and retention test values were similar 
for the RAS and No RAS condition regardless of the training improvements observed for the 
latter (see Fig. 5.1C). Thus, it is evident that for the specified measures any immediate RAS 
effects do not improve with training. Furthermore, training with auditory cues resulted in  
alterations in the No RAS condition to achieve similar changes to those immediate effects of 
RAS use. These results indicate no additional improvements in these measures with the use of 
RAS during step performance after training (i.e. observe similar POST-RTW8 values for RAS 
alterations in the No RAS condition to achieve similar changes to those immediate effects of 
RAS use. These results indicate no additional improvements in these measures with the use of 
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Figure 5.1 Mean kinematic values with and without RAS for the C group across test-days. Mean 
values of (A) direction switch duration (DSD), (B) peak step velocity (VEL), (C) step number 
(SN), (D) direction switch duration variability (DSDvar), (E) peak step velocity variability 
(VELvar ), (F) step length variability (SLvar) and (G) step height variability (SHvar) are shown for 
the pre-test (PRE), post-test (POST) and retention tests 1 week (RTW1), 4 weeks (RTW4) and 8 
weeks (RTW8) after training. All data are from the C (cue) group participants for No RAS (blue) 
and RAS (black) conditions. Blue and black asterisks represent a significant difference from the 
PRE values for the No RAS and RAS conditions respectively. Error bars represent 1 standard 


















































































































RAS during step performance after training (i.e. observe similar POST-RTW8 values for RAS 
and No RAS, Fig. 5.1A-C). In contrast, no immediate changes for DSDvar were found with RAS 
application, but DSDvar decreased after training completion and remained that way during all No 
RAS (see group C, Table 4.2) and RAS (Fig. 4.3A) post-training tests. Figure 5.1D shows these 
results plotted together, emphasizing a greater variability reduction for DSD with the use of RAS 
during post training evaluations. The reductions in DSDvar observed after training with RAS 
results in DSDvar reductions for stepping with and without cues, however stepping with cues will 
offer additional reductions in this variable for those with PD. Like DSDvar, variability of step 
length, (SLvar), step height (SHvar) and peak step velocity (VELvar) did not change significantly 
with RAS use on pre-tests (chapter 2) but did change significantly after training completion for 
the RAS condition (Fig. 4.3B-D and Fig. 5.1E-G). No alterations in these variables were 
observed for the No RAS condition across different test days (Fig. 5.1E-G). It appears that for 
these variables RAS training effects are context specific. Together, these results provide 
evidence for immediate RAS effects on absolute temporal variables and training RAS effects on 
spatial and temporal variability measures for the multi-directional step task. Previous work on 
RAS effects for either its immediate or long term use support the findings just listed, and were 
discussed in chapters 2 (immediate) and 4 (long term). 
The Underlying Mechanisms 
By including C and NC groups and testing functional and kinematic parameters we are 
able to make several speculations regarding the underlying mechanisms involved for the 
observed changes. As specified earlier RAS use with training for participants with PD resulted in 
several kinematic measurement alterations in the No RAS condition that were maintained on 
follow-up evaluations (see DSD, VEL and SN plots, Fig. 4.2). Alteration in one functional 
measure was also determined for post- and follow up tests exclusively for the C group (see 
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FOGQ values in Table 3.2). In other cases training resulted in kinematic and function 
measurement alterations regardless of RAS use, however the measurement changes retained for a 
longer period of time in PD participants that trained with RAS (see DSDvar values, Table 4.3; 
DGI plots, Fig. 3.2 and UPDRS-ADL, UPDRS-composite, Tinetti-gait and TUG values, Table 
3.2). These observations indicate that the underlying factors for the observed alterations differed 
between groups. Thus different mechanisms can be suggested for practice with and without 
RAS. 
Two suggestions have been posed to explain the carry over effects of RAS use to a no 
RAS condition for people with PD. One suggestion is that RAS resets the central time keepers 
which allow the movement to be entrained to temporal features of RAS [8]. This assumption is 
based on the ability of PD participants to regenerate a given movement with high levels of 
accuracy and low levels of temporal variability during a no RAS walking condition performed 
immediately after a RAS walking condition [8]. This explanation leaves one to wonder how the 
central time keepers reset in PD with a deficient component. Thus, a second suggestion to 
explain the carry over effects of RAS use in PD is the activation of a compensatory pathway 
which bypasses the defective BG. Projections from the cerebellum to the SMA and higher 
cortical areas offer a suitable compensatory pathway for explaining kinematic and functional 
findings in general [11]. Activation of such a pathway was proposed when associated activities 
were observed during a PET scan of finger tapping without RAS immediately after RAS gait 
training in the same participants with PD. Not only was there a transfer to an environment with 
no external cueing, the movement task changed from the lower to upper limbs. A similar 
pathway has also been suggested to take over auditory paced finger tapping compared to 
internally generated tapping [12]. Outcomes of the current and other RAS studies offer 
behavioral evidence for insights to the neural compensation abilities using external cueing.    
 98 
Practice without RAS also results in central changes which can explain some of the 
improvements observed for the NC participants. PET scans [13] and functional magnetic 
resonance imaging (FMRI) [14] results after practice reflect the patient’s ability to overcome 
certain deficiencies by recruiting greater neural areas. After learning sequential aiming tasks, PD 
patients revealed additional brain activation in pre-frontal and parietal cortices compared to 
healthy individuals [13]. Patients who presented with abnormal activity in the BG recruited 
additional areas including parts of the cerebellum, pre-motor, pre-frontal and parietal cortices 
after learning a sequential finger movement sequence while counting letters [14]. Similar 
increased activation exists following learning of sequential arm movements [15] and aiming 
tasks [16]. Evidently, patients recruit multiple cortical and sub-cortical regions to override the 
inappropriate output of the BG and to overcome certain motor deficits during motor learning. 
While practice without the use of RAS helps individuals with PD activate additional brain areas, 
the primary neural pathway involving the deficient BG does not change. Alternatively, externally 
paced movements using RAS are better performed because they are controlled through a 
pathway that circumvents the BG. Thus while similar compensatory brain areas are involved 
with or without RAS practice the abnormal signals from the deficient BG do not interfere when 
RAS is applied. This can be a possible advantage for adding RAS to a regular practice regiment 
and might be the primary source of the observed differences between C and NC participants.  
It is possible that the aforementioned central mechanisms are not the only factors behind 
the observed changes. The improvements that occurred only during the RAS testing for the C 
group (SLvar and SHvar) which did not transfer to the No RAS condition is an indication of this 
issue. In addition lack of correlation between DSDvar and functional tests that improved in the 
NC group indicates that other factors might be involved. Reports indicate changes in muscle 
activation symmetry in lower extremities during gait after RAS gait training [8] and increases in 
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muscle strength after No RAS balance training [17]. It is possible that similar muscular related 
changes occurred but we cannot verify this as they were not collected in this study. Furthermore, 
it is difficult to make assumptions regarding the underlying muscle changes based on the current 
findings because several gait related kinetic and kinematic measures appear to be independent of 
one another. For example, the generated power in the lower extremity appears to have no 
connections to gait velocity [18]. Elsewhere, the generated forces during walking are 
independent of walking speed, gait symmetry and gait swing durations [19]. More research is 
required to clarify muscular mechanisms involved with training in PD and RAS use. Such 
findings would allow us to better understand the underlying causes of behavioral improvements 
post-training and to better identify the effectiveness of various training programs. 
Limitations 
 Limitations that may affect generalization of findings exist in every study. Those linked 
to participant characteristics are listed first. This is followed by those linked to study 
methodology. 
 One of the primary limitations is that associated with the participants’ disease 
characteristics. Participants in the current study were primarily at the moderate stage of the 
disease. While those with more severe disease within this group revealed observed 
improvements, the overall lack of distribution in terms of disease severity poses limitations to 
generalizing the current results to individuals at more and less severe stages of the disease.  
 Other participant characteristics present potential limitations in the present study. Since 
most of the participants were recruited from a local support group, it is likely that participants 
were seeking strategies to deal with their disease and were highly motivated, thus represent a 
limited group of individuals with PD. The participating individuals also lacked obvious cognitive 
disorders. Lack of cognitive deficits is used as the primary inclusion criterion for many of the 
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rehabilitation studies [8, 20-22]. Yet research indicates that the annual MMSE decline for those 
with PD is 1 point per year [23]. One in 5 individuals with Parkinson’s disease has dementia [24] 
and declines 2 points per year in the MMSE scores [23]. These observations make one wonder 
whether the training protocol could be generalized to people with PD with less motivation or 
greater cognitive deficits.  
  Other limitations of the study were not dependent on participant characteristics. Although 
numbers of participants needed to achieve 80% power on the main functional measure of the 
DGI were only 6 in each group, this number did not ensure appropriate power on all variables of 
interest. Having a design with a tester not blind to the study is another limitation. It is clear that 
double blind placebo controlled studies can produce more credible results. Lastly, including a 
healthy age-matched control group would have provided more insight to the pre-test deficits and 
nature of improvements in those with PD.  
Regardless of study limitations, several positive outcomes were identified. Overall, use of 
auditory cues for multi-directional step training altered certain movement abilities to mimic those 
of controls and/or helped with maintenance of abilities in people with Parkinson’s. 
Future Directions 
Rehabilitation is considered a useful non-pharmacological approach to accompany 
regular medication in controlling motor complications in PD (Morris, 2000). Reviews of the 
previous rehabilitation literature [25-27]  indicate beneficial effects of practice for PD [28]. 
Training through rehabilitation appears to be a valuable means for improving motor abilities of 
PD, including those identified by the UPDRS-Motor and ADL scores and the PD disability scale 
[29]. With numerous techniques and no unified rehabilitation approach it is difficult to 
specifically determine a single beneficial rehab regime for those with PD [28]. Rehabilitation 
effects on motor deficits in PD should continue to add to the evidence-based practices to devise 
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such a regime or a series of specific well-accepted guidelines to better assist individuals from 
this population. Studies addressing the limitations listed for the current study are suggested in 
addition to the following. 
Weeks of motor training are reported to cause improvements when certain strategies are 
followed. These strategies offer evidence based procedures for future rehab studies and may 
contribute to the final ―specific guidelines‖ for therapists to assist individuals with PD. PD 
patients learned to correct their own body position errors and retain these abilities for a relatively 
long period of time when given more practice time than healthy individuals [30]. Providing these 
people with constant augmented feedback (observing their body sway via their center of pressure 
measurement on a computer screen) also resulted in improvements and maintenance in balance 1 
week post training [31]. Positive reinforcement allowed people with PD to learn and maintain 
compensatory stepping strategies up to 1 month after 7 weeks of gait training [32]. Practice 
schedules that began with easy skills and progressed to more difficult skills likely contributed to 
the improvements observed for stepping [32] and body positioning [30] just reported, as breaking 
down a sequential movement at initial training period is also suggested for this population [33]. 
We observed several successful outcomes in the present study by following several of these 
strategies. While C and NC groups followed similar training techniques, RAS use resulted in 
longer retention and better improvements for the C group participants. Our knowledge of the 
neural mechanisms involved with externally paced movements, the behavioral evidence 
regarding RAS use and more importantly the simplicity of RAS application makes this modality 
a suitable candidate for further use in other training programs for those with PD. Future research 
should incorporate this modality with effective learning strategies in order to enhance the 
training outcomes in individuals with PD with mild and severe levels of disability. 
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Physical activity is an essential factor for preventing many motor complication associated 
with sedentary life and alleviating emotional problems associated with PD [34]. Recent 
investigations also indicate neuro-protective benefits of exercise in a PD animal model [35]. 
However research indicates low rates of participation in physical activity and sports in those with 
PD [23]. Similar to these findings over half the participants (9/16) in the current study were not 
involved in a regular activity or a rehabilitation program. These participants expressed many 
reasons for activity limitations including transportation limitations (11/16), financial issues 
(9/16) and insurance restrictions (14/16). These concerns are not limited to the current 
participants as the average health care costs for an individual with PD is twice and much as a 
healthy age matched individual [36], while the amount of rehabilitation covered by insurance for 
these individuals is limited [37]. Therefore it is clear that designing a safe yet effective exercise 
protocols that can be performed by individuals with PD at home is essential. In fact, research 
indicates that 8 weeks of self-supervised home exercise can be as effective as a physical therapist 
supervised design in reducing UPDRS-Motor and TUG scores[21]. However, safety should be a 
major concern. Use of the multi-directional step protocol from the current study may be a home-
based training possibility for these people. Stepping from a stationary position where one can use 
a walker for assistance should be easier and safer for those at later stages of the disease with 
severe difficulties in balance and walking. Other techniques, such as mental imagery [38], have 
been successful to combat motor complications in this population and may offer greater safety in 
the home. However, evidence regarding its effects on retention abilities are not currently 
identified. Thus, future investigations are needed to explore and design safe, simple and effective 
activities specific for individuals with PD at various disease stage that can be performed in the 
convenience of their home. Based on results from the present work, we suggest that the multi-
direction step task with RAS may be such an activity.  
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APPENDIX A: LITERATURE REVIEW 
 
Effectiveness of auditory stimulation on movement control in Parkinson’s: 
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AS—Auditory Stimulation,  
BG—Basal Ganglia 
bmp—beats per minute 
BOS—Base Of Support 
COG—Center Of Gravity               
COM—Center Of Mass                   
COP—Center Of Pressure            
CPG—Central Pattern Generators  
DBS—Deep Brain Stimulation 
DLPFC—DorsoLateral Prefrontal Cortex 
FEF—Frontal Eye Field  
FMRI—Functional Magnetic Resonance Imaging 
FOG—Freezing Of Gait 
GM—Gastrocnemius muscle                                      
GP—Globus Pallidus 
GPe—Globus Pallidus pars externa 
GPi—Globus Pallidus pars interna 
HSV—Herpes Simplex Virus    
IRI—Inter-Response Interval  
M1—Primary Motor cortex    
MLR—Mesencephalic Locomotor Region   
MT—Movement Time   
NAC—Nucleus Accumbens 
PD—Parkinson’s Disease  
PET—Positron Emission Tomography      
PM—Premotor cortex 
PMv—Premotor Area ventral region  
PNF—Proprioceptive Neuromuscular Facilitation 
PPN—PedunculoPontine Nucleus  
PT—Physical Therapy 
ROM—Range Of Motion 
RT—Reaction Time      
SAPDDS—Self Assessment Parkinson’s Disease Disability 
SIP—Sickness Impact Profile 
SL—Soleus muscle 
SMA—Supplementary Motor Area  
SNc—Substantia Nigra pars compacta       
SNr—Substantia Nigra pars reticulate     
STN—Subthalamic Nucleus     
STR—Striatum      
TA—Tibialis Anterior muscle 
TMS—Transcranial Magnetic Stimulation 
UPDRS—Unified Parkinson’s Disease Rating Scale 
VL—Vastus Lateralis 
VP—Ventral Pallidus    
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1. INTRODUCTION 
1.1. Aims of Review 
 
Ever since James Parkinson described the clinical features of Parkinson’s disease (PD) in 
1817, scientists became curious to know more about this disease. Despite the arduous efforts of 
scientists that have increased our knowledge of the disease, there is neither a cure for PD nor a 
definitive treatment for its symptoms. Consequently, motor deficits remain a primary complaint 
of patients from this population.  
Current rehabilitation techniques provide a means for reducing some of the motor 
complications associated with PD. Use of external stimuli to help trigger movement has received 
special attention, as PD patients show the ability to improve some of their symptoms under 
externally triggered conditions that do not occur with other treatments. Emphasis will be on 
auditory stimulation because of the greater temporal benefits identified with its use. 
The first aim of this review is to introduce major motor complications of people with PD. 
The second aim of this document is to review the rehabilitation techniques applied to Parkinson’s 
patients, incorporating the benefits of using auditory stimulation as the external stimulation for 
improved motor outcomes for those with PD.  
1.2. Scope of Review 
 
Because PD reflects the dysfunctional basal ganglia, these complicated nuclei and their 
cortical and sub-cortical connections are introduced first. These findings will lead to the 
description of the disease and its pathophysiology with emphasis on motor complications. The 
role of the basal ganglia in motor control is then addressed in theoretical links. A complete 
review on the medical and surgical interventions is beyond the scope of this review; therefore a 
brief discussion on these interventions is provided and followed by a more detailed review of 
different rehabilitation techniques and motor learning outcomes in PD patients. Presentation of 
movement alterations in PD patients from rehabilitation using auditory stimulation complete the 
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topics reviewed. Finally, a summary of the findings, which lead to questions for future research 
and the associated hypotheses, are offered.  
                                  2. OVERVIEW OF PARKINSON’S DISEASE 
Parkinson’s Disease (PD) is a neurodegenerative disease which was first introduced by 
James Parkinson in Essay on the Shaking Palsy in 1817 as ―Paralysis agitans‖ [1]. PD is the most 
common neurodegenerative disease after Alzheimer’s disease. The incidence of PD is 13.4 in 
10,000 Americans per year [2]. The main problem in PD is mainly the dopaminergic deficiency 
of the basal ganglia [3]. Under normal conditions dopamine release allows the basal ganglia to 
serve as an internal trigger, enabling movements to occur in a sequential manner. Disruption of 
dopamine due to PD disrupts the normal functioning of the basal ganglia, thus voluntary 
movements. Clearly, to better understand PD and its associated deficiencies, one should first 
understand the normal functioning of associated neural structures and pathways. The focus of 
this chapter is to examine the major neural structures and pathways associated with PD, 
including the major nuclei of the basal ganglia and its connections, and to review the 
pathophysiology of the disease.  
2.1. Neural Structure Overview  
2.1.1. Major Nuclei and Pathways of the Basal Ganglia 
The basal ganglia (BG) are a group of sub-cortical nuclei that have been grouped and 
sub-grouped various ways in the literature. For this manuscript BG composition will include: the 
striatum (STR), which includes the caudate, putamen and nucleus accumbens (NAC); the 
subthalamic nucleus (STN); the two sections of the substantia nigra (substantia nigra pars 
reticulata-SNr  and substantia nigra pars compacta-SNc), the globus pallidus (GP) divisions of 
the internal segment (GPi), external segment (GPe) and the ventral pallidum (VP) [4]. The 





Many BG nuclei are involved in inhibition or dis-inhibition of their associated targets. 
The STR [5] and STN [6] serve as the input nuclei. While GPi and SNr are considered the major 
output nuclei of BG [7], VP is also known as an output nucleus [8]. The striatum receives input 
from different areas of the cerebral cortex [6], the hippocampus and the amygdala [9]. The 
Figure 1. A schematic diagram of the major connections of the Basal Ganglia (BG). Arrow ends connect the 
structure(s) releasing neurotransmitters and points connect to the targeted structure(s). Excitatory 
connections are represented by filled arrows and inhibitory connections are represented by empty arrows. 
Bold arrows represent connections of the BG to external cortical and sub-cortical structures (see key). The 
orange, blue and red lines represent direct, hyperdirect and indirect pathways, respectively. D1 and D2 are 
the dopamine receptors located on most striatum neurons. (SNc—substantia nigra pars compacta; SNr—
substantia nigra pars reticulata; STN—sub-thalamic nucleus; Gpe—globus pallidus pars externa; Gpi—
globus pallidus pars interna; PPN—pedunculopontine nucleus; BS—brain stem; VP—ventral pallidum) 
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structures of the striatum contain several receptors for different types of neurotransmitters. Of 
our interest are the dopamine receptors, D1 and D2, which receive their dopamine from the SNc. 
D1 receptors project to output nuclei, while D2 receptors project to GPe. Upon receiving the 
dopamine, D1 receptors facilitate the neural transmission of cortically received information in 
striatum while D2 receptors inhibit such transmission. The output nuclei GPi, VP and SNr 
receive projections from STN, STR and GPe prior to sending the signals to the ventro-lateral 
(VL), ventro-anterior (VA), mediodorsal (MD) and intralaminar (IL) nuclei of thalamus, which 
further target different areas of the cortex (for further details, see [10]). Figure 1 shows a 
schematic representation of these connections. 
Research on BG has led to the proposal of a classic view including two parallel cerebro-
basal ganglia loops which start in cerebral cortex, pass through the BG and end back in the 
cerebral cortex [11-13]. The loop involves direct and indirect pathways which are responsible for 
excitation and inhibition of voluntary movements, respectively. In the direct pathway the STR 
inhibit the major output nuclei (yellow arrow, Fig. 1), removing their inhibitory effect on the 
thalamus, resulting in excitation of the cortex and facilitation of voluntary movements [13]. 
However in the indirect pathway the STR first inhibit the GPe, which removes the inhibition 
over the STN (red arrows, Fig. 1), thus facilitating the inhibitory effect of the output nuclei on 
the thalamus [13].  
Although projections of cortex to STN were identified long ago [6] only recently a third 
pathway was added to the cerebro-basal ganglia model [14, 15]. The relatively new hyperdirect 
pathway (blue arrow, Fig. 1) involves direct activation of STN from frontal lobe projections [14] 
leading to movement inhibition similar to the indirect pathway, but faster [15]. It is suggested 
that during the voluntary movement the three pathways work together to withhold (hyperdirect), 
release (direct pathway) and terminate (indirect) the desired motor commands [15]. In addition to 
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these three external pathways several other external and internal circuits exist (Fig. 1), which 
contribute a great deal to the normal functioning of the BG [16]. For example besides the 
aforementioned indirect influence, GPe receives feedback from the STN and has direct 
projections to the output nuclei [17], and the thalamus [18]. The dopaminergic connection of the 
SNc to the STR [19] is another example of an internal circuit essential for normal functioning of 
the input nuclei.  
2.1.2. Other Connections of the Basal Ganglia 
 Just listing the structures associated with basal ganglia pathways allows one to 
appreciate the intricate nature of BG function. However, knowledge of the cortical and sub-
cortical connections will assist in understanding complications following disruption of BG. 
Anatomical techniques such as anterograde and retrograde viral injections [20] and electrical 
stimulation [21] have made it possible to reveal projections among the BG and cortical or sub-
cortical structures. Activities in some of the cortical areas have been noted through single neuron 
recordings to identify the specific functions of different regions [22]. 
2.1.2.1. Cortical Connections  
The input and output nuclei of the BG have well organized topographic areas for several 
cortical regions [23]. For example, through retrograde viral transportation a certain location 
within GPi directly linked to the distinct arm area of primary motor cortex (M1) [24]. Support 
for this finding includes evidence that stimulation of M1 led to the inhibition of GPi [25] and that 
trans-neuronal transport of herpes simplex virus (HSV1) revealed that the mid-rostrocaudal level 
of the GPi nucleus had direct connections to M1 [20]. Similar results exist for the input nuclei 
where anterograde transmissions show the connection of BG to the motor cortex, as injection of 
anterograde traces in forelimb and hind limb areas of rats label dorsolateral quarters of the 
caudate and putamen [26].  
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Similar examples are available for areas other than M1 and non-motor regions. Research 
indicates links between supplementary motor area (SMA) neurons and dorsal regions of GPi as 
well as pre-motor cortex/ventral section (PMv) and the ventrolateral portion of GPi [20]. Frontal 
eye fields (FEF) connect to the lateral region of posterior two third of SNr [20] and dorsomedial 
regions of striatum [26]. Gpi and SNr projections also target areas in prefrontal cortex [20], 
suggesting that areas in GPi and SNr are not only limited to motor areas.  
The evidence regarding cortical area connections with the BG are numerous. These 
studies converge on the fact that cortico-basal ganglia connections via input or output nuclei are 
related to motor and non-motor areas, are topographically separated and the separation allows for 
parallel processing of sensory and motor information [27]. Organization of BG could be thought 
of as reentering loops that start from a specific region in cortical area, pass through functionally 
related BG region by entering input nuclei and returning to the cortical areas once again. 
Therefore basal ganglia cortical circuits could be referred to as cortico-basal ganglia-thalamo-
cortical circuits. 
General functions of different cortical areas are fairly well-known. Through connections 
with the BG, knowing the major functions of each cortical area will assist with understanding the 
function of the BG. For example, knowing that SMA is involved in internal guidance of 
sequential movements [20] will allow us to make sense of how the BG could be involved in such 
guidance. Moreover, understanding that a patient with damage to dorsal regions of GPi will 
likely have difficulty with sequential guided movements will help with their rehabilitation. 
2.1.2.2. Sub-cortical Connections  
The basal ganglia have direct and indirect connections to sub-cortical structures. Direct 
outputs of BG target the brainstem or more specifically the midbrain [28, 29]. Projections of BG 
connect to the mesencephalic locomotor region (MLR) [30, 31] and the pedunculopontine 
 116 
nucleus (PPN) [32] of the mesopontine tegmentum (the junction of midbrain and pons) [33]. 
Some connections of midbrain and BG are reciprocal but indirect, as the midbrain is the major 
recipient of BG output [34-37]. Other examples include STN connection to PPN [38],  and 
unidirectional projections from the PPN to SNc [39]. Topographical organization observed in the 
cortical region is also reported for BG-tegmental projections [36, 40].  
The connections of the BG nuclei to midbrain are of importance because the medial 
reticulo-spinal tract, which passes through the ventromedial medulla and therefore spinal cord, 
stems from the midbrain region [41]. There is evidence that projection of MLR to the spinal cord 
through medial reticulospinal tract activates central pattern generators (CPG) in cats [42], 
therefore it is also linked to locomotion control [28]. The involvement of MLR in locomotion is 
further supported as stimulation of areas (e.g. PPN and SNr) with major associations to MLR 
evoke locomotion in rats [43] and cats [40, 44]. 
 More specifically, descending projections of PPN can reduce inhibition of muscular tone 
[21] and increase muscle tone inhibition via reticulo-spinal tract connections [40, 44-46]. If the 
MLR through its connection to PPN controls muscular activity and contributes to initiation of 
locomotion and its maintenance [21], it is reasonable to assume that projections of BG to MLR 
control locomotion by projecting to PPN and controlling muscular activation.  
Although neurological structures of cats or rats are not identical to that of human, some 
scientists regard the PPN as a BG nucleus (Webster, 1990), while others regard it as a close 
family member [47]. In humans it seems that the efferent projections of the brainstem (PPN) to 
the BG may be more important to movement compared to afferent stimuli [48], however its exact 




2.1.2.3. Functions of the Basal Ganglia Based on Connections  
Regardless of whether through the cortical or sub-cortical connections, functions of the 
BG involve contributions to movement. Review of the major functions of the corresponding 
connections with these nuclei will precede the associated pathophysiology in the following text. 
As mentioned previously, the input nuclei of the BG receive numerous projections from 
different cortical areas in a topographic manner [49]. However, indications of several 
overlapping areas result in common functions of separate regions [50]. For example, because of 
prefrontal cortical projections to the caudate and pre-commisural putamen and somatosensory 
cortical projections to the putamen with few to the caudate, it should not be surprising that the 
caudate appears to be mostly involved in preparation of the movement (prefrontal) and that parts 
of caudate and the anterior putamen are involved in preparation (prefrontal), response and 
generation (somatosensory) of movement [51]. Due to the nature of connections malfunction of 
the caudate cause behavioral disorders [52], cognitive disorders  [53], spatial neglect [54], 
language difficulty (aphasia) [55] and other major prefrontal syndromes such as dysfunctions in 
planning, abstracting rules and working memory function [56]. The putamen on the other hand 
has a significant roles in control of movement and is rarely involved in emotional or cognitive 
control [57-59].  
Because of the nature of these connections the projections of the STR and STN could be 
regarded as the sensori-motor, associative or limbic [60]. The function of other nuclei such as 
GPi/SNr, GPe and SNr cannot be evaluated in isolation. These nuclei complete the loop 
originally started from the cortex and the input nuclei and similar to the input nuclei these areas 
are topographically and functionally distinct [48, 61]. Therefore, the function of each specific 
region within these nuclei depends on their anatomical connection to the STR and STN. For 
example, the area of GPe associated with caudate will regulate emotion and cognition [62]. The 
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section of SNr receiving input from head and body of caudate contributes to saccadic eye 
movement [63]. Therefore the functions of different areas of GPi/SNr in internal generation of 
sequential movements, or control of cognition and executive function depend on the origin 
within the BG or the cortex [20, 58]). Specifically, inputs to the BG specify what type of 
information these nuclei can process, while outputs from the BG reflect their function [64]. 
Connectional organization of the BG shown in Fig. 2 should help with understanding these 
functions.  
The numerous individual roles of the BG nuclei act collectively, so that they function as a whole. 
Thus, a BG lesion in one nucleus will affect whole system function [65]. During the review of 
the pathophysiology of PD the focus is on the function of BG once again, but only relative to the 
associated pathology.  
2.2. Pathophysiology 
PD results from a dopaminergic deficiency within the nigrostriatal pathway of the BG 
[3]. Loss of neurons within the SNc, faster turnover of dopamine and reduction in the enzyme 
that converts the amino acid, L-Dopa, to dopamine cause dopamine depletion within the STR [1, 
66]. Reduction of dopamine levels, which vary from individual to individual, is more apparent in 
the putamen than the caudate, both of which contain major receptors for dopamine [58] 
discussed previously (i.e. D1 and D2). In the classic model upon reception of dopamine, D1 
receptors facilitate the direct pathway, while D2 receptors inhibit (suppress) the indirect 
pathway, thus lack of dopamine reduces the activity of the direct pathway and over activating 
that of the indirect [67]. This excessive inhibition of the output nuclei suppress thalamic and 
corresponding cortical activity, leading to akinesia or other hypokinetic symptoms observed in 
PD. However, findings from more recent experiments oppose the classical model as they show 
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that dopamine does not affect the direct and indirect pathway as previously assumed [68]. In a 
newer dynamic perspective (discussed in detail in chapter III) researchers suggest 
 
Figure 2. A schematic representation of functional organization of the Basal Ganglia (BG) based on 
cortical connections. The input and output BG nuclei are usually segregated based on three major 
functions: limbic function (behavior, emotion, attention, memory, learning), associative function 
(planning, oculo-motor, perception, speech) and sensori-motor function (planning and execution of motor 
actions). Each function is not limited to one pathway (note multiple pathways for each function). From top 
to bottom each schema includes: the cortical areas that project to the BG, the input BG nuclei (1
st
 bold 
box), the output BG nuclei (2
nd
 bold box), the thalamic nuclei and the cortical efferent target(s). Bold font 
represents structures that receive or send more prominent projections than normal font structures. Efferent 
cortical areas and thalamic nuclei vary depending on the cotical source. (Association areas—the 
dorsolateral and ventrolateral pre-frontal cortices, areas 8, 9, 10, 46, portions of the intraparietal sulcus and 
the border of the superior temporal sulcus; Gpi—Globus Pallidus pars interna; Gpe—Globus Pallidus pars 
externa; MD—Medio-Dorsal thalamic nucleus; M1—primary motor area; SMA—Supplementary Motor 
Area; SNr—Substantia Nigra pars reticulate; VA—Ventro-Anterior thalamic nucleus; VAL—Ventral 
Antero-Lateral thalamic nucleus; VApc—Ventro-Anterior parvocellularis thalamic nucleus; VAmc—
Ventro-Anterior pars magnocellularis thalamic nucleus; VL—Ventro-Lateral thalamus nucleus; VLa—
Ventro-Lateral thalamic nucleus anterior part; VLd—Ventro-Lateral thalamic nucleus dorsal part; VLp—
Ventro-Lateral thalamic nucleus principal part; VM—Ventro-Medial thalamic nucleus; VP—Ventral 
Pallidus). 
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that the depletion of dopamine changes the synchronized activity of the direct, indirect 
and hyperdirect pathways [16]. After depletion of dopamine, the weak direct pathway can no 
longer oppose the stronger hyperdirect pathway [16] and therefore fails to release the selected 
motor command(s) withheld by the hyperdirect pathway [69]. As a result the hyperdirect 
pathway expands its target areas in the thalamus and cortex and remains active for a longer 
period of time [15]. Even in cases where the selected motor command is released, it is present for 
a shorter duration of time [15]. How the indirect pathway is affected is not clear, however it is 
assumed that the initiation of a movement is associated with a sharp activity of the adjacent 
areas, therefore the striatal region related to the direct pathway [70]. This sudden activity is 
conducted to the region of the striatum designated for the indirect pathway to trigger the 
termination of the movement [70]. In PD the weak signals of the direct pathway are not 
sufficient to trigger the neighboring indirect pathway, thus terminating the motor command [70]. 
The complete pathophysiology of PD remains unclear. Although a general consensus in 
dopamine deficiency and nigrostriatal pathway involvement in PD exists, the role of dopamine 
involvement is still under debate. No matter what the role of dopamine, its contribution to the 
motor dysfunction cannot be denied. In the next section research on motor dysfunctions 
associated with PD are presented.  
3. TEMPORAL CONTROL AND HUMAN MOVEMENT 
When it comes to temporal control of movement there are discrepancies regarding the 
role of BG and cerebellum in timing sequential movements [71-74]. The focus of this section is 
to review the literature on temporal control and human movement, differentiating the role of the 




3.1. Central Representation of Time 
Internal generation of a rhythmic movement requires accurate perception of the temporal 
sequence, preparation of the motor plan and production of the rhythm which is sometimes based 
on the perceived temporal characteristics [75]. An accurate temporal perception and a temporally 
organized motor output necessitate a central representation of time through which a neural 
control could occur (Ivry 2001). This representation serves as an internal clock that characterizes 
the time point, duration or interval and will therefore determine the temporal characteristics of an 
event [76]. 
The internal representation is viewed as a system of oscillatory pacemakers with flexible 
and reproducible frequencies [77] or as a battery of hour glasses [78], each corresponding to a 
specific frequency or duration. In humans several oscillatory units might interact and form 
various temporal patterns, which then serve as a reference for estimating a specific duration or 
performing a rhythmic action [77, 79]. Rhythm is defined here as ―a patterned sequence of 
events, which can be completely characterized by the number of events in the sequence and the 
time interval between those event‖ [75]. 
Use of the ―multiple time model,‖ an expansion of the hour glass model, may help 
explain the internal representation of time [80]. According to the authors the representation of 
time, whether perceptual or motor, is composed of elements with specific connections and 
duration. These elements can be considered a group of neurons, which habituate to a specific 
temporal range as one starts to learn a specific rhythm, produce a rhythmic movement or 
perceive a rhythmic modality. For a rhythmic action to occur distinct temporal representations 
are set for each effector system. Several motor commands compete and the first motor plan to 
reach the specified temporal threshold will be selected. If a novel rhythm is introduced, the set 
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effectors are inhibited to allow for development of a new element, temporal range and associated 
motor responses.  
Temporal elements can be located in any cortical or sub-cortical area. Cortical regions 
which are active during performance of rhythmic motor tasks may involve motor, premotor, 
parietal and prefrontal, cortices [75, 81-83]. Certain areas within each region make specific 
contributions. For example, SMA and Pre-SMA regulate movement initiation and its internal 
guidance, while pre-motor cortex (PM) and M1 contribute to preparation and execution of the 
movement [75]. The controversial issue revolves around the role of sub-cortical areas, such as 
the roles of the BG and cerebellum in temporal perception and performance. 
3.2. Comparison of BG and Cerebellum in their Temporal Role 
The BG are associated with different aspects of temporal control including perception, 
learning and execution. Unfortunately, some of these functions are also related to the cerebellum 
and therefore complicate the exact role of the BG. The focus of this section is to review the 
literature on the temporal roles of the BG and cerebellum. 
Numerous investigators that recognize the cerebellum as the major sub-cortical structure 
for temporal processing, perception [84], learning [85, 86] and execution [84-86]. These 
functions are attributed to cerebellum as patients with cerebellar atrophy are incapable of 
detecting time interval changes in rhythmic auditory stimulation, show a significant amount of 
inter-response interval (IRI) variability when tapping to a rhythmic pattern [84] and severing 
different areas of cerebellum interferes with learning and executing a new temporal sequences 
[85]. The role of the BG in temporal control is less clear. 
The BG play a role in temporal perception [87, 88]. This assumption is based on activity 
of the BG during temporal discrimination tasks [88], increase in the minimal threshold of the 
temporal discrimination in PD [87] and deficiency of these patients in estimating time intervals 
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of presented rhythmic stimuli [89]. Such deficiency in perception of temporal intervals is not 
modality specific and is present with tactile, visual and auditory rhythmic sequences [87]. On the 
other hand because of the pattern of activation of the STR and cerebellum during temporal 
sequence learning, the BG are associated with encoding time intervals, while the cerebellum is 
associated with temporal perception [74]. In this case the BG contribute to learning temporal 
sequences, while the cerebellum functions to optimize sensory input upon receiving it from the 
associated areas. 
The role of BG in movement timing is implied from various experiments involving PD 
patients. It is suggested that the increase in variability of the IRI during generation of a self-
paced rhythmic movements in PD patients reflects involvement of the BG in temporal control of 
internally generated movements [89-91]. Because the ability to synchronize finger tapping to 
external stimulation is also impaired, the BG may contribute to externally guided rhythmic 
movements as well [92]. EEG recordings of the PD patients during cued and uncued rhythmic 
movements reveal reduced BG and SMA activity prior, during and after the uncued rhythmic 
movement compared to the cued movement [93]. Such pattern of an activity and its sensitivity to 
the temporal component, bring further evidence for the role of BG in internal temporal control of 
movement via connections to SMA.   
The role of the BG in temporal control of movement has been viewed yet another way. It 
is suggested that the BG play a functional role in integration of spatial and temporal components 
of a sequence, as PD patients are capable of performing [72] and learning [94] spatial and 
temporal sequences in isolation, but they fail to do so when the two are combined. In contrast, 
because of the inability of cerebellar patients to perform temporal or sequential tasks in isolation, 
the cerebellum is associated with forming temporal or spatial sequences. [72]. 
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The temporal role of the BG  is rejected by other investigators who report activation of 
cerebellum only during changes of temporal intervals of a rhythm [95, 96] and those who show 
insensitivity of the BG to temporal sequencing of the movement [97]. The latter study makes a 
comparison between temporal and ordinal sequencing. Their ordinal sequence involved 
performing a rhythm in different tone orders (fixed intervals) with several key pads (one for each 
tone), while the temporal sequence involved producing a rhythm with one key pad by changing 
the stroke interval. FMRI recordings of the BG and cerebellum under these conditions suggested 
that the BG have no role in temporal control of movement, but contribute significantly to ordinal 
organization. They further propose that the cerebellum is important for temporal control, 
spatiotemporal organization and ordinal control of the movement. However, in a case where 
primates were trained to reach to a sequence of fixed number illuminated targets but in various 
orders of presentations (ordinal task), the BG became active only if a target was presented in a 
specific order and formed a temporal relationship with the other targets [98]. The temporal 
control of movement viewed in a different context may help explain these differences.  
Rhythmic movements can be categorized into those that need event-based timing 
(discrete rhythmic movements) or emergent timing (continuous rhythmic movements) [99]. 
Comparison of PD patients with those of cerebellar lesion and healthy controls reveals a similar 
performance in PD patients and healthy individuals for event-based timing task [99]. It is also 
reported that patients with unilateral striatum damage show no evidence of motor timing problem 
during finger tapping to auditory rhythmic stimulation in ipsilesional and contralesional hands 
[100]. These findings suggest: 1) event-based timing deficits are dissociated from the emergent 
timing; 2) tasks that require precise timing are more vulnerable to cerebellar damage; 3) the BG 
are involved in emergent-based timing task; and 4) PD is not a good model for studying temporal 
movement dysfunction. Unlike the studies mentioned previously [91, 101], these experiments 
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reject the role of BG in precise timing of rhythmic sequential movement (event-based timing), 
however may help explain discrepancies regarding the role of the BG in temporal control. 
Some investigators relate the controversy regarding temporal role of BG and cerebellum 
to the complexity of the rhythmic tasks [75, 102]. Both the cerebellum and BG are involved in 
temporal organization of sequential movements, however considerable reduction in BG activity 
and escalation in cerebellum activity with the increased complexity of the rhythmic motor task 
(defined as number of different time intervals implanted within the rhythm) occur [75]. An 
opposite pattern of BG activation is suggested for temporal perception [102]. In this case 
temporal duration estimation of simple rhythms relate to activation of the cerebellum, however 
as the duration estimation task becomes more difficult other brain areas such as the BG, 
dorsolateral prefrontal cortex (DLPFC), PM and SMA are recruited, suggesting a context 
dependent activity of BG but a constant control of cerebellum in temporal perception. 
Some authors suggest that some tasks are inadequate in bringing out the contribution of 
the BG [78, 103]. The following roles are reported for the cerebellum (Penhune, Zattore, & 
Evans, 1998): 1) Extracting temporal aspects of the perceived sensory information: 2) Extracting 
temporal aspects of motor output; and 3) ―leaning novel temporally precise motor responses‖ 
[103] and temporal characteristics of the sequence in response to the environment (Dreher & 
Grafman 2000). These authors further describe the ―non-significant‖ role of the BG as detectors 
of the unpredictable temporal errors in a task including ordinal information alone (anterior STR) 
or a combination of timing and task order (posterior putamen, head of the caudate). It is possible 
that those who deny the role of the BG in temporal control probably did not design a task that 
could tap the BG.  
In a comprehensive literature review Ivry and Spencer, 2004 propose that the cerebellum 
is the major structure for rhythmic perception, learning and execution and the BG are the 
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threshold regulators to determine the amount of required sensory input (perception) and to 
regulate the threshold for the desired response (motor execution). Therefore, if the BG lower the 
threshold for a specific response, it has a better chance to be selected and executed. Considering 
that a dysfunctional BG may cause a rise in the threshold [104], may explain why PD patients 
recognize two distinct temporal stimuli at a higher interval and threshold [87]. Reflecting back to 
the ―multiple time model‖ the function of the BG would select the first movement plan to reach 
the minimum threshold set. 
One should be aware that the debate over the distinct function of cerebellum and BG 
continues to this date. Investigations are successful in clarifying some of the overlap, but not all. 
The presented models have their limitations as they fail to explain the behavior of the BG during 
ordinal and temporal tasks and across sequential movements with different complexities. It 
seems that the BG are important in emergent-timing, but their control over event-based timing 
and therefore temporal organization of sequential movements is negligible. In this case gaining 
temporal control over rhythmic movements for PD by recruiting the intact cortical and sub-
cortical areas does not appear to be an impossible task. 
4. MOTOR COMPLICATIONS AND PARKINSON’S DISEASE 
People with PD can possess several motor and non-motor symptoms classified as 
Parkinsonism or non-Parkinsonism syndromes, respectively. Parkinsonism syndrome includes 
tremor, bradykinesia, postural instability and rigidity, while non-Parkinsonism syndrome 
involves depression, cognitive disorders, sleep disorders or autonomic dysfunction. According to 
UK Parkinson’s Disease Society Brain Bank a patient is diagnosed with PD if they show signs of 
bradykinesia and one other symptom within the Parkinsonism syndrome category [105].  
Because other diseases, such as multisystem atrophy or vascular pseudo-parkinsonism also share 
Parkinsonism signs [105, 106], there are exclusion and supportive criteria that help with the 
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diagnosis of PD (For details see Appendix A). Due to the overlap and lack of a standard 
measure, errors do occur and PD is not always accurately differentiated at the initial stages of the 
disease [106]. Note, that PD patients do not always present with non-Parkinsonism symptoms. 
Therefore, the focus of this chapter is to elaborate on Parkinsonism syndrome and other motor 
complications that exist in the Parkinson’s population, to review how these complications affect 
control of upper and lower extremities and to introduce a theoretical link to such control. 
Motor complications usually appear on one side of the body and gradually become 
symmetric through progression of PD [1]. For completeness each major basic motor 
complication associated with PD is defined and in Appendix B. These include those categorized 
as Parkinsonism syndrome as well as other common motor complication. Motor complications, 
as they apply to the upper and lower extremities, are presented in the corresponding sections that 
follow. 
4.1. Motor Complications and Control of Upper Extremities 
Upper extremity movements are an integral part of activities of daily living. It is of no 
surprise that complications in performing such tasks can limit an individual at a functional level. 
Functional abilities of upper extremity control in those with PD become worse with the severity 
of the disease [107]. Simple tasks such as grasping a cup to drink may require more time and 
effort for people from this population [108, 109]. The focus of this section is to review the motor 
complications for people with PD identified for unilateral reaching and grasping tasks and tasks 
involving bimanual coordination. These actions will provide insight to upper extremity 
movements performed concurrently in those with PD.  
4.1.1. Reaching and Grasping 
Aiming, reaching and grasping tasks, the most common tasks used to evaluate control of 
the upper extremities in PD [110-113], offer a good action for evaluating upper extremity 
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control. As common tasks they are well-practiced relatively easy movements for various 
populations to perform. Moreover, they represent goal-directed sequential movements, which 
demand coordination of transportation and grasp phases [114] to not only provide insight to 
movement coordination, but also movement precision similar to that of a single aiming 
movement [115].  
Patients with PD perform the reaching aspect of a reach and grasp task different than 
people with no known movement disorders. They underestimate target distance [116] and move 
towards an object in an irregular and jerky matter [117, 118]. Movement time (MT) of reaching 
increases significantly in PD patients [110, 117] usually due to a prolonged initial segment of 
movement execution [110, 119, 120], which can increase up to 30% compared to that of healthy 
population [117].  
Investigations on the two components of the reach and grasp reveal temporal and spatial 
deficiencies in those with PD. A temporal link between the maximum grasp aperture and the 
hand transport phase in healthy individuals exist [115, 121] such that maximum aperture occurs 
at the time of maximum deceleration of the transport phase [115]. Consistency of the relative 
distance of peak aperture to the targets across varying target distances [121, 122] and sizes [121] 
while reaching toward the target, further reveal ―normal‖ spatial coordination in healthy controls. 
During reach and grasp tasks patients with PD generally vary the time and distance of the grip 
aperture regulation relative to the reaching action, unlike that of controls [122-125]. PD patients 
produce smaller maximum apertures (hypokinesia) [123] and generate grip forces at a slower 
rate [126]. They also generate the maximum grip aperture with a significant delay [117, 123], 
possibly explaining why they close the aperture close to the target [115, 124]. 
The delays in movement control could be considered secondary to bradykinesia and 
muscle force production (discussed later), as hand velocity is highly correlated to the grip 
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aperture closure time, distance as well as rate of muscular force production [124, 127]. As a 
strategy to overcome the constant oscillation of a pathological action tremor, individuals with PD 
perform the task slower than usual, a sign of secondary bradykinesia [128]. A direct correlation 
between tremor in agonist muscles and peak acceleration and velocity profiles during arm 
extension [129] further support the role of tremor in slowing movements. 
In tasks where accuracy is not an issue PD coordination and synergy between the 
acceleration and deceleration transport phases are closer to that of the normal population. The 
movement organization becomes more irregular as task performance becomes more complex 
[130, 131], like tasks demanding precise contact to small targets [130], fast accurate reaching 
[122] or simultaneous prehension of two limbs [131]. Deficits such as these indicate a central 
shortcoming in regards to coordination [122, 132]. Because many movement difficulties 
disappear during externally guided reaching tasks, some suggest this phenomenon could 
represent dysfunction of the BG in triggering internally generated movement [133, 134]. 
However, given the example above, it seems that task or type of internally generated movement 
must also be considered. It is unclear what makes the task ―too complex‖ for a Parkinson’s 
patient. However, central control involving additional demands of attention, sensorimotor 
integration or a combination of the two seem to be viable possibilities. 
PD patients also produce grasp forces that do not match object properties, again reflecting 
some degree of abnormality [126, 135]. The link to abnormal force production appears to be 
associated with object unfamiliarity. Force regulation appears to be normal for PD patients when 
manipulating familiar objects [136] or using self-regulated speeds [137, 138]. Abnormal force 
production occurred in cases involving objects lighter and smaller than expected [126] or having 
to move faster than normal [137, 138]. In the latter cases the demands of temporal and/or spatial 
accuracy elevate, possibly explaining why during tasks that involve manipulation of fine objects 
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the regulation becomes impaired [122]. In these cases evidence supports that force production 
problems result from the patient’s inability to generate regular and sufficient forces [139] for the 
novel sensory inputs, possibly resulting from inadequate sensorimotor integration [126]).   
During voluntary movements the pathological tremor can impose on the task and appear 
as an abnormality in force regulation [140]. There is evidence that when performing an action in 
the presence of tremor, the frequency of muscle bursts become entrained to that of the tremor, 
making it difficult to accumulate bursts to create the appropriate force [141]. These constant 
force oscillations are usually present during all phases of the movement and can eventually lead 
to reduction of the total grip force [142].  
PD patients produce insufficient and irregular forces [139, 143] that can affect movement 
accuracy [126], which necessitates intact proprioception and sensorimotor integration [144]. PD 
patients demonstrate proprioceptive deficits, as they show deficiencies in detecting passive upper 
extremity movements [145]. Intact proprioceptive-related evoked potentials in the brain reveal 
normal afferent information and provide evidence that suggest impairment in cortical processing 
of kinesthesia in PD [146]. Evidence for underestimation of target location in reaching to a visual 
target compared to that with a kinesthetic target [147] and for difficulty in matching a visually 
cued hand posture to that of a kinesthetic posture in individuals with PD, offer support for the 
hypothesis that proprioceptive and sensorimotor integration deficits are to blame for irregular 
force production in those with PD [148].  
Although some unilateral movement deficits are viewed as secondary to bradykinesia 
[127] and tremor [140], most PD deficits appear to result from the inability of BG to integrate 
[126]) and coordinate [132] various aspects of the movement. Thus, production of the desired 
movement [134] or force [143] and inhibition of unnecessary movement is impaired.  
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4.1.2. Bimanual Coordination 
Bimanual tasks present good examples for evaluating concurrent upper extremity control 
used for movement coordination. The BG through connections to SMA contribute to 
coordination of bimanual movements [149], thus providing a good action to study those with 
damage to the BG.  
In individuals with and without PD the ability to perform anti-phase or asymmetric 
bimanual coordination tasks becomes unstable as a function of speed, causing the anti-phase 
movements to relapse into the in-phase or symmetric movement at fast performance rates [150]. 
Not only do PD patients perform worse than controls at higher rates, but they tend to switch to 
the in-phase state at lower frequencies [151, 152]. Also, when PD patients are asked to reach for 
objects of different sizes with both upper limbs simultaneously, they tend to synchronize their 
grip patterns (unlike controls) reflecting the inability to independently adjust each limb to 
properties of the objects [153]. Not surprisingly, PD patients also perform the bimanual tasks at 
slower speed and amplitudes [151]. Bradykinesia especially occurs during conditions where 
processing of several sensory inputs is required (e.g. full vision vs. no vision), which might 
reflect an adopted strategy to allocate enough time for processing and integrating all the available 
sensory information in order to achieve maximum accuracy [154, 155]. However, sometimes 
even allocation of more time does not guarantee precision [155], possibly reflecting bradykinesia 
associated with the disease rather than that of a control strategy.  
 Variability in movement amplitude, movement duration and variability of the relative 
phase between the limbs increases in PD patients performing bimanual tasks [155-157]. The 
increase in variability for in-phase coupling of the two limbs in PD patients with great 
asymmetric symptoms is less frequent than that of anti-phase bimanual tasks [155-157]. During 
anti-phase movements such behavior might be secondary to additional sub-movements during 
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deceleration, a phenomenon that does not occur in the healthy population and that represents 
efforts to avoid switching to the more stable in-phase condition [149]. The patients’ inability to 
resist the underlying force towards synchronization more often than controls provides additional 
evidence that PD patients have greater difficulty independently controlling each limb during 
complex skills [153, 158].  
Limb dominance is another factor that can affect bimanual task performance in PD 
patients. Similar to healthy individuals, patients reveal greater movement variability and errors in 
the non-dominant hand during metronome-paced bimanual tasks, however, the difference 
between the two limbs is significantly exaggerated in the patients [131, 152]Unlike controls, PD 
patients do not synchronize the non-dominant hand to a shift in frequency ([151].  The reason is 
unclear, but by increasing use of the limb that entails more proficiency the patient exaggerates 
the movement differences of the limbs [131, 152]. 
Some scientists explain the added deficiencies in PD patients performing familiar 
bimanual skills as manifestations of the compensation of other CNS structures for the 
dysfunctional BG [131, 159]. Since the PD population is more accurate in making transitions to 
in- or anti-phase bimanual movements and maintaining the correct relative phase performing 
these tasks in the presence of external cues, the greater deficits without the cues may be 
explained by the basal ganglia’s role in internal guidance of a movement [151, 154], like that 
associated with SMA function [160]. Transcranial magnetic stimulation (TMS) of SMA affects 
anti-phase coordination tasks in such a way that it forces the anti-phase movement into the stable 
in-phase pattern [149]. Combined with the information that monkeys with SMA lesions have 
difficulty with independent limb control [161], these findings support that greater movement 
deficits in PD are linked to the altered BG connections to the SMA. 
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In summary, not only do deficits for PD patients undermine the ability to coordinate 
different segments of a movement within a limb in a reach and grasp task [132], they also 
undermine these abilities across limbs in a bimanual coordination task [153, 158]. Most evidence 
for the cause of such deficits is contributed to dysfunction in the BG-SMA connections, known 
to contribute to coordination of bimanual movements [149]. A generalization of these findings 
would suggest similar bilateral movement deficits for the lower limbs. 
4.2. Motor Complications and Control of Posture  
Postural instabilities are one of many motor complications present in patients with PD 
[162]. These complications are of special interest as they are resistant to medication and even 
some surgical procedures [162] and they increase risk of falling. A fall in an older adult, like 
many with PD, normally leads to injury and further motor complications. Insight to posture and 
its underlying control factors in this population may lead to therapies that help reduce this 
downward spiral.  
Abnormalities of postural responses in PD patients manifest in muscle reactions to 
sudden perturbations and postural transitions. PD patients show impaired muscular timing and 
amplitude for changing and coordinating motor actions [163-165]. Experiments reveal changes 
in latencies in the stabilizing and the destabilizing muscle responses to a sudden dorsiflexion for 
PD patients [166]. Reduced and impaired [167] stretch reflexes of leg muscles also exist. When 
required to make a transition from backward displacement to toe up rotation, the amplitude of 
muscle activation does not respond accordingly [165]. These deficits contribute to the abnormal 
postural responses in PD [168] through abnormal force production.  
PD patients commonly provide inadequate force to meet the sudden changes in external 
(i.e. platform movement) and internal (i.e. voluntary movements, heel rises) perturbations [163, 
169, 170]. The latter of which explains the abnormal anticipatory postural adjustment (APA) in 
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this population [171]. PD patients present with difficulties in modifying the magnitude of muscle 
force [172] and manifest unnecessary muscle activation, affecting the regulation of force 
production [162, 169, 172]. The inability to produce sufficient muscle force also explains the 
reduced center of pressure (COP) and the increased center of mass (COM) displacements in 
response to perturbations in PD [163]. Insufficient muscle activation in the lower limbs leads to a 
small COP displacement, inadequate to control the COM, therefore increasing its displacement 
[173]. Compensatory efforts to reduce the COM-COP distance (safety or stability margin) in PD 
involve a limited body movement, narrow base of support (BOS) and stiff posture [163, 174]. 
 The size of the stability margin is a good indicator of the level of stability for different 
directions in PD patients [173]. Unlike the constant stability margin of healthy individuals, 
stability margin changes for perturbations in different directions in people with PD [173]. The 
smallest margin appears to be for the backward displacement [173], explaining why PD patients 
are more susceptible to backward falls [175]. The stooped posture, which is common in PD 
patients, might be a functional compensatory strategy used to diminish backward displacement 
of the COM  for preventing backward falls [176].  The mediolateral displacement is the second 
most unstable condition for posture control, but unlike the backward displacement the condition 
improves with a wider BOS [173]. 
In summary, PD patients present with major deficits in stability, linked to muscle activation 
[172], thus force production [169]. These deficiencies also stem from insufficient postural 
reflexes in response to external forces and internal muscular noise and stiffness [163]. Some link 
the abnormality of postural reflexes to modulations in spinal and supra-spinal reflexes as a result 




4.3. Motor Complications and Control of Lower Extremities 
Normal function of the lower extremities is essential for performing certain daily 
activities. Loss of balance and difficulty with walking (gait) are two noticeable motor 
complications in patients with PD involving the lower limbs. Common contributors to these 
deficits for these patients are a forward posture and muscular rigidity [178]. The focus of this 
section is to offer insight to the motor complications associated with postural and gait control for 
PD patients.   
4.3.1. Gait Control 
Difficulty with walking is one of the most noticeable motor complications in patients 
with Parkinson’s. Higher cadences occur as a compensation to the shorter stride length [179], 
resulting in increased step numbers. The typical stooped posture, shuffling of feet, reduction of 
arm swing and joint range of motion (ROM) apparent during gait [10, 180] cause PD patients to 
walk with flexed knees, hips and ankles and therefore on their toes [10, 58, 181]. Additional 
characteristics of PD gait include decreased movement amplitude [182, 183] and gait speed [184, 
185], increased freezing of gait and asymmetric stride time (increased stride to stride variability) 
[182] and difficulties in gait initiation (akinesia) [186, 187] and termination [188]. Some of these 
characteristics are indicative of performance of other populations and do not limit daily function. 
Decreases in stride length and gait speed commonly exist in the normal older person (e.g., 
Nagasaki et al., 1996), but do not limit these people’s abilities to grocery shop or perform other 
daily tasks. Other characteristics such as freezing of gait and shuffling of feet may limit 
functional performance and/or increase fall risk, thus are of most concern within this population.  
Since approximately 80% of PD patients on medication show symptoms of freezing and 
akinesia [189] and because the risk of experiencing recurrent falls is nine times higher in PD than 
that of age-matched controls [175], gait deficits are of a major concern to this population. 
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Discussing the motor deficits in various divisions of the gait cycle (gait initiation, progression 
and termination) should help explain the major motor complications of PD gait.  
4.3.2. Gait Initiation 
Gait initiation is a motor task that involves a transition from a stationary double support 
position, to a dynamic gait cycle [190]. The initiation of the step is tightly connected to 
equilibrium [191], vertical height above the ground (posture) [192] and activation of the major 
lower limb muscles [59, 176, 190]. ―Start hesitation,‖ one landmark of Parkinson’s gait [187], 
especially occurs after long periods of immobility [186] where PD patients take several short 
steps before they can generate a large enough propulsion that can lead to a normal step length 
[186].  
In PD velocity and amplitude of forward COM displacement reduces significantly for the 
preparatory (postural) and stepping phases of gait initiation [192]. Hesitation in starting the 
movement is partly attributed to prolongation of the postural phase because attaining a stable 
condition for initiating gait demands more effort and time [193]. Slower stepping phases can 
result from improper force production in the plantar and dorsi flexors due to a stooped posture 
[194], in the antigravity muscles of the leg due to impairment in the sensory detection of body 
load [195] and in other homologous muscles due to central mechanisms [193]. In a healthy 
individual activation of SMA is observed prior to gait initiation, reflecting its role in planning 
different components of gait [194]. Activity of SMA is terminated by signals from the BG, 
which is followed by activity in M1 and  preparation for planning of the next sub movement 
[196, 197]. Therefore, the BG fail to trigger SMA on time, where the activation of M1, the 
execution of the current movement and the preparation of the subsequent movement do not occur 
[196, 197].  
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 To summarize, the dysfunction of the BG causes slowness of gait initiation in PD due to 
insufficient force production and inabilities in detecting the amount of force produced. Patients 
who are unable to accurately detect gravitation forces have difficulty adjusting their posture to 
prepare for the initial step [195]. Insufficient force production leads to reduction in COP 
displacement and a smaller and slower COM displacement, causing a delay and a smaller and 
less effective propulsive force, thus a slower and smaller step [193]. The BG delay in activating 
SMA leads to a delay in recruiting the motor units [194] needed to produce greater force. 
4.3.3. Gait Progression 
 Gait patterns within gait progression commonly adhere to a rhythmic and cyclic pattern 
in the normal functioning adult. Although this activity is much different than gait initiation, 
similar deficits can occur in PD patients. The following sections will correspond to major motor 
complications associated with the gait progression including freezing of gait, muscular activity 
and gait variability. 
 4.3.3.1. Freezing of Gait 
Freezing of gait (FOG) is a complicated motor symptom in PD with unclear 
pathophysiology [198] that represents the lack of movement during repetitive and sequential 
tasks [199]. As with start hesitation, freezing is another important subcategory of akinesia [199]. 
It is characterized by sudden, involuntary, transient and paroxysmal episodes where the 
individual becomes incapable of maintaining gait and re-starting it, despite arduous efforts [58, 
200, 201]; instead several tiny steps are produced [58, 178]. This complication especially occurs 
when patients approach a narrow space like a doorway (25% of patients), need to make a turn 
(45% of patients), cross over an obstacle, shift their attention or are under stress [58, 192, 198]. 
This phenomenon is highly debilitating, increasing the risk of falls and jeopardizing patients’ 
independence [202]. 
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The prevalence of FOG is 7% in mild cases and 45% or more in severe cases of PD 
(severity determined by the stage of the disease according to Hoehn and Yahr scale, Appendix C) 
[198, 203, 204]. Longer disease duration (>5 years) and longer medication treatment (i.e. 
levodopa) contribute to prevalence of FOG [198, 204, 205]. Only 16% of patients under no 
medication experience this phenomenon [58, 204] which, if present, will be mild and of short 
duration [203]. FOG is more prevalent in PD patients who demonstrate signs of dementia, 
dyskinesia, speech disorder, dystonia, postural instabilities and longer double support time 
during gait [200, 205], however for unknown reasons it is experienced less in those whose 
disease involves major signs of tremor [204, 205].  
FOG is often accompanied by the hastening phenomenon of festination, where the 
cadence increases just prior to the freezing [178, 206]. During this time shifting the weight 
between legs takes place more rapidly and appears to be incomplete, as the amplitude of medial-
lateral transfer of the COP decreases [178] and accompanies a decrease in stride length [206], 
signifying decreased force production and loss of control over cadence  [206]. The loss of 
temporal control is also evident when one considers that stride-to-stride duration variability is 
correlated to the severity of FOG [207]. In terms of muscular activity, FOG is viewed as the co-
activation and dys-synchronization of leg muscles [178, 208]. Unlike the consistent reciprocal 
pattern of activation in flexor and extensor muscles of the thigh and legs in a healthy individual, 
the reciprocal activation is interrupted by co-contraction of flexors and extensors in PD patients 
just prior to freezing [178]. The co-contraction of muscles describes a dystonia specific to gait 
[205]. Prominent EMG signals in the lower leg muscles are premature and prolonged  [208], 
emphasizing major irregularities in the temporal domain, which influence spatial irregularity.  
According to the current literature, freezing stems from spatial and temporal 
dysfunctions in PD muscle activation. The greater muscular dys-synchronization highlight the 
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temporal deficits such as co-contraction possibly leading to inadequate force production and the 
associated reduction in movement amplitude, as that in the shorter stride length. Limited research 
in this area makes it difficult to determine causality. However, evidence from other research on 
motor complications in PD would place emphasis on the BG-SMA connection deficits. 
4.3.3.2. Muscular Activity  
In the previous sections changes of muscular activity and their contribution to gait 
initiation and pattern complications were presented. To avoid redundancy changes that were not 
discussed previously are presented below.  
Abnormalities in muscular synergies and loss of functional symmetry of muscle 
activation complicate the gait of PD patients when performed at comfortable speeds [184, 209]. 
Some scientists suggest the general pattern of muscle activation is unsmooth, ―noisy‖ and 
variable with a significant disruption in the ―rate of force production‖ [139], while others show 
similar timing activation to healthy older adults [210] or report impairments only when excessive 
adaptation to external situations is required [211], thus for complex tasks. Some researchers 
believe that changes in muscle activity during gait in those with PD include [210][209][209] less 
amplitude in distal muscle activity, a delay in reaching the maximum force and over-activity of 
proximal muscles [139, 210].  
Problems with force production during gait are always present [211] and since the 
abnormalities become more significant in patients at later stages of the disease [210], a role of 
the BG may be in regulation of force. This would explain how the low amplitude in dorsiflexion 
and premature, prolonged and ineffective activity of plantar flexors delay the development of 
forward momentum preceding the first step in start hesitation [193]. The reduction in activity of 
the plantar flexors [195, 210-212] along with insufficient activity of the hip extensor muscles, 
cause a very weak push off [210, 211], reducing the stride length [181, 210]. Moreover, 
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significant weakness in dorsiflexors [210] further affect the swing phase resulting in shuffling of 
gait [210]. 
Production of adequate force and accurate timing of force production are essential 
contributors for accurate movement control. Deficits in the BG resulting in inadequate timing, 
through inadequate and abnormal muscle stimulation, likely contribute to dysfunctional control 
of gait initiation and patterns.  
4.3.3.3. Gait Variability 
Rhythmicity is an important feature reflected in stride-to-stride variability [184]. 
Arrhythmia describes increase in stride-to-stride variability [213], where rather than a continuous 
sequential movement the individual performs a series of disconnected strides [184]. Temporal 
and spatial variability are features that remain constant (coefficient of variation for stride length 
and stride time are 3-6% and < 3% respectively) [214] as one ages, unless some type of 
complication occurs [215, 216]. Therefore, alterations in variability of gait are important in 
reflecting a pathological dysfunction [215].  
Patients with PD show increase in variability of spatial and temporal components of gait 
[182, 184, 217]. Increases in variability of force amplitude of the leg muscles [209], stride length 
[182, 217, 218] and gait cycle duration [184, 217, 219] are present at very early stages of the 
disease [213], preceding changes in step velocity and length [219]. Variability in stride length 
and duration significantly correlate with frequency of falls and episodes of freezing in PD [207, 
213, 220, 221] and support the pathological nature of these findings. However, some 
investigators reject the connection of stride length variability to disease severity [181], report an 
increase only in stride time variability at early stages [219] or do not regard the stride length 
variability a distinct feature of PD [222], resulting in more attention towards variability of stride 
duration. Stride time and length variability are independent of other factors that can vary across 
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PD patients such as velocity [209], average gait cycle duration [184, 213], bradykinesia, rigidity 
and tremor [213], making measures of variability good candidates for evaluating motor 
complications in PD.  
Several investigators have searched for a theory to explain the increased variability in 
PD. Because pattern of spatial variability in mice differ according to the region of BG disrupted 
by neurotoxins, some researchers blame spatial variability on a specific neural pathway 
involving the BG for specifying step length and width [223]. Two causative explanations for 
temporal variability in Parkinson’s exist; central malfunction and motor fluctuations. Based on 
the two components of variability (central and motor) introduced by Wing & Kristofferson 1973, 
temporal variability is related to the central time keeping systems, due to the strong correlation 
between the variability of the central command and the IRI variability of finger tapping in PD 
[224]. This finding is in line with more recent studies that also show an increase only in the 
central component of variability during finger tapping [90] and others who report that temporal 
gait variability occurs without detection of any changes in force amplitude [219, 225] or lacks 
the correlation with amplitude of muscle force [226]. Comparison of finger tapping to gait is 
reasonable as there is evidence for significant correlation between IRI variability of finger 
tapping to that of stride duration [213]. Opposing views consider the motor component (muscular 
noise representing random variability during the execution) an additional factor to that of the 
central for explaining the increase in temporal variability in sequential movements in PD [91, 
227]. This opposition is based on the significant correlation found between the motor component 
of the variability and the variability of IRI of finger tapping in PD. 
No matter what underlies the increase in variability in PD, the presence of increased 
variability at early stages of the disease, before consumption of any medication exists. The close 
relationship between measures of variability and freezing or falls reflects the significance of 
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these measures in predicting motor complications and possibly in establishing an appropriate 
evaluation measure for the effectiveness of a treatment.  
4.3.4. Gait Termination 
Termination involves transition from a dynamic state to a static one leading to a more 
stable condition [228]. Gait termination demands control of a person’s COM, whether it is a 
transition that is planned or a response to a sudden perturbation [229]. The lower limbs must 
increase the decelerating (braking) forces in the swing limb and decrease the accelerating forces 
in the stance limb [230, 231] to keep the COM within the BOS at movement end [232].  
Complications with gait termination are relevant to the PD patient’s general inability to 
control changes of the displacement of COP and COM [163]. To compensate for a failure to 
generate sufficient braking forces in a planned gait termination, PD patients reduce gait velocity 
earlier in the course of walking, reaching the final step with a slower velocity than that of the 
control (84% vs 90%) [188]. Unlike healthy individuals PD patients also produce muscle 
activation patterns opposite to that of controls, leading to inadequate force generation and 
corresponding to use of the compensatory ―extra step strategy‖ not only during sudden stops 
[188], but also when sudden changes in direction are required [233].  
Clearly, defective force production associated with stopping difficulties in PD must result 
from ineffective muscle contraction. The limited studies on gait termination in this population 
make it difficult to offer any conclusions on muscular control. However, one can hypothesize 
similarities to our previous discussions regarding muscle activation (i.e. inadequate and 
abnormal muscle stimulation due to BG deficits) exist for gait termination. 
4.4. Theoretical Links 
Different theories and/or models have been proposed to describe the functional 
connections of the BG nuclei and to predict the pathologies related to the motor dysfunction of 
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these nuclei in PD. In the literature two theories stand out for their ability to explain functional 
pathways within the BG nuclei (internal loops) and predict results of motor malfunctions in the 
pathways among the nuclei and other neural structures used in motor control (external loops). 
The dynamic theory of the BG proposes a model to describe internal loop function and the motor 
set theory targets the external loop function.  
The dynamic theory describes the BG as a network of non linear dynamic pathways 
which work in symmetry to produce a normal behavior [15, 16, 69, 234]. The internal circuits of 
the BG are considered self stabilizers of the system whose function is necessary for ―modulating 
the excitability‖ of the BG (Obeso et al. 2000). The output is viewed as gains for the direct, 
indirect and hyperdirect pathways and the projections of the BG output nuclei, representing 
information necessary for feed-forward (projections to cortical areas not involved with input, e.g. 
second column, Fig. 2) and feedback (projections to cortical areas of input, e.g. fifth column, Fig. 
2) control of each limb (Suir, Albani, & Glattfelder, 1997). Therefore the internal self-stabilizing 
circuits regulate the net gain of the system and provide a state in which the desired motor plans 
affecting the trajectories, velocities and forces are released. Examples of such stabilizing routes 
are the connections of the GPe to the STR, the SNc to the STR and the thalamus to the STN and 
STR (Fig. 3), which work together to regulate properties of the functional units of the input 
nuclei by affecting their net membrane potential [235] or oscillation frequency [236]. 
  With PD some of the internal circuits become affected and the symmetry among the 
external BG pathways is lost. For instance, the dopamine deficiency does not allow for the 
normal interaction of all projections received by the STR, affecting the cell membrane potential. 
Therefore, repetitive movements during which the minimum cell potential is held constant and 
the discrete movements during which the cell potential is temporarily depolarized both become 
affected [235]. In other terms harmony between the projections to the STR is lost and changes 
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the oscillatory patterns of cells affecting their output [236]. Such changes in properties of the 
input nuclei not only cause the overall gains of direct, indirect and hyperdirect pathways to 
become abnormally small or large (spatial) (Suir, Albani, & Glattfelder, 1997), but also cause 
disequilibrium among the three pathways (temporal) and therefore a shift in the net output 
(Obeso et al. 2000). As a result, cortical areas and desired action become inhibited and abnormal 
behaviors occur [15, 237]. This theoretical description efficiently introduces a system of internal 
BG networks where normal functioning is essential for a normal and context appropriate output, 







Figure 3. A schematic diagram of the inter-neurons and afferent projections to the striatum that regulate 
its excitability. Two inter-neurons and two striatum neurons are depicted. Only two dopamine receptors 
(D1 and D2) located on a striatum neuron are highlighted. Excitatory connections are represented by filled 
arrows with external connections in bold and inhibitory connections are represented by empty arrows. 
(Ach—acetylcholine; GABA—gamma amino butyric acid, SNc—substantia nigra pars compacta; STN—
sub-thalamic nucleus; Gpe—globus pallidus pars externa) 
 145 
The ―motor set‖ model describes the motor functions of the BG (external connections) 
while disregarding specific internal circuits. The term set was introduced sometime before 1911. 
The idea of a set has been used in various ways including a response to a stimulus—motor set 
[238]. The idea of a motor set, was developed through experiments involving dichotic listening 
[239] and reaction times (RT) [240]. Flower and Robertson, 1985 provide us with the most 
comprehensive description of a motor set. Motor sets are ―the characteristics of an action plan 
which determine the kind of movement or sequence of movements to be executed in order to 
fulfill the goal or intention contained in the plan‖ [241]. A motor plan refers to designating one 
or more predetermined movement characteristics (motor program) for an action. In more specific 
terms motor sets execute the following actions: they 1) impede execution of alternative motor 
plans and activate the desired one(s); 2) maintain the activated motor plan(s); and 3) respond to 
changes in the environment or goals of action by changing the plan, terminating or replacing it. 
Specifically, the motor set has the function of maintenance or regulation of the motor plan which 
already harbors the appropriate motor program(s). 
 The BG via their numerous cortical and sub-cortical connections function as motor sets in 
humans. Such an assumption mounts from investigations on RT and choice RT of PD patients, 
which report no evidence for delayed formulation of central motor programs [242], only a 
significant increase in MT and therefore impairment in implementing the motor program [64]. 
The ability of PD patients to learn and generate two sequences of button pressing, each tested in 
isolation but not in sequence, and to learn and generate an action that required transformation of 
two different sequences into a new combination, suggest that the inability is not in integration or 
learning of information but rather involves the maintenance of an action plan or its modification 
in response to environmental needs [243]. 
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Various motor symptoms in PD patients relate to a dysfunctional motor set. The patients’ 
inability to perform more than one movement sequence simultaneously [101, 243], their 
difficulty in executing relatively long sequences [219, 226, 244], their failure to maintain the 
global goal during a sequence of actions [245-247], their impairment in execution of tasks that 
demand aiming to unexpected target locations [111] and their generation of movements and 
postures irrelevant to the environment [172, 248] are examples that would not occur with a 
normal motor set function. Akinesia, freezing and bradykinesia also relate to a motor set that 
cannot release or maintain a motor plan. Therefore, the ability of PD patients to gain normal 
movement magnitude [249] and initiation [250] or to decrease abnormal movement 
characteristics (i.e. variability) [219, 226] in presence of external cues suggest a compensatory 
strategy for accessing the motor plan [248, 249] via bypassing the dysfunctional motor set.  
Two theories were presented to help explain the internal and external connections of the 
BG. In order to impede alternative motor plans and activate the desired one(s), the normal 
hyperdirect and direct pathways are required. The dynamic theory explained how PD can affect 
the internal direct, hyperdirect and possibly indirect pathway connections to alter the BG output 
and produce erratic movement results. The motor set theory suggests that the external 
connections to the BG are involved in selecting, maintaining or terminating the appropriate plans 
for desired movement. Whether it is possible for the internal pathways to respond to changes in 
the environment by allowing for an alternative motor plan to replace the original (motor set 
theory) in PD is still unclear. However, since no model currently explains all aspects of the 
complex BG and a disease with unclear pathophysiology, this combination develops a 




5. TREATMENT OF PARKINSON’S DISEASE 
Various treatment strategies are used to manage motor complications associated with PD. 
Medications and surgical interventions relieve some symptoms with fewer side effects in the 
latter. Insufficient medicinal and surgical interventions in alleviating all motor symptoms in PD 
emphasize the need for careful review of successful rehabilitation strategies in this population. 
Physical therapy approaches, which are considered useful non-pharmacological treatments to 
improve motor complications in Parkinson’s patients [183] vary so greatly, that at present, it is 
impossible to suggest a universal protocol for this population. Review of the treatment 
approaches will offer insight to current treatment strategies for PD and identify gaps and 
limitation in evidence-based studies. Thus, the focus of this chapter is to briefly describe the 
current medications and surgical treatments used for this population, but to offer more detailed 
review of the therapeutic treatments to guide future study design in this area.  
5.1. Medication  
Pharmacological interventions are based on pathophysiology of PD. Administration of 
medication aims to alleviate motor and cognitive symptoms of PD [251]. Although medication is 
successful in relieving motor symptoms such as bradykinesia, tremor and rigidity in early stages, 
its long term application leads to secondary complications which debilitate PD patients, causing 
cognitive problems such as hallucinations [10, 252] and motor dysfunction such as dyskinesia 
[58, 252, 253]. Motor complications such as akinesia, freezing, postural instabilities [252] and 
changes in stride duration variability [254] are not alleviated by most medications targeting the 
dopamine system, are linked to unclear causes and require a different form of treatment.  
Several drugs are available for targeting the dopamine related symptoms of PD. At the initial 
stages drugs that cause less side effects and motor fluctuations may be prescribed (MAO-B 
inhibitors or Amantadine). With progression of the disease stronger medication (i.e. L-dopa or 
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dopamine agonists) are administered as an adjunct to earlier medication or in isolation [251]. 
Unfortunately, each medication comes with several limitations. For example, dopamine agonists 
cannot control PD symptoms for more than 3 to 5 years, obligating addition of a stronger 
medication. The stronger medication of L-dopa causes major secondary symptoms such as 
dyskinesia calling for changes in dose and frequency of the medication and/or regulation of the 
adjunct drugs. Table 1 summarizes the common drugs administered for relieving motor 
symptoms of PD. Readers are referred elsewhere [253, 255]for further information regarding 
medication for PD. As just reviewed, medications are somewhat effective in alleviating PD 
symptoms at initial stages of the disease. They lose their efficiency and cause secondary motor 
and cognitive complications, not to mention they only affect some PD symptoms. Such 
limitations call for other treatment options such as surgery and therapy. 
 5.2. Surgical Intervention 
Surgical interventions that do not prevent the neuro-degeneration process of PD, are used 
for symptomatic treatments. More importantly, this method does not lead to the debilitating side 
effects present with medication [256]. Surgical interventions for PD may involve severing 
certain parts of the basal ganglia as with pallidotomy, thalamotomy and subthalamotomy [257] 
or less abrasive methods such as deep brain stimulation (DBS) [257-260]. The latter is preferred 
because similar benefits with fewer side effects are achieved. Advantages of DBS over neural 
removal are numerous and include decreased demand for re-operation, lower morbidity rates, 
reversibility, larger improvements in motor and non-motor symptoms [259, 260] and decreased 
dose demand for medication [261, 262]. DBS can target different nuclei within the BG and its 
connections. Targeting the thalamus eliminates signs of tremor [263] without affecting other 
motor symptoms [264]. Stimulation of GPi reduces signs of drug induced dyskinesia and major 
PD motor symptoms such as bradykinesia, akinesia and rigidity [265], but the effectiveness 
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declines after the first year of the surgery [266]. The most common procedure is stimulation of 
the STN, where benefits involve general improvement in motor function (58%) and reductions in  
Table 1. Summary of major drugs prescribed for alleviating motor complication in PD. The 
characteristics of each drug and its cardinal advantages and disadvantages are included. Adopted 
from [255]b 
Drug Characteristics Advantages Disadvantages 
L-dopa Precursor of dopamine 






to prolong half life of L-
dopa. It is metabolized to 
dopamine & 3-o-methyl 
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-improves quality of 
life 
-most effective for 
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treatment of PD 
-the most effective & 
gold standard drug 
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-causes dyskinesia 
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-high risks of daytime 
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-with L-dopa increases 
nausea, dyskinesia, 
confusion, hallucination, 
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(orthostatic hypotension)  
Amantadine Exact mechanism 
unknown. 
Enhances release of 
dopamine from 
dopamine terminals.  
Increases affinity of 
dopamine receptors 
 






-compared to L-dopa 
mild side effects with 
appropriate dosage 
-efficacy reduces after 
months of continuous use 
-side effects include 
livedo reticularis, ankle 
edema, dryness of the 





tremor (82%), akinesia (57%,) rigidity (52%,) postural instability (49%) and drug 
induced dyskinesia (83%) [262]. The exact mechanism of DBS is not known. There is evidence 
for  inhibitory and excitatory effects of stimulation on neuronal activity of the targeted nuclei 
[267]. Investigators suggest that DBS works by regulating the neural oscillation of the targeted 
nuclei [268]. Stimulation appears to terminate the dysfunctional activity of neurons and shifts the 
temporal pattern of their discharge to a more optimal and synchronized frequency [269]. This 
pattern of activity replaces the random deleterious pattern of BG network with a regular pattern 
of neural bursts causing a stabilized and symmetric activity across different regions within BG 
[267].  
Benefits of DBS, although promising, are most effective when used in conjunction with 
patients’ regular medication [253]. Unfortunately, not all PD patients can undergo such surgery. 
The suitable surgery candidate is responsive to medication, less than 75 years of age with 
relatively normal cognitive status and disease onset greater than 5 years [270-272]. Therefore, 
research continues for discovering more effective medical and surgical techniques, including less 
invasive techniques such as rehabilitation. 
5.3. Rehabilitation 
The goal of rehabilitation in PD is to overcome the associated motor symptoms for 
improved functioning. It is assumed that the ability to generate the correct movement is not lost 
in PD [243], rather that major motor complications rise from the loss of internal ability to 
activate the appropriate motor plan or suppress the unwanted plans [237, 243].  Incidentally, 
different rehabilitation techniques such as physical therapy (PT) should focus on activating the 
correct motor plan.  
The beneficial effects of rehabilitation are reported in previous investigations ([273, 274], 
some almost three decades old [275]), yet the numerous techniques have no unified therapeutic 
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approach. The focus of the next sections is to review the major therapeutic techniques and the 
motor learning studies in the literature as they apply to rehab in PD patients to offer insight to 
successful learning strategies and outcomes that lay the framework for future and/or other 
interventions. 
5.3.1. Physical Therapy 
Some scientists report benefits of combining training techniques. Training PD patients 
with Proprioceptive Neuromuscular Facilitation (PNF), water resistance exercises and 
coordination exercises of upper and lower extremities [276] for twenty weeks (60 sessions), 
revealed improvements in the Unified Parkinson’s Disease Rating Scale (UPDRS) scores, 
walking time and the Self Assessment Parkinson’s Disease Disability Scale (SAPDDS) scores. 
Franklyn & Stern also report a ―modest‖ improvement in PD patients who attended a four week 
physical therapy program 2 times per week based on PNF and Bobath and Peto methods which 
aim at improving balance, posture and gait complications. Similar to Pellachia et al., they believe 
that the results are successful in improving patients’ quality of life and further report long term 
beneficial effects even five weeks after cessation of the PT program. Others state advantages of 
long term PT programs involving passive and active mobilization exercises and walking for four 
months [277], six weeks (12 sessions) of training with a combination of cardiovascular activities, 
stretching, strengthening, gait with auditory stimulation, balance training and relaxation 
exercises [274], or 16 session of stretching, strengthening and balance training over 8 weeks 
[278]. PT techniques involving repetitive exercises targeting ROM, endurance, balance, walking 
and motor dexterity for four weeks are also reported to be beneficial [279].These studies state 
that such techniques improve functional status of the quality of life regarding physical mobility 
based on mobility portion of Sickness Impact Profile (SIP-68) [274, 277]. Improvements in the 
activities of daily living section of the UPDRS [274, 279], the motor section of the UPDRS [278, 
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279] and total UPDRS score [274, 278] also exist in this population. Improvements in balance 
after a ten week program (30 Sessions) composed of strength and balance training where PD 
patients undergo several conditions challenging the somato-sensory and/or visual systems while 
predisposed to unstable positions are also reported [280, 281].  
More common exercise training regimes may also result in effective rehabilitation for 
PD. Twelve weeks of karate training, revealed improved coordination of fine movements, gait, 
tremor and grip strength [282]. Improved aerobic capacity in terms of VO2 max scores and better 
movement initiation were identified after sixteen weeks of cycling and/or walking [283]. A 
combination of various training exercises such as flexibility training and resistance exercises in 
water led to improvements in UPDRS scores and improved range of joint motion, strength and 
flexibility after 14 weeks of training [284]. High intensity resistance exercise lasting for 12 
weeks resulted in increased walking endurance and greater muscular force production and 
mobility during ascending and descending stair stepping [285, 286]. Focused exercises that target 
spinal flexibility improve functional reach performance in just ten weeks [287] and eight weeks 
of exercises concentrating on lower extremity resistance training reveal increases in strength, gait 
velocity and stride length [286]. The benefits PD patients take from these training types are 
successful in targeting a specific physical limitation, thus strength, flexibility and endurance 
training provide similar results to that of the normal population [286].  
Another recent intriguing rehab technique involves the practice of motor imagery [288]. 
This technique shows promising results when used in combination with PT techniques including 
sitting without support while using upper extremities, standing up, walking, stopping and 
changing direction. The motor imagery task required PD patients to imagine themselves 
performing the same tasks as trained. The benefits were more significant for patients who 
underwent the PT techniques in combination with motor imagery than performing the physical 
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therapy alone. Most improvements involved performance in sequential movements; walking, 
standing up, lying down and standing up again and turning in bed, but improvements were also 
found in the UPDRS motor score and cognitive tasks including clock drawing and stroop tests 
[288]. The fact that PD patients can practice motor imagery at their convenience makes this 
method attractive to some patients. 
The therapeutic strategies applied in the literature are numerous and results in several 
improved outcomes in PD patients. The improved functioning resulting from these techniques is 
of great importance and cannot be denied, however, the combination of techniques does not 
isolate exercise effectiveness and in some cases lacks a scientific explanation for their 
effectiveness (i.e. cannot explain how they bypass the dysfunctional BG), making it unclear 
whether all the exercises are beneficial. Several guidelines have been introduced to overcome 
some variability in techniques applied in rehabilitation settings (Table 2). Readers are referred 
elsewhere [289-291]for further information regarding rehabilitation strategies for PD.  
Table 2. Guidelines for physical therapists in developing rehabilitation strategies. 
1
 
Be knowledgeable of the disease, individual characteristics of the patient, medications and 
peak effect time (on/off periods), cognitive impairments and presence of other pathologies 
2
 
Normal movements are not lost, though it is important to find a way to activate them 
3
 
In order to avoid complexity within a sequence break the movement into components 
4
 
Allow for attention to take control and compensate for the loss of normal automaticity of a 
movement and take advantage of the cortically controlled movement 
5
 




Avoid simultaneous tasks especially at initial stages of therapy  
Adapted from Iansek 1999; Morris, 2000 
 
5.3.2. Motor Learning 
Learning is an imperative component for a successful rehabilitation. Motor learning 
abilities appear to differ according to learning conditions and tasks, making the specific aspects 
of motor learning in PD not easy to determine. The following paragraphs provide some insight to 
these aspects.   
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PD patients are able to learn motor skills with different levels of difficulty and benefit 
from practice [292]. Patients can improve their performance in pursuit rotor tasks in one day 
[292, 293] and sequential reaching movements such as pointing to a sequence of targets in two 
days [292]. Authors suggest that the improved RT (pre-motor and motor components) and MT 
with practice reflect the ability of this population to improve central (pre-motor time) and 
peripheral (motor time) components of the movement [292].  
Some researchers suggest that PD patients are not able to learn tasks that involve 
simultaneous learning of different components of a skill (i.e. spatial and temporal components) 
[72, 294]. They further suggest that PD patients are only able to learn [295] and retain [296] 
simple to moderate sequences, as those that involve less than seven sequences of upper extremity 
movements [295]. These concerns for learning abilities in PD are supported by investigators who 
recognize the BG as the major structures responsible for motor learning in humans [297].  
Interestingly, experimental findings suggest that PD patients can learn more complex 
tasks. Bimanual drawing of triangles is a perfect example. The improvements in cycle duration 
variability, speed accuracy, synchrony between the limbs and consistency of the size of the three 
sides of the triangle occur in greater extent in PD subjects compared to age-matched controls 
after two days of practice [298]. Patients also showed improvements in buttoning a vest, and 
once re-learned after only ten trials of practice, performed the task concurrently while tapping 
the foot [299]. In other experiments PD patients learned a complex Tai Kwan Do movement 
involving twelve postural sequences and coordination of upper and lower extremities within 
three weeks and retained this performance ability for three weeks after termination of practice 
[300]. Moreover, after only one day of practice these patients improved balance skills [301] and 
postural stability [302] in various aspects such as increasing the speed and the level of end point 
exertion while shifting their center of gravity (COG) and further improved speed of reaction to 
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perturbation and the length of the compensatory step a week (former) or months (latter) after 
termination of practice.  
 Success in learning of more complex skills is possibly attributed to the methodology 
used. PD patients who were given more time than healthy individuals, were allowed to correct 
their own errors in learning a Tai Kwan Do movement [300]. Those who were  provided with 
constant augmented visual feedback of their COG to improve their balance in one study [301] 
and given positive reinforcement after production of the appropriate postural response in the 
another [302] may have contributed to their improvements. For the studies on improved balance 
[300, 302] and Tai Kwan Do [300, 302] the practice schedule started with blocked practice and 
ended with a random practice order. Since blocked practice provides greater opportunity for 
early success and random practice results in better retention and transfer skill performance [303, 
304], this schedule likely aiding with learning and retention of movement.  
As indicated by positron emission tomography (PET) scan [295] and functional magnetic 
resonance imaging (FMRI) [305] studies, motor improvements reflect the PD patients’ ability to 
overcome their deficiency by recruiting greater areas within the cortical and sub-cortical regions. 
Unlike the PET scan experiment that reported compensation for simple to moderate tasks, the 
FMRI study revealed the ability of PD patients to reach automaticity for a sequence of twelve 
different movements (indicated by performing the skill accurately in presence of a secondary 
task) by recruiting additional areas such as the cerebellum, pre-motor, pre-frontal and parietal 
cortices. It appears that with sufficient time and appropriate training strategies learning is limited 
to mild or moderate skills in PD. 
Clearly, PD patients can learn tasks of various difficulties under the appropriate 
conditions. Providing the additional time, training and or feedback are likely the keys to success 
of learning more complex tasks in this population. However, whether the PD patients can 
 156 
maintain the skills for the long term and generalize the learned motor skills to their daily routine 
is less clear. Studies in these areas should offer insight to rehab in this population. 
5.3.3. External Stimulation  
―Kinesia paradoxical‖ refers to the ability of PD patients to produce normal movements 
under certain conditions [306]. The use of external stimulation is one condition that can enable 
patients to perform the correct motor task. A strategy to enable motor plan activation in PD 
involves recruiting neurons from other areas of the brain and bypassing the BG [183, 288]. This 
was observed in a study on regional cerebral flow measures, where authors report less activity in 
SMA in PD patients during self-determined tasks but similar activity of the motor cortex of PD 
patients to that of controls during an externally driven tasks [307], revealing direct access to 
other areas of the motor cortex and bypass of BG-SMA pathway under external stimulation 
[308]. These findings highlight the importance of external stimulation in generating normal 
movements in PD. 
Visual feedback is a type of external stimulation used successfully in assisting PD 
patients in a single session. Providing patients with visual cues (i.e. providing dots on the paper 
as cues) can aid in controlling hypokinesia (small hand writing) and therefore enlarging the 
amplitude and size of their strokes [309]. In reaching tasks PD patients behave similar to controls 
in providing appropriate force and velocity possibly because of the visual feedback provided by 
the moving target of interest [133]. Aiming tasks with visual feedback of the movement can 
improve the accuracy of speed and duration of the movement [310]. Stride length and velocity 
increase with visual feedback of ―appropriate‖ step placement [249, 311, 312]. Balance control 
with visual feedback of the COP can decrease postural instabilities [313].  
PD patients also benefit from practice of visually enhanced gait (walking on the marked 
floor) [314, 315] and balance (moving the trunk to colored targets) [315]. After four weeks of 
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practice they improved functionality by increasing independence in activities of daily living 
measured by performance in walking, dressing, eating and hygiene based on Northwestern 
University Disability Scale [315] and increased step length and gait speed [314]. These 
improvements were retained three months (former) and one month (latter) after termination of 
practice. 
Other types of external stimuli were also investigated. An example is an insole vibration 
device that improved the gait complications of PD patients [316]. Stimulating the feet with 
vibrating insoles as they contact the ground increased the stride length, speed and cadence and 
decreased the stride duration variability [316]. The effect of somato-sensory cues in form of 
vibration for improving stride length was noted elsewhere [317] and appears to be a novel 
effective strategy. Cutaneous triggers in forms of electrical stimulation of the feet used as a go 
signal were advantageous in increasing the produced force and anticipatory postural adjustments 
during gait initiation [170]. During gait presence of cutaneous cues decreased COP displacement, 
velocity and the abnormally prolonged double support time were evident [318]. Unfortunately, 
these studies are performed in a single session and long term effects of these stimuli still require 
further study. 
Clearly, the use of external stimuli can improve some of the motor complications in PD. 
The most valuable stimuli, effectiveness of external stimuli and strategies for their incorporation 
into patients’ daily routines require further investigation. The next chapter will concentrate on a 
detailed review of the use of auditory stimulation and how it applies to the PD population.  
5.4. Summary 
Studies on the use of medications, surgery and rehabilitation can result in improved 
motor performance for those with PD. It seems that understanding the purpose and limitation of 
each strategy is imperative to effectively treat PD. Moreover, with greater improvements 
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identified for the use of combined strategies compared to that of a single strategy (i.e. benefits of 
PT in improving certain motor symptoms were greatest when used in conjunction with patients 
medication [276, 289], it is probable that the most successful treatments will involve multiple 
techniques.  
6. AUDITORY STIMULATION, MOTOR CONTROL AND PARKINSON’S    
DISEASE 
 
Auditory stimulation (AS) is only one type of external stimuli used to manage motor 
complications associated with PD by replacing the lost internal trigger for movement 
modulation. Outcomes with visual and tactile cues discussed in the previous chapter gave insight 
to the successful use of these stimuli, primarily in short sessions with relatively long term effects. 
Clearly, the review of literature on outcomes of using auditory cues for motor control in this 
population is warranted, as are the limitations in this research. However, these findings are not as 
meaningful without motivation for using this technique. Therefore, the first focus of this section 
is to show why auditory stimulation may have benefits over other sensory modalities.  
6.1. Why Use Auditory Stimulation? 
Auditory and visual cues are the most common modalities used as external stimuli for 
treatment of PD symptoms. Researchers consider many outcomes associated with their use 
successful, explaining why these cues are commonly used and why the following discussion 
concentrates on outcome studies using these modalities.  
Based on measures of variability of the IRI of finger tapping to external stimuli and the 
ability to coordinate each tap to the stimulus, normal subjects produce less stable and less 
accurate synchronized and syncopated movements in response to visual stimuli compared to 
auditory while pacing the finger tapping [319, 320], and continuing it upon removal of the 
stimuli [319, 320]. In these experiments the subject is asked to synchronize (pace movements 
with each stimulus presentation) or syncopate (pace movements between each stimulus 
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presentation) the motor response to a rhythmic external stimulation, and is required to continue 
the pattern after removal of the stimulus. The outcomes suggest that auditory cues are easier for 
the healthy subject to follow no matter the task complexity; syncopation, which requires more 
cognitive effort than synchronization, is considered to be more complex [321].  
 Investigators also report an ―auditory dominance in temporal processing‖ [322] 
compared to visual and tactile counterparts. In a bimodal condition, where rhythmic auditory and 
visual stimuli are both present, the temporal pattern of inter response duration of finger tapping is 
similar to that of auditory alone [322]. Individuals have a higher tendency to match the pattern of 
their finger tapping to auditory distracters during  a visual synchronization task than to visual 
distracters during an auditory synchronization task [320]. Use of auditory stimulation in 
combination with visual cues during gait have no benefits in improving gait velocity and stride 
length over using the auditory stimulation alone [323]. In addition, perceiving duration of visual 
intervals are more variable than those of auditory [321, 324] and RT is longest for vision, 
followed by that of touch, then by audition [325]. Together, these results support the auditory 
dominance hypothesis.  
CNS recordings, which provide evidence for modality dependent mechanisms, 
compliment the previous findings [319, 321]. The continuous activity of visual specific brain 
areas after removal of the visual stimulation [321] is unlike that for auditory stimulation, where 
the auditory specific brain areas become inactive during this time [319, 321]. Interpretation by 
these researchers include that auditory information directly transfers into an accurate and stable 
motor output, dismissing the need for continuous activation after stimulus removal [321] and/or 
that visual information is ―too demanding‖ for directly generating a motor response [319]. 
Evidence regarding encoding of temporal characteristics of rhythmic visual stimulation to the 
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auditory cortex accounts for the prolonged brain activity of the visual modality [326] and likely 
accounts for the auditory dominance previously reported. 
The evidence for sub-cortical processing of auditory stimuli [327, 328] adds to the 
potential benefits of its use. Results that auditory stimulation can increase the excitability of 
spinal motor neurons via the reticulo-spinal pathway in response to an unexpected loud noise 
[329] and that listening to a low threshold single tone can facilitate the H-reflex [330] exist. The 
latter findings manifest the enhanced motor response with auditory stimulation [330] without use 
of the startle reflex, suggesting support for the auditory signal rather than just an autonomic 
response. 
 In summary, advantages of auditory stimulation are numerous. Auditory stimulation 
offers superior temporal organization of movement and perception thus appears to be the most 
appropriate external stimulation modality for motor control. 
6.2. Outcomes of Auditory Stimulation 
Playing music or generating beats with a metronome or computer enable researchers to 
study the effects of auditory stimulation on movement control. Most scientists that study effects 
of auditory stimulation use rhythmic beats of a metronome instead of that from music to 
eliminate the emotional and motivational effect of music (e.g. Pacchetti, Mancini, Aglieri, 
Fundaro, Martignoni, & Nappi, 2000). Moreover, dance students synchronize their steps better 
with the rhythm of a metronome compared to music [331], suggesting another advantage for 
metronome use for movement control. 
Several studies use finger tapping to an external rhythm as a common task for 
investigating sequential movement disorders in PD. However, the aims of these studies involve 
the role of the BG in control of sequential movements rather than its effects on movement 
control [90-93]. Therefore, the focus of this section is to review investigations on the study of 
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short term effects and practice effects of auditory stimulation for enhancing the motor 
performance in PD and not the roles of the BG.  
6.2.1. Short Term Effects 
Investigations on the short term benefits of auditory stimulation evaluate the movement 
during externally driven tasks or during and immediately after removal of the auditory stimuli. 
Although beneficial effects of AS on different gait parameters are commonly proposed, scientists 
do not always agree on the training method(s) and the nature of the benefits. Such discrepancies 
partially rise from the inconsistent methodology across studies. Table 3 offers a brief synopsis of 
short term training effects of AS on movement control (single session studies), highlighting the 
methodological differences, while the following text summarizes the major findings and lists the 
corresponding conclusions. 
A fixed AS frequency set to that of a preferred cadence appears to be beneficial for 
improving control of cadence during the externally driven gait [332, 333]. A 100 beats per 
minute (bmp) metronome frequency caused changes in PD muscular activity patterns when 
walking 8.5 meters, revealing increased EMG slope, decreased time to reach maximum force as 
well as reduced variability of selected EMG time patterns in the lower leg muscles to levels 
similar to age-matched controls [334] . Patients were also able to walk 40 meters in a shorter 
duration, with fewer steps and less freezing episodes to a metronome set at 96 bpm compared to 
a self-selected walk [335]. These findings suggest that the temporal control offered by fixed AS 
frequencies faster than preferred walking speed alter temporal organization of muscle activity 
and the ensuing force production and minimize certain undesirable symptoms of PD.  
Relative frequencies of AS also reveal mixed findings for short term alterations in people 
with PD. Decreased double support time [333] and increased step length (Freedland et al., 2002; 
McIntosh, Brown, Rice, & Thaut, 1997), gait velocity [336] and cadence [332]; [336] are 
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reported in this population for metronome frequencies set above baselines set at either 
comfortable or maximum cadence. In contrast there are reports of no change in step length [332, 
337, 338, 340] and double support time [332] and speed [338] for rhythmic auditory frequencies 
15% higher than the preferred cadence or less. The double support time was reported to improve 
when compared to comfortable self-paced gait [333] but showed no changes when compared to 
gait synchronized with metronome set at preferred gait cadence[332]. Gait speed showed no 
changes in one experiment where subjects practiced to five different frequencies set above that of 
the preferred cadence[338]. Recanzone, 2003 suggests that spatial changes are not expected with 
auditory stimulation, as this type of modality is more beneficial in terms of temporal 
organization of movement. However, opposing outcomes regarding the double support time, step 
length and speed may result from methodological differences. 
Interestingly, significant effects when walking to AS frequencies above preferred and 
maximum cadence did transfer to free walking conditions. Cadence, step length [336]; Freedland 
et al. 2002), step velocity [336] and cycle time (Freedland et al. 2002) are reported for walking 
without stimuli after the application of frequencies at preferred cadence and 10% above. At a 
more functional level benefits of auditory stimulation also appear to be promising [339]. For 
example, training PD patients to walk to an auditory rhythm set at the preferred speed while 
carrying a tray of cups from the kitchen helps increase gait velocity without influencing cadence 
[339].  
 A frequency set at -7.5% of preferred cadence bears no effect on gait velocity, stride 
length, cadence and double support time [332, 340], while that of a -10% does not affect MT or 
gait velocity [110]. Yet a metronome set at -10% of the preferred cadence increases the stride 
length and double support time, while decreasing the gait velocity [332]. A frequency of -15% 
only decreases gait velocity and cadence without affecting the stride length [340], but imposing a 
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rhythm as low as -20% appears not to affect gait velocity, stride length and cadence beyond that 
of the -15% [332]. In addition, the -20% frequency increases the step to step variability of the 
step length and duration and is considered detrimental [222].  
A single auditory signal is shown to alter muscular activity affecting the initiation of a 
task in PD subjects. A single cue can enhance the initiation of the movement by facilitating the 
suppression of the plantar flexor muscles before the PD individual takes the first step to walk 
[341]. MT and variability decrease and peak velocity increase during a task where patients reach 
for a pen and begin to write, if the task is triggered by an initial auditory signal compared to a 
self-selected start [250]. A single audiovisual signal can increase the peak hip flexion and knee 
extension torque as the individual with PD starts to rise from a chair, reducing the time to 
complete the sit to stand task when compared to a self-regulatory condition [342]. Although not 
performed in isolation, auditory stimulation alone is likely to have a significant effect in the 
findings of this experiment similar to previous findings [341]. Whether the single auditory 
stimulus is superior to a visual cue is still unclear, as an increased COP velocity for the single AS 
condition was associated with a smaller step length than the condition in response to a single 
visual stimulus [318]. 
There is also evidence that short term practice with AS contributes to the neural plasticity 
[343].TMS of M1 evoked thumb flexion changes in movement amplitude and direction after 
practice of thumb extension movements under rhythmic AS with a 1 Hz metronome beat for 15 
minutes. Post practice, TMS that evoked thumb flexion initially, resulted in more regular 
(symmetrical) extension movements. These findings were significantly stronger when subjects 
practiced thumb extension with auditory cue compared to self-paced practice. 
 Some of the abovementioned improvements such as increase in efficiency of reaching 
for a pen, peak reaching velocity [250] and suppression of plantar flexors of the step initiation 
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[341] occur only for PD patients. These observations not only reveal the ability of PD patients to 
improve but also suggest that unlike the healthy individuals, PD patients possess some 
movement deficits which open the space for improvements [250]. 
Review of the short term effects of auditory stimulation are appealing for some aspects of 
movement control. The use of different methodologies, resulting in varying results, offers some 
insight to successful protocols. For example, it is probable that the changes that occur during gait 
practice with AS generalize to normal walking, at least for the short term. However, when the 
use of similar methodology result in varying results, one must wonder if other factors such as 
motivation or fatigue during the session are to blame. Results from longer term practice may 
offer greater insight to the role of AS on movement control. 
6.2.2. Practice Effects 
The effects of short term training are only successful as a rehabilitation technique if they 
bear long term benefits. Therefore, the initial focus of this section was to not only determine any 
additional benefits observed with long term use of auditory stimulation, but also to determine 
whether the benefits of its use will remain for the long term after termination of practice and 
upon removal of the external stimulation. However, since no studies involving movement 
benefits for the long term after the use of AS were identified, the focus of this section is limited 
to long term use. A brief synopsis of relatively long term training effects of AS on movement 
control are presented (Table 4), while the following text summarizes the major findings and lists 
the corresponding conclusions. 
               Initial studies for relatively long term use of AS in PD patients reveal benefits at the 
muscular and functional levels. Three weeks of walking to AS of beats imbedded in music at a 
preferred cadence for 25 minutes per day resulted a significant reduction in variability of the 
pattern of the activity of lower leg muscles, increase in the symmetry of bilateral leg muscles and 
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increase in gait velocity and stride length [209]. Over a similar training time for 30 minutes per 
day using a similar rhythmic auditory stimulation but with frequency ranging from preferred 
cadence to 10% and 20% faster resulted in increased gait velocity, stride length, symmetry of 
bilateral leg muscles and a more rapid termination muscle pattern; like that of controls [344]. 
Training in the latter study was altered such that performances were on flat and inclined surfaces 
with possible ―stop and go‖ cues or while stair stepping. Together, these findings suggest that the 
effects of auditory stimulation are important in regulating the motor unit recruitment patterns 
[209] that result in certain functional alterations. 
 Movement alterations in PD subjects were also found for practice sessions lasting 60 min 
for five days a week for four weeks. Training required PD patients to walk to the rhythmic AS of 
a metronome with frequencies ranging from 30 to 150 bpm while performing manual tasks that 
became more complex along the course of a four week practice [345]. Gait velocity, step length 
and cadence increased for preferred walking pace with and without upper limb movement and at 
maximum speed for 7.62 meters. The variability of the step duration decreased to baseline 
control level for preferred pace walking with no upper limb movement. Since the variability 
measures for PD patients were originally similar to that of controls for the maximum speed, no 
change was expected in this case. However, because walking with upper limb movements offers 
a higher level of complexity and greater deficits in patients, they had more room for 
improvement, thus could benefit from a longer practice. 
  There is no evidence that one week of AS training at the preferred walking speed can 
reduce the number or duration of freezing episodes in PD subjects [346]. In fact, authors found 
an increase in their gait duration on a 60 foot track with 2 U-turns and one doorway. Whether 
alterations in their methodology would result in reduction in the freezing episode number or 
duration remains to be tested.  
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Experiments regarding the effect of auditory stimulation on cortical and sub-cortical 
regions after practice are few in number, especially when considering PD patients. One recent 
study has addressed this issue. After four weeks of performing manual tasks and walking to 
auditory cues ranging from 30 to 150 bpm, PD patients reduced the amount of variability of IRI 
for gait and finger tapping [347]. Although there were no significant changes in other parameters 
such as movement velocity, stride length and gait or tapping cadence, a significant increase in 
activation of parietal and temporal lobes as well as right cerebellum hemisphere and dentate 
nucleus after therapy were identified during finger tapping. According to investigators AS 
therapy resulted in activation of a pathway used for temporal control of movement [347]. 
Whether these findings are long lasting and can circumvent the damaged BG over the long term 
remain to be tested, however the initial results are promising.  
6.3. Limitations of Previous Research 
 The aforementioned studies showed various effects of short and long term practice with 
AS on different aspects of movement in those with Parkinson’s. Although several alterations 
were considered beneficial for improving the function in this population, acknowledging the 
limitations of previous studies will not only highlight the areas that need more research but also 
guide future investigation improvements. 
The first apparent limitation is on the number of studies involving AS effects on 
movement outcomes in PD. For example, brain imaging studies are numerous when it comes to 
evaluating brain areas activated during auditory stimulation application [319, 321] or during 
assessment of general learning abilities [305, 348] in the normal and PD population . However, 
only a few of the published studies were identified using PD subjects. Moreover, the number of 
studies identifying long term outcomes for this population is limited. Since the longest reported 
alterations were recorded only one day after termination of practice [336, 344, 345, 347] it is 
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very difficult to determine and/or predict the benefits of auditory stimulation as a rehabilitation 
regiment. Rehabilitation methods should focus on the individuals’ ability to apply what they 
learn beyond the doors of clinics or research labs. 
Understanding the optimal training or practice methodology is not clear because of the 
presence of different or combined methodologies used and conflicting results. Varied [332, 338, 
339, 344, 345, 347]  and constant [335] frequencies of AS have resulted in movement alterations 
in PD, leaving one to wonder which is better. The most difficult training methodology to follow 
are those studies lacking the clear description of the training condition [344 345, 346], especially 
when it changes across time and conditions. Although few studies have incorporated different 
levels of complexities within their auditory stimulation intervention [209, 345] and such changes 
may be beneficial for the subjects, none used an objective measure to present the new level of 
complexity. The researchers that set a baseline cadence for practice comparisons have used a 
maximal [323, 336] or preferred [337, 339, 344, 346] cadence, thus producing varied outcomes 
due to comparison difference. Auditory stimulation has not been used exclusively in all 
experiments; it has been used in combination with visual cues for gait [323] or gait initiation 
[342]. Using multiple stimuli and embedding metronome-like beats in music [336, 349] could 
offer different results than pure metronome training.  
Further limitations are noted with precise inspection of the methodologies. Without a 
control group [333] it is difficult to determine if PD patients improve to the level of their peers 
without neurological deficits. It becomes very difficult to make conclusions in some cases 
because authors do not report the effects of AS on some of the recorded depended variables 
[333] or lack information regarding the patient population such as duration of the disease [340] 
or whether patients were tested on or off their medication [333].   
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Auditory stimulation superiority previously reported for temporal organization of 
movement and perception is not necessarily true for spatial measures. It has been suggested that 
vision is of more importance for spatial organization [350]. The fact that AS use does alter 
spatial measures such as step/stride length [337, 344] is an added benefit, however the extent of 
such improvement may be incomplete.  
The limitations listed above are not inclusive, nor do they deny the movement alterations 
that have occurred with AS practice in Parkinson’s patients. Rather, they are a reminder that 
there is still much to learn about the use of AS for movement improvements in this population. 
Greater insights to the particular use of AS in PD subjects are offered below in the ―Future 
Directions‖ section. 
          7. SUMMARY 
As a disease of unknown etiology, the pathology of Parkinson’s disease is difficult to 
understand. The major motor symptoms of tremor, bradykinesia, postural instability and rigidity, 
used for diagnosis, result from a defective BG with well-mapped connections, however the exact 
motor role(s) and functional organization of the BG remain a mystery. Although controversies 
exist in regards to the exact role of the BG and cerebellum in temporal movement control, it is 
obvious that PD patients are less capable of releasing and inhibiting the appropriate movement at 
the appropriate time for proper control. 
Motor complications resulting from damage to the BG in PD lead to control deficits in 
this population. Complications of posture and gait that ensue from these deficits are of great 
importance as they affect independent functioning of the individual, making the person prone to 
falls and the associated consequences. Although new surgical interventions are promising and 
lack debilitating side effects present with medication, the outcomes are limited and not all 
patients qualify for its use. 
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 Because PD patients show preserved motor learning abilities, rehabilitation can play an 
important role in keeping the individuals active and in overcoming some of their motor 
complications. Of the various rehabilitation techniques external stimuli are of great interest as 
they may replace the malfunctioned BG, the lost internal trigger for movement modulation. As 
the dominating stimulus for temporal processing, auditory stimulation can significantly assist 
individuals with PD to regain temporal control over their actions with the hope of improving 
their motor performance. 
There is ample evidence that treatment for motor complications associated with PD is 
multidimensional. For example, Parkinson’s patients on medication commonly receive greater 
benefits from rehabilitation and surgical techniques than when not medicated. Understanding the 
literature in regards to successful treatment outcomes is imperative to offering insight to more 
effective rehabilitation techniques. Summary of the major gaps in the rehabilitation literature and 
major limitations of previous studies is presented next to offer insight to future directions of 
treatment for this population. 
                                            8. FUTURE DIRECTIONS 
8.1. Need for Future Investigations 
 
Reaching, grasping and walking, motor abilities simply and sub-consciously performed 
by people with no neurological problems, become strenuous activities for patients with PD. No 
current treatments exist to help these people overcome all their motor deficits. In fact, some 
treatments cause detrimental secondary side effects.  
A century has passed since PD was discovered based on its significant motor symptoms, 
however no consensus on effective rehabilitation techniques for PD symptoms exists. It is 
possible that early scientists failed to recognize the plastic nature of the central nervous system 
and the roles rehabilitation can play, as training use for therapeutic regimes using specialists is 
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relatively new (PT inception, world war I [351]) and the use of evidence-based research in this 
field is lacking [352, 353]. Clearly, there is need for additional research on rehabilitation of 
motor symptoms in people with PD.  
8.2. Rehabilitation in Future Investigations 
Auditory stimulation has been used to successfully alter temporal control in PD patients. 
(See the Why use auditory stimulation? section in chapter six for the rationale of using auditory 
stimulation for rehabilitation for people with PD). Even though researchers report the positive 
effects of auditory stimulation on movement control, there is still much to be learned about its 
short and long term effects and how it should be used in rehabilitation efforts. It is clear that with 
the different stimulus frequencies, durations and methods used previously (see Tables 3 and 4), 
there is a need for more research on the application of rhythmic auditory stimulation for 
movement control. 
As a preliminary to studying the effect of auditory stimulation on movement of 
individuals with PD, some initial questions posed to fill gaps regarding stimulus frequency were 
included in a pilot study. Does training with different frequencies of auditory stimulation affect 
the temporal outcomes of gait? Does the order of application of different frequencies of auditory 
stimulation affect the temporal outcomes of gait? Does training in one specific sequence help 
individuals apply the results to a different sequence? Although order of frequency application did 
not affect the temporal outcomes of gait in normal young subjects, training in different sequences 
did. Although similar training outcomes are probable for people with PD, the training effects for 
using multiple frequencies remain to be tested. 
Three major limitations of most, if not all previous experiments on AS, used in PD 
include: the effects of treatment over a longer time period, its long term effects and the 
determination of whether it generalizes to daily activity. Although one time training sessions are 
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easy to arrange and provide insight to AS effectiveness, they provide little time for changes in 
neural plasticity. Furthermore, in previous AS studies re-evaluation of PD patients’ control long 
term after practice do not exist, while testing control with stimulus removal in a different context 
is limited. Thus, how long the benefits last and how well they serve this population in the context 
of everyday life is unclear. To improve the use of auditory stimulation in a rehab setting, several 
questions still need to be answered. Accordingly, the following aims and hypotheses are 
proposed. 
8.3. Developed Aims and Hypotheses 
Aim1: To investigate the effect of using multiple frequencies and tones of auditory 
stimuli within a single trial for PD patients. As mentioned previously, the BG are important in 
selecting, releasing and switching a motor plan which allows for sub-cortical or more automated 
performance of a sequence of actions. To bypass the BG one should take advantage of 
performing the tasks at a cortical level. Using one frequency within each session or trial allows 
one to predict the following beat, habituates the patient and does not challenge the CNS in 
withholding the competing plans required for daily living. Assigning different tones to different 
actions will demand constant monitoring of the presented beats to modulate the movement, likely 
encouraging facilitation of compensatory pathways. It is hypothesized that using different tones 
or frequencies within a trial will result in improved movement control for PD patients. 
Aim 2: To investigate how PD patients benefit from longer practice duration that is 
organized with feedback. There is evidence that PD patients struggle to execute certain 
movements, especially activities that are more complex in nature and require several sequential 
movements. However, significant learning and retention of complex sequential movements has 
occurred in this population often when practice time was extended and feedback was provided. 
Taking advantage of longer practice schedules and other successful motor learning principals 
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such as providing feedback and beginning with a simple blocked practice design and moving 
towards more random design with improvement should foster a good learning environment. It is 
hypothesized that using different tones or frequencies within trials in an unpredictable random 
manner after some blocked practice will initially be more difficult for PD patients to perform, but 
ultimately result in improved movement control abilities. 
Aim3. To investigate the ability of PD patients to generalize what they practice to similar 
conditions but in different contexts. Many studies test patients after training in a very similar 
environment of practice. Thus, improvements with training are evident in this environment. 
However, whether these results transfer to different tasks or environments remains unanswered. 
It is hypothesized that using different tones or frequencies within trials in an unpredictable 











                                                     REFERENCES 
 
 
1. Vick, N.A., Disorders of the Basal Ganglia and Thalamus, in Grinker's Neurology, A. Gabell, 
Editor. 1976, Charles C Thomas. p. 335. 
 
2. Van Den Eeden, S.K., et al., Incidence of Parkinson's disease: variation by age, gender, and 
race/ethnicity. Am J Epidemiol, 2003. 157(11): p. 1015-22. 
 
3. Tedroff, J., et al., Regulation of dopaminergic activity in early Parkinson's disease. Ann Neurol, 
1999. 46(3): p. 359-65. 
 
4. Mink, J.W., Functional Organization of the Basal Ganglia, in Parkinson's Disease and 
Movement Disorder J. Jankovic and T. Eduardo, Editors. 2007, Lippincott Williams & Wilkins: 
Philadelphia. p. 1. 
 
5. Donoghue, J.P. and M. Herkenham, Neostriatal projections from individual cortical fields 
conform to histochemically distinct striatal compartments in the rat. Brain Res, 1986. 365(2): p. 
397-403. 
 
6. Monakow, K.H., K. Akert, and H. Kunzle, Projections of the precentral motor cortex and other 
cortical areas of the frontal lobe to the subthalamic nucleus in the monkey. Exp Brain Res, 1978. 
33(3-4): p. 395-403. 
 
7. Nauta, H.J., A proposed conceptual reorganization of the basal ganglia and telencephalon. 
Neuroscience, 1979. 4(12): p. 1875-81. 
 
8. Mink, J.W., Functional Organization of the Basal Ganglia, in Parkinson's Disease and 
Movement Disorder J. Jankovic and T. Eduardo, Editors. 2007, Lippincott Williams & Wilkins: 
Philadelphia. p. 3. 
 
9. Russchen, F.T., et al., The amygdalostriatal projections in the monkey. An anterograde tracing 
study. Brain Res, 1985. 329(1-2): p. 241-57. 
 
10. Jankovic, J. and T. Eduardo, Parkinson's Disease and Movement Disorders. 5 ed. 2007, 
Philadelphia: Lippincott Williams & Wilkins. 720. 
 
11. Albin, R.L., A.B. Young, and J.B. Penney, The functional anatomy of disorders of the basal 
ganglia. Trends Neurosci, 1995. 18(2): p. 63-4. 
 
12. DeLong, M.R., Primate models of movement disorders of basal ganglia origin. Trends Neurosci, 
1990. 13(7): p. 281-5. 
 
13. Alexander, G.E., M.R. DeLong, and P.L. Strick, Parallel organization of functionally segregated 
circuits linking basal ganglia and cortex. Annu Rev Neurosci, 1986. 9: p. 357-81. 
 
14. Nambu, A., et al., Excitatory cortical inputs to pallidal neurons via the subthalamic nucleus in 
the monkey. J Neurophysiol, 2000. 84(1): p. 289-300. 
 
15. Nambu, A., A new dynamic model of the cortico-basal ganglia loop. Prog Brain Res, 2004. 143: 
p. 461-6. 
 174 
16. Obeso, J.A., et al., Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci, 
2000. 23(10 Suppl): p. S8-19. 
 
17. Hazrati, L.N., et al., Evidence for interconnections between the two segments of the globus 
pallidus in primates: a PHA-L anterograde tracing study. Brain Res, 1990. 533(1): p. 171-5. 
 
18. Hazrati, L.N. and A. Parent, Projection from the external pallidum to the reticular thalamic 
nucleus in the squirrel monkey. Brain Res, 1991. 550(1): p. 142-6. 
 
19. Mink, J.W., Functional Organization of the Basal Ganglia, in Parkinson's Disease and 
Movement Disorder J. Jankovic and T. Eduardo, Editors. 2007, Lippincott Williams & Wilkins: 
Philadelphia. p. 1-3. 
 
20. Middleton, F.A. and P.L. Strick, New concepts about the organization of basal ganglia output. 
Adv Neurol, 1997. 74: p. 57-68. 
 
21. Takakusaki, K., et al., Discharge properties of medullary reticulospinal neurons during postural 
changes induced by intrapontine injections of carbachol, atropine and serotonin, and their 
functional linkages to hindlimb motoneurons in cats. Exp Brain Res, 1994. 99(3): p. 361-74. 
 
22. Pakhotin, P. and E. Bracci, Cholinergic interneurons control the excitatory input to the striatum. 
J Neurosci, 2007. 27(2): p. 391-400. 
 
23. Glynn, G. and S.O. Ahmad, Three-dimensional electrophysiological topography of the rat 
corticostriatal system. J Comp Physiol A Neuroethol Sens Neural Behav Physiol, 2002. 188(9): 
p. 695-703. 
 
24. Holsapple, J.W., J.B. Preston, and P.L. Strick, The origin of thalamic inputs to the "hand" 
representation in the primary motor cortex. J Neurosci, 1991. 11(9): p. 2644-54. 
 
25. Yoshida, S., A. Nambu, and K. Jinnai, The distribution of the globus pallidus neurons with input 
from various cortical areas in the monkeys. Brain Res, 1993. 611(1): p. 170-4. 
 
26. Ebrahimi, A., R. Pochet, and M. Roger, Topographical organization of the projections from 
physiologically identified areas of the motor cortex to the striatum in the rat. Neurosci Res, 1992. 
14(1): p. 39-60. 
 
27. Hoover, J.E. and P.L. Strick, Multiple output channels in the basal ganglia. Science, 1993. 
259(5096): p. 819-21. 
 
28. Inglis, W.L. and P. Winn, The pedunculopontine tegmental nucleus: where the striatum meets the 
reticular formation. Prog Neurobiol, 1995. 47(1): p. 1-29. 
 
29. Inglis, W.L., et al., An investigation into the role of the pedunculopontine tegmental nucleus in 
the mediation of locomotion and orofacial stereotypy induced by d-amphetamine and 
apomorphine in the rat. Neuroscience, 1994. 58(4): p. 817-33. 
 
30. Skinner, R.D. and E. Garcia-Rill, The mesencephalic locomotor region (MLR) in the rat. Brain 
Res, 1984. 323(2): p. 385-9. 
 
 175 
31. Mileykovskiy, B.Y., et al., Activation of pontine and medullary motor inhibitory regions reduces 
discharge in neurons located in the locus coeruleus and the anatomical equivalent of the 
midbrain locomotor region. J Neurosci, 2000. 20(22): p. 8551-8. 
 
32. Kelland, M.D. and D. Asdourian, Pedunculopontine tegmental nucleus-induced inhibition of 
muscle activity in the rat. Behav Brain Res, 1989. 34(3): p. 213-34. 
 
33. Shik, M.L., F.V. Severin, and G.N. Orlovskii, [Control of walking and running by means of 
electric stimulation of the midbrain]. Biofizika, 1966. 11(4): p. 659-66. 
 
34. Beckstead, R.M., V.B. Domesick, and W.J. Nauta, Efferent connections of the substantia nigra 
and ventral tegmental area in the rat. Brain Res, 1979. 175(2): p. 191-217. 
 
35. Spann, B.M. and I. Grofova, Nigropedunculopontine projection in the rat: an anterograde 
tracing study with phaseolus vulgaris-leucoagglutinin (PHA-L). J Comp Neurol, 1991. 311(3): p. 
375-88. 
 
36. Moriizumi, T., et al., Topographic projections from the basal ganglia to the nucleus tegmenti 
pedunculopontinus pars compacta of the cat with special reference to pallidal projection. Exp 
Brain Res, 1988. 71(2): p. 298-306. 
 
37. Hazrati, L.N. and A. Parent, Contralateral pallidothalamic and pallidotegmental projections in 
primates: an anterograde and retrograde labeling study. Brain Res, 1991. 567(2): p. 212-23. 
 
38. Bevan, M.D. and J.P. Bolam, Cholinergic, GABAergic, and glutamate-enriched inputs from the 
mesopontine tegmentum to the subthalamic nucleus in the rat. J Neurosci, 1995. 15(11): p. 7105-
20. 
 
39. Carpenter, M.B., et al., Connections of the subthalamic nucleus in the monkey. Brain Res, 1981. 
224(1): p. 1-29. 
 
40. Takakusaki, K., et al., Basal ganglia efferents to the brainstem centers controlling postural 
muscle tone and locomotion: a new concept for understanding motor disorders in basal ganglia 
dysfunction. Neuroscience, 2003. 119(1): p. 293-308. 
 
41. Rye, D.B., et al., Medullary and spinal efferents of the pedunculopontine tegmental nucleus and 
adjacent mesopontine tegmentum in the rat. J Comp Neurol, 1988. 269(3): p. 315-41. 
 
42. Garcia-Rill, E., The pedunculopontine nucleus. Prog Neurobiol, 1991. 36(5): p. 363-89. 
 
43. Skinner, R.D., et al., Locomotor projections from the pedunculopontine nucleus to the 
medioventral medulla. Neuroreport, 1990. 1(3-4): p. 207-10. 
 
44. Lai, Y.Y. and J.M. Siegel, Muscle tone suppression and stepping produced by stimulation of 
midbrain and rostral pontine reticular formation. J Neurosci, 1990. 10(8): p. 2727-34. 
 
45. Shiromani, P.J., Y.Y. Lai, and J.M. Siegel, Descending projections from the dorsolateral pontine 
tegmentum to the paramedian reticular nucleus of the caudal medulla in the cat. Brain Res, 1990. 
517(1-2): p. 224-8. 
 
 176 
46. Lai, Y.Y., J.R. Clements, and J.M. Siegel, Glutamatergic and cholinergic projections to the 
pontine inhibitory area identified with horseradish peroxidase retrograde transport and 
immunohistochemistry. J Comp Neurol, 1993. 336(3): p. 321-30. 
 
47. Mena-Segovia, J., J.P. Bolam, and P.J. Magill, Pedunculopontine nucleus and basal ganglia: 
distant relatives or part of the same family? Trends Neurosci, 2004. 27(10): p. 585-8. 
 
48. Parent, A. and L.N. Hazrati, Functional anatomy of the basal ganglia. I. The cortico-basal 
ganglia-thalamo-cortical loop. Brain Res Brain Res Rev, 1995. 20(1): p. 91-127. 
 
49. Wiesendanger, E., et al., Topography of cortico-striatal connections in man: anatomical evidence 
for parallel organization. Eur J Neurosci, 2004. 20(7): p. 1915-22. 
 
50. Yeterian, E.H. and D.N. Pandya, Prefrontostriatal connections in relation to cortical 
architectonic organization in rhesus monkeys. J Comp Neurol, 1991. 312(1): p. 43-67. 
 
51. Rolls, E.T., Experimental psychology: functions of different regions of the basal ganglia, in 
Parkinson's Disease, G.M. Stern, Editor. 1990, The Johns Hopkins University Press: Baltimore. 
p. 152-163. 
 
52. Starkstein, S.E., et al., Depression in classic versus akinetic-rigid Parkinson's disease. Mov 
Disord, 1998. 13(1): p. 29-33. 
 
53. Bokura, H. and R.G. Robinson, Long-term cognitive impairment associated with caudate stroke. 
Stroke, 1997. 28(5): p. 970-5. 
 
54. Caplan, L.R., et al., Caudate infarcts. Arch Neurol, 1990. 47(2): p. 133-43. 
 
55. Nadeau, S.E. and B. Crosson, Subcortical aphasia. Brain Lang, 1997. 58(3): p. 355-402; 
discussion 418-23. 
 
56. Kumral, E., D. Evyapan, and K. Balkir, Acute caudate vascular lesions. Stroke, 1999. 30(1): p. 
100-8. 
 
57. Kandel, E.R.S., J. H. Jessell, T. M. 3 ed. 1991: Appleton & Lange. 
 
58. Stern, G.M., Parkinson's Disease. 1 ed. 1990, Baltimore: The Johns Hopkins University Press. 
688. 
59. Jankovic, J. and E. Tolosa, Parkinson's Disease and Movement Disorders. 5 ed. 2007, 
Philadelphia: LIPPINCOTT WILLIAMS & WILKINS. 720. 
 
60. Parent, A., Extrinsic connections of the basal ganglia. Trends Neurosci, 1990. 13(7): p. 254-8. 
 
61. Parent, A. and L.N. Hazrati, Functional anatomy of the basal ganglia. II. The place of 
subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev, 
1995. 20(1): p. 128-54. 
 
62. Grabli, D., et al., Behavioural disorders induced by external globus pallidus dysfunction in 
primates: I. Behavioural study. Brain, 2004. 127(Pt 9): p. 2039-54. 
 
63. Kato, M., et al., Eye movements in monkeys with local dopamine depletion in the caudate 
nucleus. I. Deficits in spontaneous saccades. J Neurosci, 1995. 15(1 Pt 2): p. 912-27. 
 177 
64. Marsden, C.D., The mysterious motor function of the basal ganglia: the Robert Wartenberg 
Lecture. Neurology, 1982. 32(5): p. 514-39. 
 
65. Vick, N.A., Disorders of the Basal Ganglia and Thalamus. , in Grinker's Neurology., A. Gabell, 
Editor. 1976, Charles C Thomas: Springfield. p. 329. 
 
66. Stern, G.M., Advances In Neurology. 1 ed, ed. G.M. Stern. Vol. 80. 1999, Philadelphia: 
Lippincott Williams & Wilins. 670. 
 
67. Lang, A.E. and A.M. Lozano, Parkinson's disease. Second of two parts. N Engl J Med, 1998. 
339(16): p. 1130-43. 
 
68. Joel, D. and I. Weiner, The connections of the dopaminergic system with the striatum in rats and 
primates: an analysis with respect to the functional and compartmental organization of the 
striatum. Neuroscience, 2000. 96(3): p. 451-74. 
 
69. Leblois, A., et al., Competition between feedback loops underlies normal and pathological 
dynamics in the basal ganglia. J Neurosci, 2006. 26(13): p. 3567-83. 
 
70. Kropotov, J.D. and S.C. Etlinger, Selection of actions in the basal ganglia-thalamocortical 
circuits: review and model. Int J Psychophysiol, 1999. 31(3): p. 197-217. 
 
71. Alpherts, W.C., et al., Lateralization of auditory rhythm length in temporal lobe lesions. Brain 
Cogn, 2002. 49(1): p. 114-22. 
 
72. Shin, J.C. and R.B. Ivry, Spatial and temporal sequence learning in patients with Parkinson's 
disease or cerebellar lesions. J Cogn Neurosci, 2003. 15(8): p. 1232-43. 
 
73. Penhune, V.B. and J. Doyon, Cerebellum and M1 interaction during early learning of timed 
motor sequences. Neuroimage, 2005. 26(3): p. 801-12. 
 
74. Rao, S.M., A.R. Mayer, and D.L. Harrington, The evolution of brain activation during temporal 
processing. Nat Neurosci, 2001. 4(3): p. 317-23. 
 
75. Dhamala, M., et al., Neural correlates of the complexity of rhythmic finger tapping. Neuroimage, 
2003. 20(2): p. 918-26. 
 
76. Rensing, L., U. Meyer-Grahle, and P. Ruoff, Biological timing and the clock metaphor: 
oscillatory and hourglass mechanisms. Chronobiol Int, 2001. 18(3): p. 329-69. 
 
77. Treisman, M., et al., The internal clock: electroencephalographic evidence for oscillatory 
processes underlying time perception. Q J Exp Psychol A, 1994. 47(2): p. 241-89. 
 
78. Ivry, R.B., The representation of temporal information in perception and motor control. Curr 
Opin Neurobiol, 1996. 6(6): p. 851-7. 
 
79. Cattaert, D., A. Semjen, and J.J. Summers, Simulating a neural cross-talk model for between-
hand interference during bimanual circle drawing. Biol Cybern, 1999. 81(4): p. 343-58. 
 
80. Ivry, R.B. and T.C. Richardson, Temporal control and coordination: the multiple timer model. 
Brain Cogn, 2002. 48(1): p. 117-32. 
 178 
81. Kansaku, K., et al., Cortical activity in multiple motor areas during sequential finger movements: 
an application of independent component analysis. Neuroimage, 2005. 28(3): p. 669-81. 
 
82. Gordon, A.M., et al., Functional magnetic resonance imaging of motor, sensory, and posterior 
parietal cortical areas during performance of sequential typing movements. Exp Brain Res, 1998. 
121(2): p. 153-66. 
 
83. Tanji, J., K. Shima, and H. Mushiake, Multiple cortical motor areas and temporal sequencing of 
movements. Brain Res Cogn Brain Res, 1996. 5(1-2): p. 117-22. 
 
84. Molinari, M., et al., Neurobiology of rhythmic motor entrainment. Ann N Y Acad Sci, 2003. 999: 
p. 313-21. 
 
85. Lu, X., O. Hikosaka, and S. Miyachi, Role of monkey cerebellar nuclei in skill for sequential 
movement. J Neurophysiol, 1998. 79(5): p. 2245-54. 
 
86. Bloedel, J.R., et al., Cerebellar contributions to the acquisition and execution of learned reflex 
and volitional movements. Prog Brain Res, 1997. 114: p. 499-509. 
 
87. Artieda, J., et al., Temporal discrimination is abnormal in Parkinson's disease. Brain, 1992. 115 
Pt 1: p. 199-210. 
 
88. Pastor, M.A., et al., The neural basis of temporal auditory discrimination. Neuroimage, 2006. 
30(2): p. 512-20. 
 
89. Pastor, M.A., et al., Time estimation and reproduction is abnormal in Parkinson's disease. Brain, 
1992. 115 Pt 1: p. 211-25. 
 
90. Harrington, D.L., K.Y. Haaland, and N. Hermanowicz, Temporal processing in the basal ganglia. 
Neuropsychology, 1998. 12(1): p. 3-12. 
 
91. O'Boyle, D.J., J.S. Freeman, and F.W. Cody, The accuracy and precision of timing of self-paced, 
repetitive movements in subjects with Parkinson's disease. Brain, 1996. 119 ( Pt 1): p. 51-70. 
 
92. Freeman, J.S., F.W. Cody, and W. Schady, The influence of external timing cues upon the rhythm 
of voluntary movements in Parkinson's disease. J Neurol Neurosurg Psychiatry, 1993. 56(10): p. 
1078-84. 
 
93. Cunnington, R., et al., Movement-related potentials in Parkinson's disease. Presence and 
predictability of temporal and spatial cues. Brain, 1995. 118 ( Pt 4): p. 935-50. 
 
94. Shin, J.C., P. Aparicio, and R.B. Ivry, Multidimensional sequence learning in patients with focal 
basal ganglia lesions. Brain Cogn, 2005. 58(1): p. 75-83. 
 
95. Ramnani, N. and R.E. Passingham, Changes in the human brain during rhythm learning. J Cogn 
Neurosci, 2001. 13(7): p. 952-66. 
 
96. Sakai, K., et al., Neural representation of a rhythm depends on its interval ratio. J Neurosci, 
1999. 19(22): p. 10074-81. 
 
97. Bengtsson, S.L., et al., Dissociating brain regions controlling the temporal and ordinal structure 
of learned movement sequences. Eur J Neurosci, 2004. 19(9): p. 2591-602. 
 179 
98. Kermadi, I. and J.P. Joseph, Activity in the caudate nucleus of monkey during spatial sequencing. 
J Neurophysiol, 1995. 74(3): p. 911-33. 
 
99. Spencer, R.M. and R.B. Ivry, Comparison of patients with Parkinson's disease or cerebellar 
lesions in the production of periodic movements involving event-based or emergent timing. Brain 
Cogn, 2005. 58(1): p. 84-93. 
 
100. Aparicio, P., J. Diedrichsen, and R.B. Ivry, Effects of focal basal ganglia lesions on timing and 
force control. Brain Cogn, 2005. 58(1): p. 62-74. 
 
101. Harrington, D.L. and K.Y. Haaland, Sequencing in Parkinson's disease. Abnormalities in 
programming and controlling movement. Brain, 1991. 114 ( Pt 1A): p. 99-115. 
 
102. Tregellas, J.R., D.B. Davalos, and D.C. Rojas, Effect of task difficulty on the functional anatomy 
of temporal processing. Neuroimage, 2006. 32(1): p. 307-15. 
 
103. Penhune, V.B., R.J. Zattore, and A.C. Evans, Cerebellar contributions to motor timing: a PET 
study of auditory and visual rhythm reproduction. J Cogn Neurosci, 1998. 10(6): p. 752-65. 
 
104. Ivry, R.B. and R.M. Spencer, The neural representation of time. Curr Opin Neurobiol, 2004. 
14(2): p. 225-32. 
 
105. Valls-Sole, J., Neurophysiology of Motor Control and Movement Disorders, in Parkinson's 
Disease and Movement Disorder, J. Jankovic, Editor. 2007, Lippincott Williams & Wilkins. 
: Philadelphia. p. 14. 
 
106. Meara, J., B.K. Bhowmick, and P. Hobson, Accuracy of diagnosis in patients with presumed 
Parkinson's disease. Age Ageing, 1999. 28(2): p. 99-102. 
 
107. Deroost, N., et al., Learning sequence movements in a homogenous sample of patients with 
Parkinson's disease. Neuropsychologia, 2006. 44(10): p. 1653-62. 
 
108. Bennett, K.M., et al., The drinking action of Parkinson's disease subjects. Brain, 1995. 118 ( Pt 
4): p. 959-70. 
 
109. Whishaw, I.Q., et al., Impairment of pronation, supination, and body co-ordination in reach-to-
grasp tasks in human Parkinson's disease (PD) reveals homology to deficits in animal models. 
Behav Brain Res, 2002. 133(2): p. 165-76. 
 
110. Platz, T., R.G. Brown, and C.D. Marsden, Training improves the speed of aimed movements in 
Parkinson's disease. Brain, 1998. 121 ( Pt 3): p. 505-14. 
 
111. Leis, B.C., et al., Movement precues in planning and execution of aiming movements in 
Parkinson's disease. Exp Neurol, 2005. 194(2): p. 393-409. 
 
112. Teasdale, N., J. Phillips, and G.E. Stelmach, Temporal movement control in patients with 
Parkinson's disease. J Neurol Neurosurg Psychiatry, 1990. 53(10): p. 862-8. 
 
113. Romero, D.H., et al., Altered aiming movements in Parkinson's disease patients and elderly 
adults as a function of delays in movement onset. Exp Brain Res, 2003. 151(2): p. 249-61. 
 
 180 
114. Tresilian, J.R. and G.E. Stelmach, Common organization for unimanual and bimanual reach-to-
grasp tasks. Exp Brain Res, 1997. 115(2): p. 283-99. 
 
115. Jeannerod, M., The timing of natural prehension movements. J Mot Behav, 1984. 16(3): p. 235-
54. 
 
116. Jackson, S.R., et al., The internal control of action and Parkinson's disease: a kinematic analysis 
of visually-guided and memory-guided prehension movements. Exp Brain Res, 1995. 105(1): p. 
147-62. 
 
117. Tresilian, J.R., G.E. Stelmach, and C.H. Adler, Stability of reach-to-grasp movement patterns in 
Parkinson's disease. Brain, 1997. 120 ( Pt 11): p. 2093-111. 
 
118. Stelmach, G.E. and C.J. Worringham, The preparation and production of isometric force in 
Parkinson's disease. Neuropsychologia, 1988. 26(1): p. 93-103. 
 
119. Rafal, R.D., J.H. Friedman, and M.C. Lannon, Preparation of manual movements in 
hemiparkinsonism. J Neurol Neurosurg Psychiatry, 1989. 52(3): p. 399-402. 
 
120. Grosvenor, C.E. and N.S. Whitworth, Secretion rate and metabolic clearance rate of prolactin in 
the rat during mid- and late lactation. J Endocrinol, 1979. 82(3): p. 409-15. 
 
121. Wang, J. and G.E. Stelmach, Spatial and temporal control of trunk-assisted prehensile actions. 
Exp Brain Res, 2001. 136(2): p. 231-40. 
 
122. Alberts, J.L., et al., Disruptions in the reach-to-grasp actions of Parkinson's patients. Exp Brain 
Res, 2000. 134(3): p. 353-62. 
 
123. Castiello, U., G.E. Stelmach, and A.N. Lieberman, Temporal dissociation of the prehension 
pattern in Parkinson's disease. Neuropsychologia, 1993. 31(4): p. 395-402. 
 
124. Rand, M.K., et al., Control of aperture closure during reach-to-grasp movements in Parkinson's 
disease. Exp Brain Res, 2006. 168(1-2): p. 131-42. 
 
125. Schettino, L.F., et al., Deficits in the evolution of hand preshaping in Parkinson's disease. 
Neuropsychologia, 2004. 42(1): p. 82-94. 
 
126. Fellows, S.J., J. Noth, and M. Schwarz, Precision grip and Parkinson's disease. Brain, 1998. 121 
( Pt 9): p. 1771-84. 
 
127. Godaux, E., D. Koulischer, and J. Jacquy, Parkinsonian bradykinesia is due to depression in the 
rate of rise of muscle activity. Ann Neurol, 1992. 31(1): p. 93-100. 
 
128. Raethjen, J., et al., Parkinsonian action tremor: interference with object manipulation and 
lacking levodopa response. Exp Neurol, 2005. 194(1): p. 151-60. 
 
129. Carboncini, M.C., et al., The relation between EMG activity and kinematic parameters strongly 
supports a role of the action tremor in parkinsonian bradykinesia. Mov Disord, 2001. 16(1): p. 
47-57. 
 
130. Rand, M.K., G.E. Stelmach, and J.R. Bloedel, Movement accuracy constraints in Parkinson's 
disease patients. Neuropsychologia, 2000. 38(2): p. 203-12. 
 181 
131. Castiello, U. and K.M. Bennett, The bilateral reach-to-grasp movement of Parkinson's disease 
subjects. Brain, 1997. 120 ( Pt 4): p. 593-604. 
 
132. Isenberg, C. and B. Conrad, Kinematic properties of slow arm movements in Parkinson's disease. 
J Neurol, 1994. 241(5): p. 323-30. 
 
133. Majsak, M.J., et al., The reaching movements of patients with Parkinson's disease under self-
determined maximal speed and visually cued conditions. Brain, 1998. 121 ( Pt 4): p. 755-66. 
 
134. Siegert, R.J., et al., Self-initiated versus externally cued reaction times in Parkinson's disease. J 
Clin Exp Neuropsychol, 2002. 24(2): p. 146-53. 
 
135. Vaillancourt, D.E., A.B. Slifkin, and K.M. Newell, Visual control of isometric force in 
Parkinson's disease. Neuropsychologia, 2001. 39(13): p. 1410-8. 
 
136. Gordon, A.M., P.E. Ingvarsson, and H. Forssberg, Anticipatory control of manipulative forces in 
Parkinson's disease. Exp Neurol, 1997. 145(2 Pt 1): p. 477-88. 
 
137. Gordon, A.M., Task-dependent deficits during object release in Parkinson's disease. Exp Neurol, 
1998. 153(2): p. 287-98. 
 
138. Park, J.H. and G.E. Stelmach, Force development during target-directed isometric force 
production in Parkinson's disease. Neurosci Lett, 2007. 412(2): p. 173-8. 
 
139. Stelmach, G.E., et al., Force production characteristics in Parkinson's disease. Exp Brain Res, 
1989. 76(1): p. 165-72. 
 
140. Ingvarsson, P.E., A.M. Gordon, and H. Forssberg, Coordination of manipulative forces in 
Parkinson's disease. Exp Neurol, 1997. 145(2 Pt 1): p. 489-501. 
 
141. Brown, P., D.M. Corcos, and J.C. Rothwell, Does parkinsonian action tremor contribute to 
muscle weakness in Parkinson's disease? Brain, 1997. 120 ( Pt 3): p. 401-8. 
 
142. Forssberg, H., et al., Action tremor during object manipulation in Parkinson's disease. Mov 
Disord, 2000. 15(2): p. 244-54. 
 
143. Berardelli, A., et al., Single-joint rapid arm movements in normal subjects and in patients with 
motor disorders. Brain, 1996. 119 ( Pt 2): p. 661-74. 
 
144. Rickards, C. and F.W. Cody, Proprioceptive control of wrist movements in Parkinson's disease. 
Reduced muscle vibration-induced errors. Brain, 1997. 120 ( Pt 6): p. 977-90. 
 
145. Maschke, M., et al., Dysfunction of the basal ganglia, but not the cerebellum, impairs 
kinaesthesia. Brain, 2003. 126(Pt 10): p. 2312-22. 
 
146. Seiss, E., et al., Proprioceptive sensory function in Parkinson's disease and Huntington's disease: 
evidence from proprioception-related EEG potentials. Exp Brain Res, 2003. 148(3): p. 308-19. 
 
147. Demirci, M., et al., A mismatch between kinesthetic and visual perception in Parkinson's disease. 
Ann Neurol, 1997. 41(6): p. 781-8. 
 
 182 
148. Contreras-Vidal, J.L. and D.R. Gold, Dynamic estimation of hand position is abnormal in 
Parkinson's disease. Parkinsonism Relat Disord, 2004. 10(8): p. 501-6. 
 
149. Meyer-Lindenberg, A., et al., Transitions between dynamical states of differing stability in the 
human brain. Proc Natl Acad Sci U S A, 2002. 99(17): p. 10948-53. 
 
150. Verheul, M.H. and R.H. Geuze, Inter-limb coupling in bimanual rhythmic coordination in 
Parkinson's disease. Hum Mov Sci, 2004. 23(3-4): p. 503-25. 
 
151. Byblow, W.D., et al., Bimanual coordination in Parkinson's disease: deficits in movement 
frequency, amplitude, and pattern switching. Mov Disord, 2002. 17(1): p. 20-9. 
 
152. Ponsen, M.M., et al., Bimanual coordination dysfunction in early, untreated Parkinson's disease. 
Parkinsonism Relat Disord, 2006. 12(4): p. 246-52. 
 
153. Alberts, J.L., J.R. Tresilian, and G.E. Stelmach, The co-ordination and phasing of a bilateral 
prehension task. The influence of Parkinson's disease. Brain, 1998. 121 ( Pt 4): p. 725-42. 
 
154. Verschueren, S.M., et al., Interlimb coordination in patients with Parkinson's disease: motor 
learning deficits and the importance of augmented information feedback. Exp Brain Res, 1997. 
113(3): p. 497-508. 
 
155. Swinnen, S.P., et al., Interlimb coordination deficits in patients with Parkinson's disease during 
the production of two-joint oscillations in the sagittal plane. Mov Disord, 1997. 12(6): p. 958-68. 
 
156. van den Berg, C., et al., Coordination disorders in patients with Parkinson's disease: a study of 
paced rhythmic forearm movements. Exp Brain Res, 2000. 134(2): p. 174-86. 
 
157. Johnson, K.A., et al., Bimanual co-ordination in Parkinson's disease. Brain, 1998. 121 ( Pt 4): p. 
743-53. 
 
158. Almeida, Q.J., L.R. Wishart, and T.D. Lee, Bimanual coordination deficits with Parkinson's 
disease: the influence of movement speed and external cueing. Mov Disord, 2002. 17(1): p. 30-7. 
 
159. Stelmach, G.E. and C.J. Worringham, The control of bimanual aiming movements in Parkinson's 
disease. J Neurol Neurosurg Psychiatry, 1988. 51(2): p. 223-31. 
 
160. Debaere, F., et al., Internal vs external generation of movements: differential neural pathways 
involved in bimanual coordination performed in the presence or absence of augmented visual 
feedback. Neuroimage, 2003. 19(3): p. 764-76. 
 
161. Brinkman, C., Lesions in supplementary motor area interfere with a monkey's performance of a 
bimanual coordination task. Neurosci Lett, 1981. 27(3): p. 267-70. 
 
162. Maurer, C., et al., Effect of chronic bilateral subthalamic nucleus (STN) stimulation on postural 
control in Parkinson's disease. Brain, 2003. 126(Pt 5): p. 1146-63. 
 
163. Frank, J.S., F.B. Horak, and J. Nutt, Centrally initiated postural adjustments in parkinsonian 
patients on and off levodopa. J Neurophysiol, 2000. 84(5): p. 2440-8. 
 
164. Vaugoyeau, M., et al., Axial rotation in Parkinson's disease. J Neurol Neurosurg Psychiatry, 
2006. 77(7): p. 815-21. 
 183 
165. Chong, R.K., F.B. Horak, and M.H. Woollacott, Parkinson's disease impairs the ability to change 
set quickly. J Neurol Sci, 2000. 175(1): p. 57-70. 
 
166. Bloem, B.R., D.J. Beckley, and J.G. van Dijk, Are automatic postural responses in patients with 
Parkinson's disease abnormal due to their stooped posture? Exp Brain Res, 1999. 124(4): p. 481-
8. 
 
167. Hayashi, R., et al., Impaired modulation of tonic muscle activities and H-reflexes in the soleus 
muscle during standing in patients with Parkinson's disease. J Neurol Sci, 1997. 153(1): p. 61-7. 
 
168. Bloem, B.R., et al., Altered postural reflexes in Parkinson's disease: a reverse hypothesis. Med 
Hypotheses, 1992. 39(3): p. 243-7. 
 
169. Horak, F.B., J. Frank, and J. Nutt, Effects of dopamine on postural control in parkinsonian 
subjects: scaling, set, and tone. J Neurophysiol, 1996. 75(6): p. 2380-96. 
 
170. Burleigh-Jacobs, A., et al., Step initiation in Parkinson's disease: influence of levodopa and 
external sensory triggers. Mov Disord, 1997. 12(2): p. 206-15. 
 
171. Latash, M.L., et al., Anticipatory postural adjustments during self inflicted and predictable 
perturbations in Parkinson's disease. J Neurol Neurosurg Psychiatry, 1995. 58(3): p. 326-34. 
 
172. Dimitrova, D., F.B. Horak, and J.G. Nutt, Postural muscle responses to multidirectional 
translations in patients with Parkinson's disease. J Neurophysiol, 2004. 91(1): p. 489-501. 
 
173. Horak, F.B., D. Dimitrova, and J.G. Nutt, Direction-specific postural instability in subjects with 
Parkinson's disease. Exp Neurol, 2005. 193(2): p. 504-21. 
 
174. Jacobs, J.V., et al., Can stooped posture explain multidirectional postural instability in patients 
with Parkinson's disease? Exp Brain Res, 2005. 166(1): p. 78-88. 
 
175. Bloem, B.R., et al., Prospective assessment of falls in Parkinson's disease. J Neurol, 2001. 
248(11): p. 950-8. 
 
176. Bronstein, A.M., et al., Clinical Disorders of Balance, Posture And Gait. 2 ed. 2004, Euston 
Road: Arnold. 466. 
 
177. Beckley, D.J., B.R. Bloem, and M.P. Remler, Impaired scaling of long latency postural reflexes 
in patients with Parkinson's disease. Electroencephalogr Clin Neurophysiol, 1993. 89(1): p. 22-8. 
 
178. Ueno, E., N. Yanagisawa, and M. Takami, Gait disorders in parkinsonism. A study with floor 
reaction forces and EMG. Adv Neurol, 1993. 60: p. 414-8. 
 
179. Morris, M.E., et al., Ability to modulate walking cadence remains intact in Parkinson's disease. J 
Neurol Neurosurg Psychiatry, 1994. 57(12): p. 1532-4. 
 
180. Merritt, H.H., Paralysis Agitans, in A Textbook of Neurology, H.H. Merritt, Editor. 1963, Lea & 
Febiger: Philadelphia. p. 475. 
 
181. Vieregge, P., et al., Gait quantitation in Parkinson's disease--locomotor disability and correlation 
to clinical rating scales. J Neural Transm, 1997. 104(2-3): p. 237-48. 
 184 
182. Blin, O., A.M. Ferrandez, and G. Serratrice, Quantitative analysis of gait in Parkinson patients: 
increased variability of stride length. J Neurol Sci, 1990. 98(1): p. 91-7. 
 
183. Morris, M.E., Movement disorders in people with Parkinson disease: a model for physical 
therapy. Phys Ther, 2000. 80(6): p. 578-97. 
 
184. Hausdorff, J.M., et al., Gait variability and basal ganglia disorders: stride-to-stride variations of 
gait cycle timing in Parkinson's disease and Huntington's disease. Mov Disord, 1998. 13(3): p. 
428-37. 
 
185. Pedersen, S.W., et al., Gait analysis, isokinetic muscle strength measurement in patients with 
Parkinson's disease. Scand J Rehabil Med, 1997. 29(2): p. 67-74. 
 
186. Giladi, N., et al., Disorders of gait, in Parkinson's Disease and Movement Disorders J. Jankovic 
and T. Eduardo, Editors. 2007, Lippincott Williams & Wilkins: Philadelphia p. 446. 
 
187. Sellby, G., Clinical features, in Parkinson's Disease, G.M. STERN, Editor. 1990, The Johns 
Hopkins University Press.: Baltimore. p. 351. 
 
188. Bishop, M., D. Brunt, and J. Marjama-Lyons, Do people with Parkinson's disease change 
strategy during unplanned gait termination? Neurosci Lett, 2006. 397(3): p. 240-4. 
 
189. Sellby, G., Clinical features, in Parkinson's Disease G.M. Stern, Editor. 1990, The Johns 
Hopkins University Press.: Baltimore. p. 337-339. 
 
190. Levangie, P.K. and C.C. Norkin, Joint Structure and Function. 3 ed. 2001: JAYPEE BORTHERS 
MEDICAL PUBLISHERS. 495. 
 
191. Martin, M., et al., Gait initiation in community-dwelling adults with Parkinson disease: 
comparison with older and younger adults without the disease. Phys Ther, 2002. 82(6): p. 566-
77. 
 
192. Halliday, S.E., et al., The initiation of gait in young, elderly, and Parkinson's disease subjects. 
Gait Posture, 1998. 8(1): p. 8-14. 
 
193. Gantchev, N., et al., Impairment of posturo-kinetic co-ordination during initiation of forward 
oriented stepping movements in parkinsonian patients. Electroencephalogr Clin Neurophysiol, 
1996. 101(2): p. 110-20. 
 
194. Crenna, P. and C. Frigo, A motor programme for the initiation of forward-oriented movements in 
humans. J Physiol, 1991. 437: p. 635-53. 
 
195. Dietz, V., K.L. Leenders, and G. Colombo, Leg muscle activation during gait in Parkinson's 
disease: influence of body unloading. Electroencephalogr Clin Neurophysiol, 1997. 105(5): p. 
400-5. 
 
196. Meara, J. and W.C. Koller,  
Parkinson's disease and parkinsonism in the elderly  J. Meara and W.C. Koller, Editors. 2000, 
The press syndicate of the university of cambrige. 
 
197. Georgiou, N., et al., An evaluation of the role of internal cues in the pathogenesis of parkinsonian 
hypokinesia. Brain, 1993. 116 ( Pt 6): p. 1575-87. 
 185 
198. Giladi, N., et al., Motor blocks in Parkinson's disease. Neurology, 1992. 42(2): p. 333-9. 
 
199. Narabayashi, H., Three types of akinesia in the progressive course of Parkinson's disease. Adv 
Neurol, 1993. 60: p. 18-24. 
 
200. Giladi, N., R. Kao, and S. Fahn, Freezing phenomenon in patients with parkinsonian syndromes. 
Mov Disord, 1997. 12(3): p. 302-5. 
 
201. Fahn, S., The freezing phenomenon in parkinsonism. Adv Neurol, 1995. 67: p. 53-63. 
 
202. Gray, P. and K. Hildebrand, Fall risk factors in Parkinson's disease. J Neurosci Nurs, 2000. 
32(4): p. 222-8. 
 
203. Giladi, N., et al., Freezing of gait in patients with advanced Parkinson's disease. J Neural 
Transm, 2001. 108(1): p. 53-61. 
 
204. Lamberti, P., et al., Freezing gait in Parkinson's disease. Eur Neurol, 1997. 38(4): p. 297-301. 
 
205. Giladi, N., et al., Freezing of gait in PD: prospective assessment in the DATATOP cohort. 
Neurology, 2001. 56(12): p. 1712-21. 
 
206. Nieuwboer, A., et al., Abnormalities of the spatiotemporal characteristics of gait at the onset of 
freezing in Parkinson's disease. Mov Disord, 2001. 16(6): p. 1066-75. 
 
207. Hausdorff, J.M., et al., Impaired regulation of stride variability in Parkinson's disease subjects 
with freezing of gait. Exp Brain Res, 2003. 149(2): p. 187-94. 
 
208. Nieuwboer, A., et al., Electromyographic profiles of gait prior to onset of freezing episodes in 
patients with Parkinson's disease. Brain, 2004. 127(Pt 7): p. 1650-60. 
 
209. Miller, R.A., et al., Components of EMG symmetry and variability in parkinsonian and healthy 
elderly gait. Electroencephalogr Clin Neurophysiol, 1996. 101(1): p. 1-7. 
 
210. Mitoma, H., et al., Characteristics of parkinsonian and ataxic gaits: a study using surface 
electromyograms, angular displacements and floor reaction forces. J Neurol Sci, 2000. 174(1): p. 
22-39. 
 
211. Dietz, V., et al., Leg muscle activation during gait in Parkinson's disease: adaptation and 
interlimb coordination. Electroencephalogr Clin Neurophysiol, 1995. 97(6): p. 408-15. 
 
212. Albani, G., et al., Differences in the EMG pattern of leg muscle activation during locomotion in 
Parkinson's disease. Funct Neurol, 2003. 18(3): p. 165-70. 
 
213. Schaafsma, J.D., et al., Gait dynamics in Parkinson's disease: relationship to Parkinsonian 
features, falls and response to levodopa. J Neurol Sci, 2003. 212(1-2): p. 47-53. 
 
214. Menz, H.B., et al., Reliability of the GAITRite walkway system for the quantification of temporo-
spatial parameters of gait in young and older people. Gait Posture, 2004. 20(1): p. 20-5. 
 
215. Hausdorff, J.M., et al., Altered fractal dynamics of gait: reduced stride-interval correlations with 
aging and Huntington's disease. J Appl Physiol, 1997. 82(1): p. 262-9. 
 186 
216. Gabell, A. and U.S. Nayak, The effect of age on variability in gait. J Gerontol, 1984. 39(6): p. 
662-6. 
 
217. MacKay-Lyons, M., Variability in spatiotemporal gait characteristics over the course of the L-
dopa cycle in people with advanced Parkinson disease. Phys Ther, 1998. 78(10): p. 1083-94. 
 
218. Lewis, G.N., W.D. Byblow, and S.E. Walt, Stride length regulation in Parkinson's disease: the 
use of extrinsic, visual cues. Brain, 2000. 123 ( Pt 10): p. 2077-90. 
 
219. Baltadjieva, R., et al., Marked alterations in the gait timing and rhythmicity of patients with de 
novo Parkinson's disease. Eur J Neurosci, 2006. 24(6): p. 1815-20. 
 
220. Hausdorff, J.M., D.A. Rios, and H.K. Edelberg, Gait variability and fall risk in community-living 
older adults: a 1-year prospective study. Arch Phys Med Rehabil, 2001. 82(8): p. 1050-6. 
 
221. Mbourou, G.A., Y. Lajoie, and N. Teasdale, Step length variability at gait initiation in elderly 
fallers and non-fallers, and young adults. Gerontology, 2003. 49(1): p. 21-6. 
 
222. Ebersbach, G., et al., Comparative analysis of gait in Parkinson's disease, cerebellar ataxia and 
subcortical arteriosclerotic encephalopathy. Brain, 1999. 122 ( Pt 7): p. 1349-55. 
 
223. Amende, I., et al., Gait dynamics in mouse models of Parkinson's disease and Huntington's 
disease. J Neuroengineering Rehabil, 2005. 2: p. 20. 
 
224. Wing, A.M., S. Keele, and D.I. Margolin, Motor disorder and the timing of repetitive movements. 
Ann N Y Acad Sci, 1984. 423: p. 183-92. 
 
225. Ebersbach, G., et al., Interference of rhythmic constraint on gait in healthy subjects and patients 
with early Parkinson's disease: evidence for impaired locomotor pattern generation in early 
Parkinson's disease. Mov Disord, 1999. 14(4): p. 619-25. 
 
226. Sheridan, M.R. and K.A. Flowers, Movement variability and bradykinesia in Parkinson's disease. 
Brain, 1990. 113 ( Pt 4): p. 1149-61. 
 
227. Pastor, M.A., et al., Performance of repetitive wrist movements in Parkinson's disease. Brain, 
1992. 115 ( Pt 3): p. 875-91. 
 
228. Sparrow, W.A. and O. Tirosh, Gait termination: a review of experimental methods and the effects 
of ageing and gait pathologies. Gait Posture, 2005. 22(4): p. 362-71. 
 
229. Jian, Y., et al., Trajectory of the body COG and COP during initiation and termination of gait. 
Gait Posture, 1993. 1: p. 9-22. 
 
230. Bishop, M.D., et al., The interaction between leading and trailing limbs during stopping in 
humans. Neurosci Lett, 2002. 323(1): p. 1-4. 
 
231. Hase, K. and R.B. Stein, Analysis of rapid stopping during human walking. J Neurophysiol, 1998. 
80(1): p. 255-61. 
 
232. Pai, Y.C. and J. Patton, Center of mass velocity-position predictions for balance control. J 
Biomech, 1997. 30(4): p. 347-54. 
 187 
233. Stack, E.L., A.M. Ashburn, and K.E. Jupp, Strategies used by people with Parkinson's disease 
who report difficulty turning. Parkinsonism Relat Disord, 2006. 12(2): p. 87-92. 
 
234. Suri, R.E., C. Albani, and A.H. Glattfelder, A dynamic model of motor basal ganglia functions. 
Biol Cybern, 1997. 76(6): p. 451-8. 
 
235. Connolly, C.I., J.B. Burns, and M.S. Jog, A dynamical-systems model for Parkinson's disease. 
Biol Cybern, 2000. 83(1): p. 47-59. 
 
236. Brown, P., Oscillatory nature of human basal ganglia activity: relationship to the 
pathophysiology of Parkinson's disease. Mov Disord, 2003. 18(4): p. 357-63. 
 
237. Nambu, A., A new approach to understand the pathophysiology of Parkinson's disease. J Neurol, 
2005. 252 Suppl 4: p. IV1-IV4. 
 
238. Evarts, E.V., Y. Shinoda, and S.P. Wise, Preparatory set and Behavior, in Neurophysiological 
Approaches to Higher Brain Functions, E.V. Evarts, Y. Shinoda, and S.P. Wise, Editors. 1984, 
John Wiley & Sons: New York. p. 7-20. 
 
239. Cherry, E.C., Some experiments on the recognition of speech. Journal of the Acoustical Society of 
America 1953. 25: p. 975-979. 
 
240. Shiffrin, R.M. and W. Schneider, Controlled and automatic human information processing II. 
Perceptual learning, automatic attending and general theory. Psychological Review, 1977. 84: p. 
127-190. 
 
241. Flowers, K.A. and C. Robertson, The effect of Parkinson's disease on the ability to maintain a 
mental set. J Neurol Neurosurg Psychiatry, 1985. 48(6): p. 517-29. 
 
242. Evarts, E.V., H. Teravainen, and D.B. Calne, Reaction time in Parkinson's disease. Brain, 1981. 
104(Pt 1): p. 167-86. 
 
243. Robertson, C. and K.A. Flowers, Motor set in Parkinson's disease. J Neurol Neurosurg 
Psychiatry, 1990. 53(7): p. 583-92. 
 
244. Yaguez, L., H.W. Lange, and V. Homberg, Differential effect of Huntington's and Parkinson's 
diseases in programming motor sequences of varied lengths. J Neurol, 2006. 253(2): p. 186-93. 
 
245. Gentilucci, M., A. Negrotti, and M. Gangitano, Planning an action. Exp Brain Res, 1997. 115(1): 
p. 116-28. 
 
246. Gentilucci, M. and A. Negrotti, Planning and executing an action in Parkinson's disease. Mov 
Disord, 1999. 14(1): p. 69-79. 
 
247. Gentilucci, M. and A. Negrotti, The control of an action in Parkinson's disease. Exp Brain Res, 
1999. 129(2): p. 269-77. 
 
248. Morris, M., et al., Three-dimensional gait biomechanics in Parkinson's disease: evidence for a 
centrally mediated amplitude regulation disorder. Mov Disord, 2005. 20(1): p. 40-50. 
 
249. Morris, M.E., et al., Stride length regulation in Parkinson's disease. Normalization strategies and 
underlying mechanisms. Brain, 1996. 119 ( Pt 2): p. 551-68. 
 188 
250. Ma, H.I., et al., Effect of one single auditory cue on movement kinematics in patients with 
Parkinson's disease. Am J Phys Med Rehabil, 2004. 83(7): p. 530-6. 
 
251. Tolosa, E. and R. Kalzenschlager, Pharmalogical management of Parkinson's Disease, in 
Parkinson's Disease and Movement Disorder J. Jankovic and E. Tolosa, Editors. 2007  
Philadelphia: Lippincott Williams & Wilkins. p. 111-114. 
 
252. Hely, M.A., et al., Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive 
problems dominate at 15 years. Mov Disord, 2005. 20(2): p. 190-9. 
 
253. Goetz, C.G., et al., Evidence-based medical review update: pharmacological and surgical 
treatments of Parkinson's disease: 2001 to 2004. Mov Disord, 2005. 20(5): p. 523-39. 
 
254. Blin, O., et al., Dopa-sensitive and dopa-resistant gait parameters in Parkinson's disease. J 
Neurol Sci, 1991. 103(1): p. 51-4. 
 
255. Tolosa, E. and R. Kalzenschlager, Pharmalogical management of Parkinson's Disease, in 
Parkinson's Disease and Movement Disorder J. Jankovic and E. Tolosa, Editors. 2007, Lippincott 
Williams & Wilkins.: Philadelphia p. 110-145. 
 
256. Thobois, S., F. Delamarre-Damier, and P. Derkinderen, Treatment of motor dysfunction in 
Parkinson's disease: an overview. Clin Neurol Neurosurg, 2005. 107(4): p. 269-81. 
 
257. Espay, A.J., G.T. Mandybur, and F.J. Revilla, Surgical treatment of movement disorders. Clin 
Geriatr Med, 2006. 22(4): p. 813-25, vi. 
 
258. Pahwa, R., et al., Comparison of thalamotomy to deep brain stimulation of the thalamus in 
essential tremor. Mov Disord, 2001. 16(1): p. 140-3. 
 
259. Bhidayasiri, R., et al., State of the art: deep brain stimulation in Parkinson's disease. J Med 
Assoc Thai, 2006. 89(3): p. 390-400. 
 
260. Esselink, R.A., et al., Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in 
Parkinson's disease: one year follow-up of a randomised observer-blind multi centre trial. Acta 
Neurochir (Wien), 2006. 148(12): p. 1247-55. 
 
261. Benabid, A.L., et al., Deep brain stimulation of the subthalamic nucleus for Parkinson's disease: 
methodologic aspects and clinical criteria. Neurology, 2000. 55(12 Suppl 6): p. S40-4. 
 
262. Kumar, R., et al., Double-blind evaluation of subthalamic nucleus deep brain stimulation in 
advanced Parkinson's disease. Neurology, 1998. 51(3): p. 850-5. 
 
263. Koller, W., et al., High-frequency unilateral thalamic stimulation in the treatment of essential and 
parkinsonian tremor. Ann Neurol, 1997. 42(3): p. 292-9. 
 
264. Limousin, P., et al., Multicentre European study of thalamic stimulation in parkinsonian and 
essential tremor. J Neurol Neurosurg Psychiatry, 1999. 66(3): p. 289-96. 
 
265. Dostrovsky, J.O., W.D. Hutchison, and A.M. Lozano, The globus pallidus, deep brain 
stimulation, and Parkinson's disease. Neuroscientist, 2002. 8(3): p. 284-90. 
 
 189 
266. Volkmann, J., et al., Long-term results of bilateral pallidal stimulation in Parkinson's disease. 
Ann Neurol, 2004. 55(6): p. 871-5. 
 
267. McIntyre, C.C., et al., Uncovering the mechanism(s) of action of deep brain stimulation: 
activation, inhibition, or both. Clin Neurophysiol, 2004. 115(6): p. 1239-48. 
 
268. Welter, M.L., et al., Effects of high-frequency stimulation on subthalamic neuronal activity in 
parkinsonian patients. Arch Neurol, 2004. 61(1): p. 89-96. 
 
269. Hashimoto, T., et al., Stimulation of the subthalamic nucleus changes the firing pattern of pallidal 
neurons. J Neurosci, 2003. 23(5): p. 1916-23. 
 
270. Rodriguez, R.L., et al., Pearls in patient selection for deep brain stimulation. Neurologist, 2007. 
13(5): p. 253-60. 
 
271. Amick, M.M. and J. Grace, Deep brain stimulation surgery for Parkinson's disease: the role of 
neuropsychological assessment. Med Health R I, 2006. 89(4): p. 130-3. 
 
272. Chang, V.C. and K.L. Chou, Deep brain stimulation for Parkinson's disease: patient selection 
and motor outcomes. Med Health R I, 2006. 89(4): p. 142-4. 
 
273. Nieuwboer, A., et al., The effect of a home physiotherapy program for persons with Parkinson's 
disease. J Rehabil Med, 2001. 33(6): p. 266-72. 
 
274. Ellis, T., et al., Efficacy of a physical therapy program in patients with Parkinson's disease: a 
randomized controlled trial. Arch Phys Med Rehabil, 2005. 86(4): p. 626-32. 
 
275. Franklyn, S., & Stern, G. M., Controlled trial of physiotherapy and occupational therapy for 
Parkinson's disease. Br Med J (Clin Res Ed), 1981. 282(6280): p. 1969-70. 
 
276. Pellecchia, M.T., et al., Physical therapy in Parkinson's disease: an open long-term rehabilitation 
trial. J Neurol, 2004. 251(5): p. 595-8. 
 
277. Formisano, R., et al., Rehabilitation and Parkinson's disease. Scand J Rehabil Med, 1992. 24(3): 
p. 157-60. 
 
278. Lun, V., et al., Comparison of the effects of a self-supervised home exercise program with a 
physiotherapist-supervised exercise program on the motor symptoms of Parkinson's disease. Mov 
Disord, 2005. 20(8): p. 971-5. 
 
279. Comella, C.L., et al., Physical therapy and Parkinson's disease: a controlled clinical trial. 
Neurology, 1994. 44(3 Pt 1): p. 376-8. 
 
280. Toole, T., et al., The effects of a balance and strength training program on equilibrium in 
Parkinsonism: A preliminary study. NeuroRehabilitation, 2000. 14(3): p. 165-174. 
 
281. Hirsch, M.A., et al., The effects of balance training and high-intensity resistance training on 
persons with idiopathic Parkinson's disease. Arch Phys Med Rehabil, 2003. 84(8): p. 1109-17. 
 
282. Palmer, S.S., et al., Exercise therapy for Parkinson's disease. Arch Phys Med Rehabil, 1986. 
67(10): p. 741-5. 
 190 
283. Bergen, J.L., et al., Aerobic exercise intervention improves aerobic capacity and movement 
initiation in Parkinson's disease patients. NeuroRehabilitation, 2002. 17(2): p. 161-8. 
 
284. Reuter, I., et al., Therapeutic value of exercise training in Parkinson's disease. Med Sci Sports 
Exerc, 1999. 31(11): p. 1544-9. 
 
285. Dibble, L.E., et al., High-intensity resistance training amplifies muscle hypertrophy and 
functional gains in persons with Parkinson's disease. Mov Disord, 2006. 21(9): p. 1444-52. 
 
286. Scandalis, T.A., et al., Resistance training and gait function in patients with Parkinson's disease. 
Am J Phys Med Rehabil, 2001. 80(1): p. 38-43; quiz 44-6. 
 
287. Schenkman, M., et al., Exercise to improve spinal flexibility and function for people with 
Parkinson's disease: a randomized, controlled trial. J Am Geriatr Soc, 1998. 46(10): p. 1207-16. 
 
288. Tamir, R., R. Dickstein, and M. Huberman, Integration of motor imagery and physical practice in 
group treatment applied to subjects with Parkinson's disease. Neurorehabil Neural Repair, 2007. 
21(1): p. 68-75. 
 
289. de Goede, C.J., et al., The effects of physical therapy in Parkinson's disease: a research synthesis. 
Arch Phys Med Rehabil, 2001. 82(4): p. 509-15. 
 
290. Deane, K.H., et al., Physiotherapy for patients with Parkinson's Disease: a comparison of 
techniques. Cochrane Database Syst Rev, 2001(3): p. CD002817. 
 
291. Iansek, R., Interdisciplinary Rehabilitation in Parkinson's Disease, in Parkinson's Disease: 
Advances in Neurology, G.M. Stern, Editor. 1999, Lippincott Williams & Wilkins: Philadelphia. 
p. 557. 
 
292. Behrman, A.L., J.H. Cauraugh, and K.E. Light, Practice as an intervention to improve speeded 
motor performance and motor learning in Parkinson's disease. J Neurol Sci, 2000. 174(2): p. 
127-36. 
 
293. Bondi, M.W. and A.W. Kaszniak, Implicit and explicit memory in Alzheimer's disease and 
Parkinson's disease. J Clin Exp Neuropsychol, 1991. 13(2): p. 339-58. 
 
294. Helmuth, L.L., U. Mayr, and I. Daum, Sequence learning in Parkinson's disease: a comparison of 
spatial-attention and number-response sequences. Neuropsychologia, 2000. 38(11): p. 1443-51. 
 
295. Mentis, M.J., et al., Early stage Parkinson's disease patients and normal volunteers: comparative 
mechanisms of sequence learning. Hum Brain Mapp, 2003. 20(4): p. 246-58. 
 
296. Agostino, R., et al., Prolonged practice is of scarce benefit in improving motor performance in 
Parkinson's disease. Mov Disord, 2004. 19(11): p. 1285-93. 
 
297. Hikosaka, O., et al., Central mechanisms of motor skill learning. Curr Opin Neurobiol, 2002. 
12(2): p. 217-22. 
 
298. Swinnen, S.P., et al., Motor learning and Parkinson's disease: refinement of within-limb and 
between-limb coordination as a result of practice. Behav Brain Res, 2000. 111(1-2): p. 45-59. 
 
 191 
299. Soliveri, P., et al., Effect of practice on performance of a skilled motor task in patients with 
Parkinson's disease. J Neurol Neurosurg Psychiatry, 1992. 55(6): p. 454-60. 
 
300. Smiley-Oyen, A.L., K.A. Lowry, and Q.R. Emerson, Learning and retention of movement 
sequences in Parkinson's disease. Mov Disord, 2006. 21(8): p. 1078-87. 
 
301. Jessop, R.T., C. Horowicz, and L.E. Dibble, Motor learning and Parkinson disease: Refinement 
of movement velocity and endpoint excursion in a limits of stability balance task. Neurorehabil 
Neural Repair, 2006. 20(4): p. 459-67. 
 
302. Jobges, M., et al., Repetitive training of compensatory steps: a therapeutic approach for postural 
instability in Parkinson's disease. J Neurol Neurosurg Psychiatry, 2004. 75(12): p. 1682-7. 
 
303. Hall, K.G., D.A. Domingues, and R. Cavazos, Contextual interference effects with skilled 
baseball players. Percept Mot Skills, 1994. 78(3 Pt 1): p. 835-41. 
 
304. Keller, G.J., et al., Contextual interference effect on acquisition and retention of pistol-shooting 
skills. Percept Mot Skills, 2006. 103(1): p. 241-52. 
 
305. Wu, T. and M. Hallett, A functional MRI study of automatic movements in patients with 
Parkinson's disease. Brain, 2005. 128(Pt 10): p. 2250-9. 
 
306. Ballanger, B., et al., "Paradoxical kinesis" is not a hallmark of Parkinson's disease but a general 
property of the motor system. Mov Disord, 2006. 21(9): p. 1490-5. 
 
307. Jahanshahi, M., et al., Self-initiated versus externally triggered movements. I. An investigation 
using measurement of regional cerebral blood flow with PET and movement-related potentials in 
normal and Parkinson's disease subjects. Brain, 1995. 118 ( Pt 4): p. 913-33. 
 
308. Praamstra, P., et al., Reliance on external cues for movement initiation in Parkinson's disease. 
Evidence from movement-related potentials. Brain, 1998. 121 ( Pt 1): p. 167-77. 
 
309. Oliveira, R.M., et al., Micrographia in Parkinson's disease: the effect of providing external cues. 
J Neurol Neurosurg Psychiatry, 1997. 63(4): p. 429-33. 
 
310. Ghilardi, M.F., et al., Visual feedback has differential effects on reaching movements in 
Parkinson's and Alzheimer's disease. Brain Res, 2000. 876(1-2): p. 112-23. 
 
311. Morris, M.E., et al., The pathogenesis of gait hypokinesia in Parkinson's disease. Brain, 1994. 
117 ( Pt 5): p. 1169-81. 
 
312. Azulay, J.P., et al., Visual control of locomotion in Parkinson's disease. Brain, 1999. 122 ( Pt 1): 
p. 111-20. 
 
313. Waterston, J.A., et al., Influence of sensory manipulation on postural control in Parkinson's 
disease. J Neurol Neurosurg Psychiatry, 1993. 56(12): p. 1276-81. 
 
314. Sidaway, B., et al., Effects of long-term gait training using visual cues in an individual with 
Parkinson disease. Phys Ther, 2006. 86(2): p. 186-94. 
 
315. Dam, M., et al., Effects of conventional and sensory-enhanced physiotherapy on disability of 
Parkinson's disease patients. Adv Neurol, 1996. 69: p. 551-5. 
 192 
316. Novak, P. and V. Novak, Effect of step-synchronized vibration stimulation of soles on gait in 
Parkinson's disease: a pilot study. J Neuroengineering Rehabil, 2006. 3: p. 9. 
 
317. van Wegen, E., et al., The effect of rhythmic somatosensory cueing on gait in patients with 
Parkinson's disease. J Neurol Sci, 2006. 248(1-2): p. 210-4. 
 
318. Dibble, L.E., et al., Sensory cueing effects on maximal speed gait initiation in persons with 
Parkinson's disease and healthy elders. Gait Posture, 2004. 19(3): p. 215-25. 
 
319. Jancke, L., et al., Cortical activations during paced finger-tapping applying visual and auditory 
pacing stimuli. Brain Res Cogn Brain Res, 2000. 10(1-2): p. 51-66. 
 
320. Repp, B.H. and A. Penel, Rhythmic movement is attracted more strongly to auditory than to 
visual rhythms. Psychol Res, 2004. 68(4): p. 252-70. 
 
321. Jantzen, K.J., F.L. Steinberg, and J.A. Kelso, Functional MRI reveals the existence of modality 
and coordination-dependent timing networks. Neuroimage, 2005. 25(4): p. 1031-42. 
 
322. Repp, B.H. and A. Penel, Auditory dominance in temporal processing: new evidence from 
synchronization with simultaneous visual and auditory sequences. J Exp Psychol Hum Percept 
Perform, 2002. 28(5): p. 1085-99. 
 
323. Suteerawattananon, M., et al., Effects of visual and auditory cues on gait in individuals with 
Parkinson's disease. J Neurol Sci, 2004. 219(1-2): p. 63-9. 
 
324. Wearden, J.H., et al., Why "sounds are judged longer than lights": application of a model of the 
internal clock in humans. Q J Exp Psychol B, 1998. 51(2): p. 97-120. 
 
325. Naito, E., et al., Fast reaction to different sensory modalities activates common fields in the motor 
areas, but the anterior cingulate cortex is involved in the speed of reaction. J Neurophysiol, 2000. 
83(3): p. 1701-9. 
 
326. Guttman, S.E., L.A. Gilroy, and R. Blake, Hearing what the eyes see: auditory encoding of visual 
temporal sequences. Psychol Sci, 2005. 16(3): p. 228-35. 
 
327. Barnes, C.D. and J.S. Thomas, Effects of acoustic stimulation on the spinal cord. Brain Res, 
1968. 7(2): p. 303-5. 
 
328. Delwaide, P.J. and B. Schepens, Auditory startle (audio-spinal) reaction in normal man: EMG 
responses and H reflex changes in antagonistic lower limb muscles. Electroencephalogr Clin 
Neurophysiol, 1995. 97(6): p. 416-23. 
 
329. Schepens, B. and P.J. Delwaide, Modifications of audio-spinal facilitation during gait in normal 
man. Electroencephalogr Clin Neurophysiol, 1995. 97(6): p. 424-31. 
 
330. Rossignol, S. and G.M. Jones, Audio-spinal influence in man studied by the H-reflex and its 
possible role on rhythmic movements synchronized to sound. Electroencephalogr Clin 
Neurophysiol, 1976. 41(1): p. 83-92. 
 
331. Pollatou, E., V. Hiatzitaki, and K. Karadimou, Rhythm or music? Contrasting two types of 
auditory stimuli in the performance of a dancing routine. Percept Mot Skills, 2003. 97(1): p. 99-
106. 
 193 
332. Willems, A.M., et al., The use of rhythmic auditory cues to influence gait in patients with 
Parkinson's disease, the differential effect for freezers and non-freezers, an explorative study. 
Disabil Rehabil, 2006. 28(11): p. 721-8. 
 
333. Freedland, R.L., et al., The effects of pulsed auditory stimulation on various gait measurements in 
persons with Parkinson's Disease. NeuroRehabilitation, 2002. 17(1): p. 81-7. 
 
334. Fernandez del Olmo, M. and J. Cudeiro, A simple procedure using auditory stimuli to improve 
movement in Parkinson's disease: a pilot study. Neurol Clin Neurophysiol, 2003. 2003(2): p. 1-7. 
 
335. Enzensberger, W., U. Oberlander, and K. Stecker, [Metronome therapy in patients with 
Parkinson disease]. Nervenarzt, 1997. 68(12): p. 972-7. 
 
336. McIntosh, G.C., et al., Rhythmic auditory-motor facilitation of gait patterns in patients with 
Parkinson's disease. J Neurol Neurosurg Psychiatry, 1997. 62(1): p. 22-6. 
 
337. McCoy, R.W., Kohl, R. M., Elliot S. M., Joyce, A. S. , The impact of auditory cues on gait 
control of individuals with Parkinson's disease. Human Movement Studies, 2002. 42: p. 229-236. 
338. Zijlstra, W., A.W. Rutgers, and T.W. Van Weerden, Voluntary and involuntary adaptation of gait 
in Parkinson's disease. Gait Posture, 1998. 7(1): p. 53-63. 
 
339. Rochester, L., et al., The effect of external rhythmic cues (auditory and visual) on walking during 
a functional task in homes of people with Parkinson's disease. Arch Phys Med Rehabil, 2005. 
86(5): p. 999-1006. 
 
340. Howe, T.E., et al., Auditory cues can modify the gait of persons with early-stage Parkinson's 
disease: a method for enhancing parkinsonian walking performance? Clin Rehabil, 2003. 17(4): 
p. 363-7. 
 
341. Hiraoka, K., et al., The effects of external cues on ankle control during gait initiation in 
Parkinson's disease. Parkinsonism Relat Disord, 2006. 12(2): p. 97-102. 
 
342. Mak, M.K. and C.W. Hui-Chan, Audiovisual cues can enhance sit-to-stand in patients with 
Parkinson's disease. Mov Disord, 2004. 19(9): p. 1012-9. 
 
343. Chuma, T., et al., Motor learning of hands with auditory cue in patients with Parkinson's disease. 
J Neural Transm, 2006. 113(2): p. 175-85. 
 
344. Thaut, M.H., et al., Rhythmic auditory stimulation in gait training for Parkinson's disease 
patients. Mov Disord, 1996. 11(2): p. 193-200. 
 
345. del Olmo, M.F. and J. Cudeiro, Temporal variability of gait in Parkinson disease: effects of a 
rehabilitation programme based on rhythmic sound cues. Parkinsonism Relat Disord, 2005. 
11(1): p. 25-33. 
 
346. Cubo, E., S. Leurgans, and C.G. Goetz, Short-term and practice effects of metronome pacing in 
Parkinson's disease patients with gait freezing while in the 'on' state: randomized single blind 
evaluation. Parkinsonism Relat Disord, 2004. 10(8): p. 507-10. 
 
347. del Olmo, M.F., et al., Evaluation of the effect of training using auditory stimulation on rhythmic 
movement in Parkinsonian patients--a combined motor and [18F]-FDG PET study. Parkinsonism 
Relat Disord, 2006. 12(3): p. 155-64. 
 194 
348. Mentis, M.J., et al., Enhancement of brain activation during trial-and-error sequence learning in 
early PD. Neurology, 2003. 60(4): p. 612-9. 
 
349. Thaut, M.H., G.C. McIntosh, and R.R. Rice, Rhythmic facilitation of gait training in hemiparetic 
stroke rehabilitation. J Neurol Sci, 1997. 151(2): p. 207-12. 
 
350. Recanzone, G.H., Auditory influences on visual temporal rate perception. J Neurophysiol, 2003. 
89(2): p. 1078-93. 
 
351. Wakiji, E.M., Mapping the literature of physical therapy. Bull Med Libr Assoc, 1997. 85(3): p. 
284-8. 
 
352. Turner, P. and T.W. Whitfield, Physiotherapists' use of evidence based practice: a cross-national 
study. Physiother Res Int, 1997. 2(1): p. 17-29. 
 
353. Jette, D.U., et al., Evidence-based practice: beliefs, attitudes, knowledge, and behaviors of 
physical therapists. Phys Ther, 2003. 83(9): p. 786-805. 
 
354. Valls-Sole, J., Neurophysiology of Motor Control and Movement Disorders, in Parkinson's 
Disease and Movement Disorders, J. Jankovic and T. Eduardo, Editors. 2007, Lippincott 
Williams & Wilkins: Philadelphia. p. 17. 
 
355. Duvoisin, R.c., The differential diagnosis of parkinsonism, in Parkinson's Disease, G.M. STERN, 
Editor. 1990, The Johns Hopkins University Press: Baltimore. p. 442. 
 
356. van Hilten, J.J., et al., Bradykinesia and hypokinesia in Parkinson's disease: what's in a name? J 
Neural Transm, 1998. 105(2-3): p. 229-37. 
 
357. Sellby, G., Clinical features, in Parkinson's Disease G.M. Stern, Editor. 1990, The Johns 
Hopkins University Press: Baltimore. p. 343-347. 
 
358. Harold, L., A.H. Klawans, and A. Barr, Levodopa-induced dyskinesia, in Parkinson's Disease, 
G.M. Stern, Editor. 1990, The Johns Hopkins University Press: Baltimore p. 537-540. 
 
359. Deuschl, G., J. Volkmann, and J. Raethjen, Tremors: Differential diagnosis, pathophysiology and 
therapy, in Parkinson's Disease and Movement Disorders, J. Jankovic and T. Eduardo, Editors. 





A-APPENDIX A. UK Parkinson’s Disease Society Brain Bank diagnosis criteria 
 
Step1. Diagnosis of Parkinsonian syndrome 
Bradykinesia with at least one of the following: 
Muscular rigidity 
4-6 Hz resting tremor 
Postural instability not caused by primary visual, vestibular, cerebellar, or 
Proprioceptive dysfunction 
 
Step2. Exclusion criteria for Parkinson’s disease 
            History of repeated strokes with stepwise progression of Parkinsonian features 
History of repeated head injury 
History of definite encephalitis 
Oculogyric crises 
Neuroleptic treatment at onset of symptoms 
More than one affected relative 
Sustained remission 
Strictly unilateral features after 3 years 
Supranuclear gaze palsy 
Cerebellar signs 
Early severe autonomic involvement 
Early Severe dementia with disturbances of memory, language and praxis 
Babinski sign 
Presence of cerebral tumor or communicating hydrocephalus on computed tomography 
Negative response to large doses of levodopa if (if malabsorption excluded) 
1-methyl-4phenyl-1,2,3,6-tetrahydropyridine exposure 
 
Step3. Supportive prospective positive criteria for Parkinson’s disease 
(Three or more required for diagnosis of definite Parkinson’s disease) 
Unilateral onset 
Rest tremor present 
Progressive disorder 
Persistent asymmetry affecting the side of onset 
Excellent response (70-100%) to levodopa 
Severe levodopa-induced chorea 
Levodopa response for 5 years or more 
Clinical course of 10 years or more 
 
Source: Meara, J., Bhowmick, B. K., & Hobson, P. (1999). Accuracy of diagnosis in  




A-APPENDIX B. Modified Hoehn and Yahr Scale for identifying stage of Parkinson’s 
disease 
Stage 0—No signs of disease. 
Stage 1—Unilateral disease. 
Stage 1.5—Unilateral plus axial involvement. 
Stage 2—Bilateral disease, without impairment of balance. 
Stage 2.5—Mild bilateral disease with recovery on pull test. 
Stage 3—Mild to moderate bilateral disease; some postural instability; physically independent. 
Stage 4—Severe disability; still able to walk or stand unassisted. 
Stage 5—Wheelchair-bound or bedridden unless aided. 
 
Source: Gancher, S. T. (2006). Parkinson's Disease. In R. M. Herndon (Ed.), Handbook of 
Neurological Rating Scales (2 ed., pp. 153). New York: Demos Medical Publishing. 
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A-APPENDIX C. Descriptions of Major PD Motor Complications 
Rigidity: a state of muscular stiffness; the abnormal increase in muscular resistance opposing the 
passive movement of the limb. Lead-pipe rigidity is consistent through the whole movement and 
cog-wheel rigidity is intermittent. It increases with stress and effort in performing an action and 
may contribute to reduction of deep tendon reflexes and lead to postural deformities [58, 59].  
 
Dystonia: abnormal co-contraction of antagonist muscles of upper/lower extremities. Dystonia 
involves abnormal muscle tone and appears secondary to medication. If not controlled, dystonia 
can lead to limb deformities and abnormal posture. Dystonia can characterize juvenile PD or 
advanced PD and the change in muscular tone can hardly be distinguished from that of rigidity 
[354, 355]. 
 
Hypokinesia*: reduction of movement size. It is usually the major and initial symptom of PD as 
its incident is even more common than rigidity and tremor. [356]. 
 
Bradykinesia*: Slowness of the voluntary movement [356].  
 
Akinesia*: difficulty in initiation of the movement. [357].  
 
*Unfortunately, hypokinesia, bradykinesia and akinesia are motor symptoms that are sometimes 
used interchangeably; however each term represents a different complication [356]. Akinesia, 
hypokinesia and bradykinesia interfere with activities of daily living such as buttoning a shirt, 
turning over in bed or starting a simple movement. These symptoms worsen with fatigue and 
severity of the disease but can be prevailed with cognitive effort, external stimulation or 
emergency at least for short periods of time, a phenomenon referred to as ‘kinesia paradoxical’ 
[357]. 
 
Dyskinesia: Involuntary choreic movements which usually occurs secondary to medication (i.e. 
levodopa) (prevalence of 40-90%), and it can appear in upper and lower extremities as well as 
trunk and head [58, 358].  
 
Tremor: Rhythmic oscillation of at least one functional body region [359]. This symptom is 
more prominent in upper extremities [1]. It usually starts intermittently in one finger. Tremor 
spreads to other fingers, the wrist and elbows with disease progression and possibly the head, 
face feet and other regions of the lower extremities in late stage [189]. Resting tremor is tremor 
at rest. Action tremor could be observed as postural, kinetic and isometric tremors. PD tremors 
can be categorized into 3 types: Type I (classical parkinsonian tremor)--action (kinetic and 
postural) and resting tremors with similar frequencies; Type II--similar to type I except that the 
frequency of action tremor is higher than that of the resting tremor; Type III--postural action 





Table 3: This table summerizes the major findings of the short term effects of auditory 




No Improvements Major changes Source 
Walking inside 
and outside on a 
4m x10m 
walkway with 3 
Uturns to march 
music (type I & 











episodes, (Type II: 
Step number) 
 
Tactile: Gait duration,  
Number of freezing 
episodes (Inside: Step 
number; Outside: Step 
number) 
March: Step number 
(type I) 
Metronome:  Gait 
duration, Step number,  




et al. 1997 
 





10% above  
 
21 PDon, 71 
yrs, 7.5 yrs,  
H&Y: 2-4 
10 PDoff24 
(24h), 73 yrs, 
7.5 yrs, 
H&Y: 2-3  
1 PDoff48 
(48h), 73 yrs, 
8.5 yrs, 
H&Y: 3  
10 Cont, 71 
yrs 
PDon: Symmetry 








PDon, PDoff: Cadence, 




et al. 1997  
Aiming Task: 
moving a stylus to 
a target at the 
distance of 
200mm as 
accurate and fast 
as possible with 
rhythmic beats set 
at 10% below the 
fastest reaching 
speed [2] 
8 PDoff, 62 
yrs, 7.6 yrs, 
H&Y : 2 
8 Cont, 60.8 
yrs 





Immediate effect PD & 




Retention PD & Cont:  
Maximum acceleration 
Platz et al. 
1998 




cadence to 125 
7 PDon, 44-




PD: Step length, 
Speed 
 





Walking 10m with  
 metronome set at 
20% below 
preferred cadence  
 
11 PDon, 
60.8 yrs, 20 
months 
11 PDoff,  
63.1 yrs, 16 
months 
22 Cont, 61.8 
yrs  
Cont: Variability 
of step duration 
 
 
PD (ON & OFF): 
Variability of step 
length, Variability of 
step duration, Step 
length 
Cont: Variability of step 
length, 
 Step length 
Ebersbach 
et al. 1999  
 
Reaching for a pen 
(R), bringinging 
the pen to the 
paper (B), and 
writing down a 






64.6 yrs, 6.6 
yrs, H&Y: 
2.65 
16 Cont, 65.6 
yrs 
PD: Number of 
movement units [3] 
(R), Efficiency [4] 
(B), Inter-trial 
variability (B) 
Cont: MT, Peak 
velocity, Number 




PD: Efficiency (R) 
 Peak velocity, Number 




Cont: Efficiency (R) 
 
 




with a metronome 
set at preferred 
cadence and 10% 
above  
16 PD, 74 yrs PD: Size of base of 
support  
 
PD: Step length, 
Cadence, 
FAP score (from 
GaitRite) [5],  
Double support duration, 
 Gait cycle duration 
Freedland 
et al. 2002 
Sit to stand from a 
chair with arm 
folded in front of 
the body as fast as 
possible after: 
Simultaneous 
presentation  of a 
flash light and a 










15 Cont, 69.5 
yrs 
 
PD: Peak hip 
extension torque, 
Time to peak hip 
flextion torque 
Cont: Peak hip 
flexion, hip 
extension & ankle 
torque; Time to 
peak hip flexion, 
hip extension, knee 
extension, ankle 
torque, Peak COM 
velocity, MT 
PD: Peak hip flexion, 
knee extention torque, 
Peak COM velocity, 
Time to peak hip 
extension, knee extension 
& ankle torque, MT 
Cont: Peak  knee & 
ankle torque 
Mak et al. 
2002 
 
Walking 20m with 
a metronome set at 
comfortable 
cadence (baseline) 
and 15% above on 










side (OFF) [6]: 
Stride length 
+15%, Right side 
(ON & OFF): 
Stride length 
Baseline, Right side (ON 
& OFF): Velocity, 
Cadence; Left side 
(OFF): Stride length, 
Velocity, 
Cadence; Left side (ON): 





+15% , Right side(ON): 
Velocity, 
 Cadence, Left side (ON 
& OFF): Velocity, 
Stride length, Cadence 
Walking 9m with 
a metronome set at 
small (7.5%) and 
large (15%) 
frequencies above 
(high) and below 
(low) preferred 
cadence.  









Cadence, small & 






large: Cadence, Gait 
speed 
 
Howe et al. 
2003   
 
Walking 8.5 m, 
turned 180 
degrees, returned 
to the starting 
position with 
metoronome set at 
100 bmp 
 





Cont: no change 
 
PD: TA & GM: Time to 
peak amplitude, Time 
between activation, 
Activation duration, 
Variability of Time 
between activation, Time 
to peak amplitude, 
Activation duration 
Fernandez 
del Olmo & 
Cudeiro, 
2003 
Walked 5m as fast 
as possible after a 
single metronome 
signal (SA), the 
metronome at 96 
bmp (RA), feeling 
electrical stimulus 
at 96 bpm (RE) 
7 PDon, 69 





7 Cont, age- 
matched  
PD RE, RA & SA: 
RT, Single support 
time, Sacral 
velocity 
PD RE, RA: Lateral & 
Posterior COP [7] 
displacement, COP 







Walking 7.62 m 
with Visual cues, 
metronome 25% 
above maximum 
cadence, both  
24 PDoff, 










Stride length  
Visual cue:  Stride 
length, Cadence  





al. 2004  
 
Stand up, walk to 
the kitchen, grab a 
tray with two cups 
& walk, set tray 
down & sit down 
with auditory tone 
and flash light at 
preferred cadence 
18 PDon, 





10 Cont, age 
matched   













with metronome, 1 
Hz [8] 
         
7 PDon1, 
68.1 yrs, 
H&Y: 2-3  
Experienced 
freezing 






9 Cont, 64.3 
yrs 
 PDon1 & PDon2: 
Amplitude of TMS 
induced movement, 
regularity of thumb 
movement trace, TMS 
induced movement 
changed toward extension 
(5 PDon1, 4 PDon2)  
Cont : Amplitude of 
TMS induced movement, 
Direction of TMS induced 
movement changed 





Moved two steps 
forward hearing a 
single auditory 
warning cue then 
seeing a single 
flash light (go cue) 
9 PDon, 66.1 
yrs, H&Y: 2-
4 
7 Cont, 64.6 
yrs 
PD (trailing leg): 
SOL amplitude 
Cont (trailing leg): 
SOL amplitude, 
Mean H-reflex 
amplitude of SOL 
PD (trailing leg): TA 
amplitude 
Mean H-reflex amplitude 
of SOL 






Walking 80 m 
with metronome at 
preferred cadence 
and 10% or 20% 
above and below 
 
10 PDon, 











10 Cont, 63.6 
yrs 
PD & Cont 
preferred speed: 

















PD & Cont preferred 
speed: Step frequency 
PD & Cont higher 
frequencies: Step 
frequency, Gait speed 
(non-freezers), Step 
frequency, 
Stride length (freezers) 





Gait speed, Step 
frequency 
Cont lower frequencies: 
Speed 
 Step frequency 
Willems et 
al. 2006  
 
Gastrocnemius (GM); Hoehn and Yahr scale (H&Y); healthy control subjects (Cont); 
Parkinson’s Disease (PD); on medication (PDon); off medication (PDoff); Soleus muscle (SOL); 
Tibialis Anterior (TA); Transcranial Magnetic Stimulation (TMS); Range Of Motion (ROM); 
Center Of Pressure (COP); Center Of Mass (COM); Movement Time (MT); Reaction time (RT) 
1- Data were recorded after both trials were completed 
2- After every five practice trial the frequency was adjusted to 90% of mean movement time of 
those five training trials. 
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3- Movement unit includes 1 acceleration and 1 deceleration phase 
4- Efficiency reflects peak velociy/average velocity 
5- FAP score: funcational ambulation performance calculated by GaitRite system based on 
spatial and temporal gait parameters 
6- The dominant side and the affected side were not identified 
7- The amount of COP displacement were smaller for PD in all directions compared to controls 
8- TMS evoked thumb flexion was used for testing the effect of practice 
9-  All changes were significanlty higher for those who practiced with metronome, compared to 
those who practiced thumb extension with no cues. 










Table 4. This table summerizes the major finidings of the practice effect of auditory stimulation 




Duration No Improvements Major changes Source 








71yrs, 7.2 yrs, 


















PD:  Gait 
speed, Stride 
length,  EMG 
pattern symmetry 
(TA),  EMG 
pattern variability 
(GM & TA) 
Miller et al. 
1996 
 
1-Walking on a 
6m flat surface 





a) set at a 
comfortable 
cadence 








2-Stair stepping to 
a-c  




PDon, 69 yrs, 
7.2 yrs, H&Y: 
2.3  
Training, 
similar to EX 
but no cues 
(T): 11 PDon, 
74 yrs, 5.4 
yrs, H&Y: 2.5  
Non-training 
(NT): 11 
PDon, 71 yrs, 














GM, VL), Timing 
[2] (TA, GM)  
(EX) Flat 
walkway: Onset 
duration (GM, TA, 
VL), Termination 
duration (GM) 













 (EX, T) inclined 
walkway: 
Velocity 









Thaut et al. 
1996 
 




60ft with 1 
doorway & 2 
turns. 
12 PDon,  
65.8 yrs, 12.4 
yrs, H&Y: 2-4  
freezers  
1 week Freeze duration, 
Number of freezes, 
Average duration 
of all freezes  
Gait duration, 
 




with a metronome 
15 PDon, 
61.7 yrs, 7.26 
4weeks 
5 
 PD:  
Velocity, Step 




set at 30 to 150 
bpm with and 
without upper 
limb movements 
yrs,   H&Y: 2  












uni- or bi-lateral 
arm movements  
movements with 
and without the 
use of a 





9 PDon, 61 
yrs, 5.7 yrs, 
H&Y: 1-2  
5 Cont, 63 
yrs 





















del Olmo et 
al. 2006 
Gastrocnemius (GM); Hoehn and Yahr scale (H&Y); healthy control subjects (Cont); 
Parkinson’s Disease (PD); on medication (PDon); off medication (PDoff); Positron Emission 
Tomography (PET); Soleus muscle (SOL); Tibialis Anterior (TA); Vastus Lateralis (VL)  
1- After each week of training the frequency of the metronome beats increased by 5% 
2- Timing of a muscle represents the temporal focus of EMG activity where higher values reflect 









APPENDIX B--- APPLIED FUNCTIONAL MEASURES 
 
UPDRS II (ADLs) & III (Motor) & Composite (13-15, 29-30) 
 




1—Mildly affected. No difficulty being understood. 
2—Moderately affected. Sometimes asked to repeat statements. 
3—Severely affected. Frequently asked to repeat statements. 




1—Slight but definite excess of saliva in mouth; may have nighttime drooling. 
2—Moderately excessive saliva; may have minimal drooling. 
Unified Parkinson’s Disease Rating Scale 
3—Marked excess of saliva with some drooling. 






3—Requires soft food. 




1—Slightly slow or small. 
2—Moderately slow or small; all words are legible. 
3—Severely affected; not all words are legible. 
4—The majority of words are not legible. 
 
9. Cutting food and handling utensils 
0—Normal. 
1—Somewhat slow and clumsy, but no help needed. 
2—Can cut most foods, although clumsy and slow; some help needed. 
3—Food must be cut by someone, but can still feed slowly. 







1—Somewhat slow, but no help needed. 
2—Occasional assistance with buttoning, getting arms in sleeves. 





1—Somewhat slow, but no help needed. 
2—Needs help to shower or bathe, or very slow in hygienic care. 
3—Requires assistance for washing, brushing teeth, combing hair, going to bathroom. 
4—Foley catheter or other mechanical aids. 
 
12. Turning in bed and adjusting bed clothes 
0—Normal. 
1—Somewhat slow and clumsy, but no help needed. 
2—Can turn alone or adjust sheets, but with great difficulty. 
3—Can initiate, but not turn or adjust sheets alone. 
4—Helpless. 
 
13. Falling (unrelated to freezing) 
0—None. 
1—Rare falling. 
2—Occasionally falls, less than once per day. 
3—Falls an average of once daily. 
4—Falls more than once daily. 
 
14. Freezing when walking 
0—None. 
1—Rare freezing when walking; may have start-hesitation. 
2—Occasional freezing when walking. 
3—Frequent freezing. Occasionally falls from freezing. 




1—Mild difficulty. May not swing arms or may tend to drag leg. 
2—Moderate difficulty, but requires little or no assistance. 
3—Severe disturbance of walking, requiring assistance. 







1—Slight and infrequently present. 
2—Moderate; bothersome to patient. 
3—Severe; interferes with many activities. 
4—Marked; interferes with most activities. 
 
17. Sensory complaints related to parkinsonism 
 
0—None. 
1—Occasionally has numbness, tingling, or mild aching. 
2—Frequently has numbness, tingling, or aching; not distressing. 
3—Frequent painful sensations. 
4—Excruciating pain. 
 




1—Slight loss of expression, diction, and/or volume. 
2—Monotone, slurred but understandable; moderately impaired. 
3—Marked impairment, difficult to understand. 
4—Unintelligible. 
 
19. Facial expression 
0—Normal. 
1—Minimal hypomimia, could be normal ―poker face.‖ 
2—Slight but definitely abnormal diminution of facial expression. 
3—Moderate hypomimia; lips parted some of the time. 
4—Masked or fixed facies with severe or complete loss of facial expression; lips parted 0.25 in. or more. 
 
20. Tremor at rest 
0—Absent. 
1—Slight and infrequently present. 
2—Mild in amplitude and persistent or moderate in amplitude, but only intermittently present. 
3—Moderate in amplitude and present most of the time. 
4—Marked in amplitude and present most of the time. 
 
21. Action or postural tremor of hands 
0—Absent. 
1—Slight; present with action. 
2—Moderate in amplitude, present with action. 
3—Moderate in amplitude with posture holding as well as action. 




22. Rigidity (judged on passive movement of major joints with patient relaxed in sitting position; 
cogwheeling to be ignored) 
0—Absent. 
1—Slight or detectable only when activated by mirror or other movements. 
2—Mild to moderate. 
3—Marked, but full range of motion easily achieved. 
4—Severe, range of motion achieved with difficulty. 
 
23. Finger taps (patient taps thumb with index finger in rapid succession, with widest amplitude possible, 
each hand separately) 
0—Normal. 
1—Mild slowing and/or reduction in amplitude. 
2—Moderately impaired. Definite and early fatiguing. May have occasional arrests in movement. 
3—Severely impaired. Frequent hesitation in initiating movements or arrests in ongoing movement. 
4—Can barely perform the task. 
 
24. Hand movements (patient opens and closes hand in rapid succession with widest amplitude possible, 
each hand separately) 
0—Normal. 
1—Mild slowing and/or reduction in amplitude. 
2—Moderately impaired. Definite and early fatiguing. May have occasional arrests in movement. 
3—Severely impaired. Frequent hesitation in initiating movements or arrests in ongoing movement. 
4—Can barely perform the task. 
 
25. Rapid alternating movements of hands (pronation-supination movements of hands, vertically or 
horizontally, with as large an amplitude as possible, both hands simultaneously) 
0—Normal. 
1—Mild slowing and/or reduction in amplitude. 
2—Moderately impaired. Definite and early fatiguing. May have occasional arrests in movement. 
3—Severely impaired. Frequent hesitation in initiating movements or arrests in ongoing movement. 
4—Can barely perform the task. 
 
26. Foot agility (patient taps heel on ground in rapid succession, picking up entire foot; amplitude should 
be approximately 3 in.) 
0—Normal. 
1—Mild slowing and/or reduction in amplitude. 
2—Moderately impaired. Definite and early fatiguing. May have occasional arrests in movement. 
3—Severely impaired. Frequent hesitation in initiating movements or arrests in ongoing movement. 





27. Arising from chair (patient attempts to arise from a straight-back wood or metal chair with arms 
folded across chest) 
0—Normal. 
1—Slow; or may need more than one attempt. 
2—Pushes self up from arms of seat. 
3—Tends to fall back and may have to try more than one time, but can get up without help. 




1—Not quite erect, slightly stooped posture; could be normal for older person. 
2—Moderately stooped posture, definitely abnormal; can be slightly leaning to one side. 
3—Severely stooped posture with kyphosis; can be moderately leaning to one side. 




1—Walks slowly, may shuffle with short steps, but no festination or propulsion. 
2—Walks with difficulty but requires little or no assistance; may have some festination, short steps, or 
propulsion. 
3—Severe disturbance of gait, requiring assistance. 
4—Cannot walk at all, even with assistance. 
 
30. Postural stability (response to sudden posterior displacement produced by pull on shoulders while 
patient erect with eyes open and feet slightly apart; patient is prepared) 
0—Normal. 
1—Retropulsion but recovers unaided. 
2—Absence of postural response; would fall if not caught by examiner. 
3—Very unstable, tends to lose balance spontaneously. 
4—Unable to stand without assistance. 
31. Body bradykinesia and hypokinesia (combining slowness, hesitancy, decreased arm swing, small 
amplitude, and poverty of movement in general) 
0—None. 
1—Minimal slowness, giving movement a deliberate character; could be normal for some persons. 
Possibly 
reduced amplitude. 
2—Mild degree of slowness and poverty of movement which is definitely abnormal. Alternatively, some 
reduced amplitude. 
3—Moderate slowness, poverty or small amplitude of movement. 
4—Marked slowness, poverty or small amplitude of movement. 
 






The timed "Up & Go" test measures, in seconds, the time taken by an individual 
to stand up from a standard arm chair (approximate seat height of 46 cm, arm 
height 65 cm), walk a distance of 3 meters (approximately 10 feet), turn, walk 
back to the chair, and sit down again. 
The subject wears his/her regular footwear. If participant’s usually use assistive 
devices such as canes or walkers, they should use them during the test, but this 
should be indicated on the data collection form. No physical assistance is given. 
Setting Up the test area 
 Determine a path free from obstruction 
 Place a chair with arms at one end of the path. 
 Mark off a 3 m (10 ft.) distance using tape or a cone or other clear 
marking. 
Start the test 
Speak clearly and slowly. 
Inform participant of sequence and outcome: ―When I say go, you will stand up from the chair, walk to 
the mark(cone) on the floor, turn around, walk back to the chair 
and sit down.‖ ―I will be timing you using the stopwatch.‖  
Ask participants to repeat the instructions to make sure they 
understand. 
Participant starts with their back against the chair, their arms resting on 
the arm rests, and their walking aid at hand 
Using a cue like ―Ready, set, go‖ might be useful. 
Either a wrist-watch with a second hand or a stop-watch can be used to 
time the performance 
Adopted from: Thrane, G., Joakimsen, R. M., & Thornquist, E. (2007). The association between timed up 





Dynamic Gait Index  
 
 
1. Gait level surface _____ 
Instructions: Walk at your normal speed from here to the next mark (20’) 
Grading: Mark the lowest category that applies. 
(3)  Normal: Walks 20’, no assistive devices, good sped, no evidence for imbalance, normal gait 
pattern 
(2)  Mild Impairment: Walks 20’, uses assistive devices, slower speed, mild gait deviations. 
(1) Moderate Impairment: Walks 20’, slow speed, abnormal gait pattern, evidence for imbalance. 
(0) Severe Impairment: Cannot walk 20’ without assistance, severe gait deviations or imbalance. 
 
2. Change in gait speed _____ 
Instructions: Begin walking at your normal pace (for 5’), when I tell you ―go,‖ walk as fast as you can 
(for 5’). When I tell you ―slow,‖ walk as slowly as you can (for 5’). 
Grading: Mark the lowest category that applies. 
(3)  Normal: Able to smoothly change walking speed without loss of balance or gait deviation. Shows 
a significant difference in walking speeds between normal, fast and slow speeds. 
(2)  Mild Impairment: Is able to change speed but demonstrates mild gait deviations, or not gait 
deviations but unable to achieve a significant change in velocity, or uses an assistive device. 
(1) Moderate Impairment: Makes only minor adjustments to walking speed, or accomplishes a 
change in speed with significant gait deviations, or changes speed but has significant gait 
deviations, or changes speed but loses balance but is able to recover and continue walking. 
(0) Severe Impairment: Cannot change speeds, or loses balance and has to reach for wall or be 
caught. 
 
3. Gait with horizontal head turns _____ 
Instructions:  Begin walking at your normal pace. When I tell you to ―look right,‖ keep walking straight, 
but turn your head to the right. Keep looking to the right until I tell you, ―look left,‖ then keep walking 
straight and turn your head to the left. Keep your head to the left until I tell you ―look straight,― then keep 
walking straight, but return your head to the center. 
Grading: Mark the lowest category that applies. 
(3)  Normal: Performs head turns smoothly with no change in gait. 
(2)  Mild Impairment: Performs head turns smoothly with slight change in gait velocity, i.e., minor 
disruption to smooth gait path or uses walking aid. 
(1) Moderate Impairment: Performs head turns with moderate change in gait velocity, slows down, 
staggers but recovers, can continue to walk. 
(0) Severe Impairment: Performs task with severe disruption of gait, i.e., staggers 
       outside 15‖ path, loses balance, stops, reaches for wall. 
 
4. Gait with vertical head turns _____ 
Instructions: Begin walking at your normal pace. When I tell you to ―look up,‖ keep walking straight, but 
tip your head up. Keep looking up until I tell you, ―look down,‖ then keep walking straight and tip your 
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head down. Keep your head down until I tell you ―look straight,― then keep walking straight, but return 
your head to the center. 
Grading: Mark the lowest category that applies. 
(3)  Normal: Performs head turns smoothly with no change in gait. 
(2) Mild Impairment: Performs head turns smoothly with slight change in gait velocity, i.e., minor 
disruption to smooth gait path or uses walking aid. 
(1) Moderate Impairment: Performs head turns with moderate change in gait velocity, slows down, 
staggers but recovers, can continue to walk. 
(0)  Severe Impairment: Performs task with severe disruption of gait, i.e., staggers 
       outside 15‖ path, loses balance, stops, reaches for wall. 
 
5. Gait and pivot turn _____ 
Instructions: Begin walking at your normal pace. When I tell you, ―turn and stop,‖ turn as quickly as you 
can to face the opposite direction and stop. 
Grading: Mark the lowest category that applies. 
(3)    Normal: Pivot turns safely within 3 seconds and stops quickly with no loss of balance. 
(2)    Mild Impairment: Pivot turns safely in > 3 seconds and stops with no loss of balance. 
(1) Moderate Impairment: Turns slowly, requires verbal cueing, requires several small steps to catch 
balance following turn and stop. 
(0) Severe Impairment: Cannot turn safely, requires assistance to turn and stop. 
 
6. Step over obstacle ____ 
Instructions: Begin walking at your normal speed. When you come to the shoebox, step over it, not 
around it, and keep walking. 
Grading: Mark the lowest category that applies. 
(3)    Normal: Is able to step over the box without changing gait speed, no evidence of imbalance. 
(2) Mild Impairment: Is able to step over box, but must slow down and adjust steps to clear box 
safely. 
(1) Moderate Impairment: Is able to step over box but must stop, then step over. May require verbal 
cueing. 
(0) Severe Impairment: Cannot perform without assistance. 
7. Step around obstacles _____ 
Instructions: Begin walking at normal speed. When you come to the first cone (about 6’ away), walk 
around the right side of it. When you come to the second cone (6’ past first cone), walk around it to the 
left. 
Grading: Mark the lowest category that applies. 
(3) Normal: Is able to walk around cones safely without changing gait speed; no  evidence of 
imbalance. 
(2) Mild Impairment: Is able to step around both cones, but must slow down and adjust steps to clear 
cones. 
(1) Moderate Impairment: Is able to clear cones but must significantly slow, speed to accomplish 
task, or requires verbal cueing. 
(0) Severe Impairment: Unable to clear cones, walks into one or both cones, or requires physical 
assistance. 
8. Steps _____ 
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Instructions: Walk up these stairs as you would at home, i.e., using the railing if necessary. At the top, 
turn around and walk down. 
Grading: Mark the lowest category that applies. 
(3)  Normal: Alternating feet, no rail. 
(2)  Mild Impairment: Alternating feet, must use rail. 
(1) Moderate Impairment: Two feet to a stair, must use rail. 
(0)  Severe Impairment: Cannot do safely. 
Adopted from: Shumway-Cook A, Woollacott M. Motor Control Theory and Applications, Williams and 
Wilkins Baltimore, 1995: 323-324 
 




Tinetti Mobility Test 
 
 Tinetti Assessment Tool: Balance 
 
Initial Instructions: Subject is seated in a hard, armless chair. The following maneuvers are tested. 
 
1. Sitting balance: Leans or slides in chair =0 
Steady, safe =1 
 
2. Arises: Unable without help =0 
Able, uses arms to help =1 
Able without using arms =2 
 
3. Attempts to arise: Unable without help =0 
Able, requires> 1 attempt =1 
Able to arise, 1 attempt =2 
 
4. Immediate standing balance (first five seconds): 
Unsteady (swaggers, moves feet, trunk sway =0 
Steady but uses walker or other support =1 
Steady without walker or other support =2 
 
5. Standing balance Unsteady =0 
Steady but wide stance (medial heels >4 in. 
apart) and uses cane or other support =1 
Narrow stance without support =2 
 
6. Nudged (subject at maximum position with feet as close 
together as possible, examiner pushes lightly on 
subject’s sternum with palm of hand 3 times): 
Begins to fall =0 
Staggers, grabs, catches self =1 
Steady =2 
 




8. Turning 360 degrees Discontinuous Steps =0 
Continuous =1 
Unsteady (grabs, staggers) =0 
Steady =1 
9. Sitting down Unsafe (misjudges distance, falls into chair) =0 
Uses arms or not a smooth motion =1 
Safe, smooth motion =2 
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Tinetti Assessment Tool: Gait 
 
Initial instructions: Subject stands with examiner, walks down hallway or across room, first at ―usual‖ 
pace, then back at ―rapid, but safe‖ pace (using usual walking aids). 
 
10. Initiation of gait (immediately after told to ―go‖) 
Any hesitancy or multiple attempts to start =0 
No hesitancy =1 
 
11. Step length and height 
a. Right swing foot: does not pass left stance foot with step =0 
passes left stance foot =1 
right foot does not clear floor completely with step =0 
right foot completely clears floor =1 
b. Left swing foot: does not pass right stance foot with step =0 
passes right stance foot =1 
left foot does not clear floor completely with step =0 
left foot completely clears floor =1 
 
12. Step Symmetry 
Right and left step length not equal (estimate) =0 
Right and left step appear equal =1 
 
13. Step Continuity 
Stopping or discontinuity between steps =0 
Steps appear continuous =1 
 
14. Path (estimated in relation to floor tiles, 12-inch diameter; 
observe excursion of 1 foot over about 10 ft. of 
the course.) 
Marked deviation =0 
Mild/moderate deviator or uses walking aid =1 
Straight without walking aid =2 
 
15. Trunk Marked sway or uses walking aid =0 
No sway but flexion of knees or back or spreads 
arms out while walking =1 
No sway, no flexion, no use of arms, and not use 





16. Walking Time Heels apart =0 
Heels almost touching while walking =1 
 
 
Adopted from: Tinetti ME. Performance-oriented assessment of mobility problems in elderly 
patients. J Am Geriatr Soc. 
1986;34:119-126. 
 




Freezing of Gait Questionnaire 
 
Freezing of Gait Questionnaire (FOGQ) 
 
1. During your worst state—do you walk: 
0 Normally   
 1 Almost normally—somewhat slow 
2 Slow but fully independent 
3 Need assistance or walking aid 
4 Unable to walk 
 
2. Are your gait difficulties affecting your daily activities and independence? 
 0 Not at all 
 1 Mildly 
2 Moderately 
3 Severely 
4 Unable to walk 
 
3. Do you feel that your feet get glued to the floor while walking, making a turn or when trying to initiate 
walking (freezing)? 
 0 Never 
 1 Very rarely—about once a month 
 2 Rarely—about once a week 
 3 Often—about once a day 
 4 Always—whenever walking 
 
4. How long is your longest freezing episode? 
 0 Never happened 
 1 1 – 2 s 
 2 3 – 10 s 
 3 11 – 30 s 
 4 Unable to walk for more than 30 s 
 
5. How long is your typical start hesitation episode (freezing when initiating the first step)? 
 0 None  
 1 Takes longer than 1 s to start walking 
 2 Takes longer than 3 s to start walking 
 3 Takes longer than 10 s to start walking 





6. How long is you typical turning hesitation (freezing when turning)? 
 0 None 
 1 Resume turning in 1 – 2 s 
 2 Resume turning in 3 – 10 s 
 3 Resume turning in 11 – 30 s 
 4 Unable to resume turning for more than 30 s 
 
Adopted from: Giladi, N., Shabtai, H., Simon, E. S., Biran, S., Tal, J., & Korczyn, A. D. (2000). 
Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat 




APPENDIX C--- AVERAGE STEP NUMBER AND AVERAGE RAS BEATS 
Average step number from participants in the C (Cue) group and the average number of rhythmic 















C1 11.31 13 15.52 16 16.32 18 
C2 9.02 11 13.36 13 13.436 15 
C3 6.11 8 9.35 10 12.51 13 
C4 5.33 6 7.28 8 10.35 10 
C5 6.15 7 8.38 9 12.01 12 
C6 6.07 8 10.31 11 11.42 12 
C7 4.37 5 6.13 7 8.13 9 
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